US20020148476A1 - Method of ligating hollow anatomical structures - Google Patents
Method of ligating hollow anatomical structures Download PDFInfo
- Publication number
- US20020148476A1 US20020148476A1 US10/164,928 US16492802A US2002148476A1 US 20020148476 A1 US20020148476 A1 US 20020148476A1 US 16492802 A US16492802 A US 16492802A US 2002148476 A1 US2002148476 A1 US 2002148476A1
- Authority
- US
- United States
- Prior art keywords
- primary
- catheter
- leads
- primary leads
- lead
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00488—Esophagus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00589—Coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00898—Alarms or notifications created in response to an abnormal condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/124—Generators therefor switching the output to different electrodes, e.g. sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/126—Generators therefor characterised by the output polarity bipolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
- A61B2090/3782—Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
Definitions
- the invention relates generally to a method for applying energy to shrink a hollow anatomical structure, such as a fallopian tube or a vein, including, but not limited to, superficial and perforator veins, hemorrhoids, and esophageal varices, and more particularly, to a method using an electrode device having multiple leads for applying radio frequency (RF) energy, microwave energy, or thermal energy.
- RF radio frequency
- the human venous system of the lower limbs consists essentially of the superficial venous system and the deep venous system with perforating veins connecting the two systems.
- the superficial system includes the long or great saphenous vein and the short saphenous vein.
- the deep venous system includes the anterior and posterior tibial veins which unite to form the popliteal vein, which in turn becomes the femoral vein when joined by the short saphenous vein.
- the venous system contains numerous one-way valves for directing blood flow back to the heart.
- Venous valves are usually bicuspid valves, with each cusp forming a sack or reservoir for blood which, under retrograde blood pressure, forces the free surfaces of the cusps together to prevent retrograde flow of the blood and allows only antegrade blood flow to the heart.
- an incompetent valve is in the flow path, the valve is unable to close because the cusps do not form a proper seal and retrograde flow of the blood cannot be stopped.
- a venous valve fails, increased strain and pressure occur within the lower venous sections and overlying tissues, sometimes leading to additional valvular failure.
- Two venous conditions which often result from valve failure are varicose veins and more symptomatic chronic venous insufficiency.
- the varicose vein condition includes dilation and tortuosity of the superficial veins of the lower limbs, resulting in unsightly discoloration, pain, swelling, and possibly ulceration.
- Varicose veins often involve incompetence of one or more venous valves, which allow reflux of blood within the superficial system. This can also worsen deep venous reflux and perforator reflux.
- Current treatments of vein insufficiency include surgical procedures such as vein stripping, ligation, and occasionally, vein-segment transplant.
- Chronic venous insufficiency involves an aggravated condition of varicose veins which may be caused by degenerative weakness in the vein valve segment, or by hydrodynamic forces acting on the tissues of the body, such as the legs, ankles, and feet.
- the hydrostatic pressure increases on the next venous valves down, causing those veins to dilate.
- more venous valves will eventually fail.
- the effective height of the column of blood above the feet and ankles grows, and the weight and hydrostatic pressure exerted on the tissues of the ankle and foot increases.
- ulcerations of the ankle begin to form, which start deep and eventually come to the surface. These ulcerations do not heal easily because of poor venous circulation due to valvular incompetence in the deep venous system and other vein systems.
- Other related venous conditions include dilated hemorrhoids and esophageal varices. Pressure and dilation of the hemorrhoid venous plexus may cause internal hemorrhoids to dilate and/or prolapse and be forced through the anal opening. If a hemorrhoid remains prolapsed, considerable discomfort, including itching and bleeding, may result. The venous return from these prolapsed hemorrhoids becomes obstructed by the anal sphincters, which gives rise to a strangulated hemorrhoid. Thromboses result where the blood within the prolapsed vein becomes clotted. This extremely painful.
- Varicose veins called esophageal varices can form in the venous system with submucosa of the lower esophagus, and bleeding can occur from the dilated veins. Bleeding or hemorrhaging may result from esophageal varices, which can be difficult to stop and, if untreated, could develop into a life threatening condition. Such varices erode easily, and lead to a massive gastrointestinal hemorrhage.
- Ligation of a fallopian tube (tubal ligation) for sterilization or other purposes is typically performed by laparoscopy. A doctor severs the fallopian tube or tubes and ties the ends. External cauterization or clamps may also be used. General or regional anesthetic must be used. All of the above are performed from outside the fallopian tube.
- Hemorrhoids and esophageal varices may be alleviated by intra-luminal ligation.
- ligation or “intra-luminal ligation” comprises the occlusion, collapse, or closure of a lumen or hollow anatomical structure by the application of electrical energy from within the lumen or structure.
- ligation or “intra-luminal ligation” includes electro-ligation. In the case of fallopian tube ligation, it would be desirable to perform the ligation from within the fallopian tube itself (intra-fallopian tube) to avoid the trauma associated with external methods.
- Ligation involves the cauterization or coagulation of a lumen using energy, such as that applied through an electrode device.
- An electrode device is introduced into the lumen and positioned so that it contacts the lumen wall. Once properly positioned, RF energy is applied to the wall by the electrode device thereby causing the lumen to shrink in cross-sectional diameter.
- a reduction in cross-sectional diameter of the vein for example from 5 mm (0.2 in) to 1 mm (0.04 in), significantly reduces the flow of blood through a lumen and results in an effective occlusion.
- the vein wall may completely collapse thereby resulting in a full-lumen obstruction that blocks the flow of blood through the vein.
- a fallopian tube may collapse sufficient to effect a sterilization of the patient.
- One apparatus for performing ligation includes a tubular shaft having an electrode device attached at the distal tip.
- the leads terminate at an electrical connector, while at the distal end of the shaft the leads are connected to the electrode device.
- the electrical connector provides the interface between the leads and a power source, typically an RF generator.
- the RF generator operates under the guidance of a control device, usually a microprocessor.
- the ligation apparatus may be operated in either a monopolar or bipolar configuration.
- the electrode device consists of an electrode that is either positively or negatively charged.
- a return path for the current passing through the electrode is provided externally from the body, as for example by placing the patient in physical contact with a large low-impedance pad. The current flows from the ligation device through the patient to the low impedance pad.
- the electrode device In a bipolar configuration, the electrode device consists of a pair of oppositely charged electrodes of approximately equal size, separated from each other, such as by a dielectric material or by a spatial relationship. Accordingly, in the bipolar mode, the return path for current is provided by an electrode or electrodes of the electrode device itself. The current flows from one electrode, through the tissue, and returns by way of the oppositely charged electrode.
- a temperature sensing device is attached to the electrode device.
- the temperature sensing device may be a thermocouple that monitors the temperature of the venous tissue.
- the thermocouple interfaces with the RF generator and the controller through the shaft and provides electrical signals to the controller which monitors the temperature and adjusts the energy applied to the tissue through the electrode device accordingly.
- a fixed-size electrode device typically contacts the vein wall at only one point on the circumference or inner diameter of the vein wall.
- the application of RF energy is highly concentrated within the contacting venous tissue, while the flow of RF current through the remainder of the venous tissue is disproportionately weak.
- the regions of the vein wall near the point of contact collapse at a faster rate then other regions of the vein wall, resulting in non-uniform shrinkage of the vein lumen which can result in inadequacy of the overall strength of the occlusion and the lumen may eventually reopen.
- RF energy must be applied for an extended period of time so that the current flows through the tissue generating thermal energy including through the tissue not in contact with the electrode to cause that tissue to shrink sufficiently also.
- Extended applications of energy have a greater possibility of increasing the temperature of the blood to an unacceptable level and may result in a significant amount of heat-induced coagulum forming on the electrode and in the vein which is not desirable. This can be prevented by exsanguination of the vein prior to the treatment, and through the use of temperature regulated power delivery.
- the effectiveness of a ligating apparatus having a fixed-size electrode device is limited to certain sized veins.
- An attempt to ligate a vein having a diameter that is substantially greater than the electrode device can result in not only non-uniform heating of the vein wall as just described, but also insufficient shrinkage of the vein diameter.
- the greater the diameter of the vein relative to the diameter of the electrode device the weaker the energy applied to the vein wall at points distant from the point of electrode contact. Accordingly the vein wall is likely to not completely collapse prior to the venous tissue becoming over cauterized at the point of electrode contact. While coagulation as such may initially occlude the vein, such occlusion may only be temporary in that the coagulated blood may eventually dissolve recanalizing the vein.
- the present invention provides a method for applying energy along a generally circumferential band of the wall of a hollow anatomical structure, such as a fallopian tube, a hemorrhoid, or an esophageal varix.
- a hollow anatomical structure such as a fallopian tube, a hemorrhoid, or an esophageal varix.
- the application of energy in accordance with this method results in a more uniform and predictable shrinkage of the vein wall.
- the invention comprises a method of applying energy to a hollow anatomical structure from within the structure.
- the method includes the step of introducing a catheter into the anatomical structure; the catheter having a working end and a plurality of leads, each lead having a distal end, and each lead being connected to a power source.
- the method also includes the step of expanding the leads outwardly through the distal orifice and expanding the leads until each electrode contacts the anatomical structure.
- the method further includes the step of applying energy to the anatomical structure from the distal end of the leads, until the anatomical structure collapses to an effective occlusion.
- the invention is directed to a method of applying energy intraluminally to a fallopian tube from a power source, comprising the steps of introducing into the fallopian tube, hemorrhoid, or esophageal varix a catheter having a working end with a plurality of primary leads disposed at the working end, each primary lead having a distal end and being connected to the power source, expanding the primary leads outwardly from the working end of the catheter, wherein the distal ends of the primary leads move away from each other and into contact with the wall of the fallopian tube, hemorrhoid, or esophageal varix, and applying energy to the fallopian tube, hemorrhoid, or esophageal varix from the distal end of the primary leads to collapse the fallopian tube, hemorrhoid, or esophageal varix to effectively occlude the fallopian tube, hemorrhoid, or esophageal varix
- the step of expanding the primary leads comprises the step of expanding the primary leads such that the distal ends of the primary leads are spaced no more than five millimeters apart along the fallopian tube, hemorrhoid, or esophageal varix.
- the method further comprises the step of extending the primary leads through an orifice formed in the working end of the catheter and expanding the primary leads, wherein the distance between two mutually opposed expanded distal ends is greater than the diameter of the working end.
- the method comprises the step of moving an outer sleeve away from the primary leads such that the primary leads extend past an orifice of the outer sleeve at the working end of the catheter and expand outwardly.
- the method further comprising the steps of maintaining separation between the primary leads at a selected location with an alignment device positioned inside an outer sheath of the catheter, and moving the outer sheath in relation to the alignment device to extend the primary leads out the orifice. Furthermore, the method further comprises the steps of attaching the primary leads to an inner sheath, maintaining separation between the primary leads at a selected location with an alignment device positioned inside an outer sheath of the catheter, and moving the outer sheath in relation to the inner sheath to extend the primary leads through the orifice.
- the step of introducing a catheter having a plurality of primary leads into the fallopian tube, hemorrhoid, or esophageal varix comprises the step of introducing a plurality of primary leads that are mounted to the working end in a cantilever arrangement.
- the method further comprises the step of moving an outer sleeve away from the cantilevered primary leads such that the primary leads extend past an orifice of the outer sleeve at the working end of the catheter and expand outwardly.
- the method further comprises the step of moving the catheter in the fallopian tube, hemorrhoid, or esophageal varix while continuing to apply energy to the fallopian tube, hemorrhoid, or esophageal varix.
- the method further comprises the step of mounting a secondary lead to the working end, the secondary lead having a distal end and having a length exceeding that of the primary leads, wherein the step of extending the plurality of primary leads further includes the step of extending the secondary lead through the distal orifice.
- the step of applying energy to the fallopian tube, hemorrhoid, or esophageal varix comprises the steps of controlling the power source so that adjacent primary leads are of opposite polarity while maintaining the secondary lead so that it is electrically neutral, switching the polarity of the primary leads so that they are all of the same polarity upon collapse of the fallopian tube, hemorrhoid, or esophageal varix around the primary leads, and controlling the power source so that the secondary lead is of opposite polarity relative to the primary leads upon performing the step of switching the polarity of the primary leads so that they are of the same polarity.
- a bend is formed in each primary lead, the bend formed in the direction away from the other primary leads such that each primary lead tends to move outward away from the other primary leads in the step of expanding the primary leads away from each other.
- the steps of sensing the temperature at the distal end of a primary lead and controlling the application of power to the primary leads in response to the temperature sensed at the distal end may also be included.
- the method includes the step of compressing the hollow anatomical structure, such as a vein or fallopian tube, to reduce the anatomical structure to a desired size, and for exsanguination, before and/or during the application of energy to occlude or ligate the structure.
- the hollow anatomical structure such as a vein or fallopian tube
- the method includes the step of flushing the hollow anatomical structure with fluid before the step of applying energy.
- FIG. 1 is a diagram of an energy application system with a partial cutaway view of a catheter showing both the working end which includes a plurality of outwardly expandable electrodes for applying energy to tissue and the connecting end which is connected to a power source controlled by a microprocessor controller for controlling the energy applied to the electrodes of the working end;
- FIG. 2 is a cross-sectional view of the working end of a first embodiment of a catheter in accordance with aspects of the invention depicting the electrodes in a fully expanded position;
- FIG. 2 a is an end view of the working end of the first embodiment of the catheter taken along line 2 a - 2 a of FIG. 2;
- FIG. 3 is a cross-sectional view of the working end of the first embodiment depicting the electrodes in a fully retracted position
- FIG. 4 is a cross-sectional view of the working end of a second catheter in accordance with principles of the invention depicting the electrodes in a fully expanded position;
- FIG. 4 a is an end view of the second embodiment of the invention taken along line 4 a - 4 a of FIG. 4;
- FIG. 5 is a cross-sectional view of the working end of the second embodiment of the catheter of FIG. 4 depicting the electrodes in a fully retracted position;
- FIG. 6 is a cross-sectional view of an anatomical structure containing the catheter of FIG. 2 with the electrodes in apposition with the anatomical structure;
- FIG. 6 a is an end view of the anatomical structure containing the catheter taken along line 6 a - 6 a of FIG. 6;
- FIGS. 7 a through 7 c are cross-sectional views of the anatomical structure containing a catheter in accordance with the first embodiment of the invention and depicting the anatomical structure at various stages of ligation;
- FIG. 8 is a cross-sectional view of an anatomical structure containing a catheter in accordance with the second embodiment of the invention as depicted in FIG. 4;
- FIG. 8 a is an end view of the anatomical structure containing the catheter taken along line 8 a - 8 a of FIG. 8;
- FIGS. 9 a and 9 b are cross-sectional views of the anatomical structure containing the catheter in accordance with the second embodiment of the invention and depicting the anatomical structure at various stages of ligation;
- FIG. 10 is a cross-sectional view of the working end of a third embodiment of a catheter in accordance with the invention depicting the electrodes in a fully retracted position;
- FIG. 10 a is an end view of the working end of the third embodiment of the catheter taken along line 10 a - 10 a of FIG. 10;
- FIG. 11 is a cross-sectional view of the working end of the third embodiment depicting the electrodes in a fully expanded position
- FIG. 12 is a cross-sectional view of an anatomical structure containing the catheter of FIG. 10 with the electrodes in apposition with the anatomical structure;
- FIG. 13 is a cross-sectional view of the anatomical structure containing the catheter of FIG. 10 where the anatomical structure is being ligated by the application of energy from the electrodes;
- FIG. 14 is a cross-sectional view of an anatomical structure containing the catheter of FIG. 10 with the electrodes in apposition with the anatomical structure where external compression is being applied to reduce the diameter of the hollow structure before the application of energy from the electrodes to ligate the structure;
- FIG. 15 is a side view of another embodiment of an electrode catheter having a balloon and a coaxial fluid channel
- FIG. 16 is a view of the balloon and catheter of FIG. 15 showing the balloon inflation ports formed in an inflation sheath of the catheter, also showing the inflation lumen that communicates with the inflation ports;
- FIG. 17 is a cross-sectional view of an anatomical structure containing another embodiment of the catheter having a balloon located proximal to bowable arms with electrodes, the portion of the catheter distal to the balloon having perfusion holes;
- FIG. 18 is a side view of another embodiment of an electrode catheter having a covering spanning the splayed leads of the electrodes extended out the catheter;
- FIG. 19 is a side view of another embodiment of an electrode catheter having a balloon and a coaxial fluid channel located proximal to expandable leads, the balloon having openings for receiving blood to maintain deployment of the balloon;
- FIG. 20 is a side view of another embodiment of an electrode catheter having a balloon and a coaxial fluid channel located proximal to expandable leads, the balloon having openings for receiving blood to maintain deployment of the balloon;
- FIG. 21 is a partial cross-sectional side view of another embodiment of an electrode catheter having an expandable section which is covered by a membrane;
- FIG. 22 is a partial cross-sectional side view of the embodiment of an electrode catheter of FIG. 21 in an expanded condition
- FIG. 23 is a view of a catheter used in a method in accordance with the invention to treat a hemorrhoid
- FIG. 24 is a view of a catheter used in a method in accordance with the invention to treat an esophageal varix.
- FIG. 25 is a view of a catheter used in a method in accordance with the invention for fallopian tube ligation.
- FIG. 1 shown in FIG. 1 is a catheter 10 for applying energy to an anatomical structure such as a vein.
- the catheter 10 includes an outer sheath 12 having a distal orifice 14 at its working end 15 .
- the connector end 17 of the outer sheath 12 is attached to a handle 16 that includes an electrical connector 18 for interfacing with a power source 22 , typically an RF generator, and a microprocessor controller 23 .
- the power source 22 and microprocessor 23 are usually contained in one unit.
- the controller 23 controls the power source 22 in response to external commands and data from a sensor, such as a thermocouple, located at an intraluminal venous treatment site.
- the user can select a constant power output so that automated temperature control is not present and the user can manually adjust the power output in view of the temperature on a display readout.
- the catheter 10 includes an expandable electrode device 24 (partially shown) that moves in and out of the outer sheath 12 by way of the distal orifice 14 .
- the electrode device includes a plurality of electrodes which can be expanded by moving the electrodes within the shaft, or by moving the outer shaft relative to the electrodes.
- FIG. 1 illustrates a plurality of electrodes surrounding a single central electrode, different electrode configurations will be described for the catheter.
- a fluid port 21 communicates with the interior of the outer sheath 12 .
- the catheter 10 can be periodically flushed out with saline through the port 21 .
- the flushing fluid can travel between the outer sheath and the inner sheath.
- the port also allows for the delivery of drug therapies. Flushing out the catheter prevents the buildup of biological fluid, such as blood, within the catheter 10 .
- the treatment area of the hollow anatomical structure such as a vein can be flushed with a fluid such as saline, or a dielectric fluid, in order to evacuate blood from the treatment area of the vein so as to prevent the formation of coagulum or thrombosis.
- the use of a dielectric fluid can minimize unintended heating effects away from the treatment area.
- the dielectric fluid prevents the current of RF energy from flowing away from the vein wall.
- the catheter 10 includes a lumen which begins at the distal tip of the outer sheath 12 and runs substantially along the axis of the outer sheath 12 before terminating at the guide-wire port 20 of the handle 16 .
- a guide wire can be introduced through the lumen of the catheter 10 for use in guiding the catheter to the desired treatment site.
- the catheter is sized to treat smaller veins, the outer diameter of the catheter may not allow for a fluid flush between the outer sheath 12 and the inner sheath 28 . However, a fluid flush can be introduced through the lumen for the guide wire in such an embodiment.
- the outer sheath 12 includes a shell 44 and a tip portion 46 .
- the tip 46 is preferably tapered inward at its distal end or is “nosecone” shaped.
- the tip 46 can have other shapes that facilitate tracking of the catheter 10 over a guide wire and through the bends in the venous vascular system.
- the nosecone-shaped tip 46 can, for example, be fabricated from a polymer having a soft durometer, such as 70 Shore A.
- the shell 44 comprises a biocompatible material having a low coefficient of friction.
- the outer sheath 12 is sized to fit within a venous lumen and for example may be between 5 and 9 French, which corresponds to a diameter of between 1.7 mm (0.07 in) and 3.0 mm (1.2 in), or other sizes as appropriate.
- the electrode device 24 contains a number of leads, including insulated primary leads 30 and, in some embodiments, a secondary lead 31 .
- the leads are connected to the power source 22 (FIG. 1) such that the polarity of the leads may be switched as desired.
- a microprocessor controller can be used to switch the polarity, as well as control other characteristics of the power for the electrode device.
- the electrode device can operate in either a bipolar or a monopolar configuration. When adjacent primary leads 30 have opposite polarity the electrode device 24 operates as a bipolar electrode device. When the primary leads 30 are commonly charged the electrode device 24 can operate as a monopolar electrode device.
- the electrode device 24 When the primary leads 30 are commonly charged, and a secondary lead 31 has an opposite polarity, the electrode device 24 operates as a bipolar electrode device.
- the invention is not limited to four primary leads 30 ; more or fewer leads may be used in either embodiment.
- the number of leads can be dependent on the size or diameter of the hollow anatomical structure to be treated.
- the apposed electrodes should be kept within a certain distance of one another. Larger vessels may require more primary leads to ensure proper current density and proper heat distribution.
- each electrode 34 has a hemispherical shape.
- the electrode can have either a generally spherical shape or a spoon shape.
- the electrodes have a spoon shape which can be combined to form a sphere or other shape so as to minimize its profile when the vein collapses.
- the electrodes 34 are either integrally formed at the distal end 32 , soldered, or otherwise formed to the distal end of each primary lead 30 .
- the distal end 32 when the distal end 32 is referred to as acting as an electrode, this is not limited to where the electrode 34 is integrally formed at the distal end 32 .
- the distal end can apply energy to the surrounding tissue where there is an electrode integrally formed at the distal end, or where an electrode is separately soldered to the distal end, or where there is another energy delivery device located at the distal end.
- the electrode 34 typically has a diameter greater than the diameter of the primary lead 30 .
- the primary lead 30 may have a diameter ranging from 0.18 mm (0.007 in.) to 0.28 mm (0.011 in.), while the electrode 34 has a diameter of 0.36 mm (0.014 in.) to 0.51 mm (0.020 in.).
- the primary leads 30 and the electrodes 34 are preferably made from a biologically-compatible material such as stainless steel.
- the insulation surrounding the primary leads 30 generally has a thickness of between 0.03 mm (0.001 in.) and 0.06 mm (0.0025 in.), resulting in a combined lead-insulation diameter of between 0.23 mm (0.009 in.) and 0.41 mm (0.016 in.).
- each primary lead 30 is strip-shaped with a width from 0.76 mm (0.03 in.) to 1.0 mm (0.04 in) and a thickness of approximately 0.13 mm (0.005 in.), while the secondary lead 31 is typically tubular-shaped.
- a hemispherical electrode 34 is shaped at the distal end, as for example, by sanding down a sixteenth-inch (1.6 mm) diameter sphere which is soldered to the distal end 32 of the primary lead 30 .
- the electrodes can also be constructed by stamping the desired shape or configuration from the conductive lead.
- the electrode is integral with the lead, and the remainder of the lead is insulated.
- the distal end 33 of the secondary lead 31 preferably includes a generally spherically-shaped electrode 35 .
- An alignment device 36 arranges the leads 30 , 31 such that they are mounted to the catheter at only their proximal ends and so that separation is maintained between the leads within, and distal to the alignment device.
- the leads can form cantilevers when mounted on the alignment device.
- a preferred configuration of the alignment device 36 includes a plurality of off-center, axially-aligned lumina 38 which are substantially symmetrically positioned relative to the axis of the alignment device 36 .
- the alignment device 36 is formed, for example, by extruding the plurality of axially-aligned lumina 38 through a solid cylinder composed of a dielectric material, such as polyamide.
- Each lead 30 passes through an individual off-center lumen 38 and exits out the rear of the alignment device 36 .
- the alignment device 36 may further include a central lumen 48 that may be aligned with the axis.
- the central lumen 48 is used for accepting a guide wire or for the delivery or perfusion of medicant and cooling solution to the treatment area during application of RF energy.
- the central lumen 48 may be used for the secondary lead 31 .
- the alignment device 36 may also further include an auxiliary lumen 47 for additional leads, such as the leads of a thermocouple used as a temperature sensor.
- the alignment device 36 comprises a dielectric material to prevent or minimize any coupling effect the leads 30 , 31 may have with each other and, if present, the guide wire.
- the length of the alignment device is, for example, 12.5 mm (0.5 in.) to 19.0 mm (0.75 in.) in one embodiment. However, these dimensions are provided for purposes of illustration and not by way of limitation.
- the inner sheath 28 is attached to the alignment device 36 and extends beyond the rear 37 of the alignment device.
- the inner sheath 28 completely surrounds the exterior wall of the alignment device 36 and is mounted to it by adhesive or press fit or in other manner such that it remains in a fixed position relative to the inner sheath.
- the inner sheath and alignment device can act as an inner member relative to the outer sheath.
- the inner sheath 28 comprises a biocompatible material with a low coefficient of friction.
- the inner sheath 28 provides a pathway for the interconnection between the leads 30 , 31 and the electrical connector 18 (FIG. 1). This interconnection may occur in any of several ways.
- the leads 30 , 31 themselves may be continuous and run the entire length of the inner sheath 28 .
- the positively charged leads 30 , 31 may couple with a common positively charged conductor housed in the inner sheath 28 .
- the negatively charged leads 30 , 31 may couple with a common negative conductor.
- the leads 30 , 31 are connected to a conductor that allows for the polarity of the leads to be switched.
- the conductor may comprise, for example, a 36 gauge copper lead with a polyurethane coating.
- the coupling may occur at any point within the inner sheath 28 . To reduce the amount of wire contained in the catheter, it is advantageous to couple the leads 30 , 31 at the point where the leads exit the rear 37 of the alignment device 36 .
- bonding material 40 surround the leads 30 , 31 at the front end of the alignment device 36 .
- the leads 30 , 31 exit through the distal orifice 14 as the outer sheath 12 is retracted backwards over the alignment device 36 .
- the inwardly tapered tip 46 impedes the retracting movement of the outer sheath 12 to prevent the exposure of the alignment device 36 .
- FIG. 3 shows the leads 30 and 31 in the retracted position where all leads are within the nosecone-shaped tip portion 46 and the outer shell 44 .
- the alignment device 36 has been moved relative to the outer shell 44 .
- the soft nosecone provides an atraumatic tip for when the catheter is maneuvered through the tortuous venous system.
- the electrode at the distal end of the secondary lead 31 can be sized to approximately the same size as the opening formed in the nosecone 46 .
- the nosecone forms a closed atraumatic tip together with the electrode of the secondary lead when the alignment device is retracted into the outer sheath of the catheter. This can present an atraumatic tip even where the nosecone is not constructed from a material having a soft durometer.
- the alignment device 36 is attached to the outer sheath 12 and thereby remains immobile in relation to it.
- the inner sheath 28 is movably positioned at the rear of the alignment device 36 and again provides a pathway for the interconnection between the primary leads 30 and the electrical connector 18 (FIG. 1).
- the inner sheath 28 contains a guide-wire tube 49 that runs the entire length of the inner sheath.
- the guide-wire tube 49 is aligned to communicate with the central lumen 48 of the alignment device 36 at one end and with the guide-wire port 20 (FIG. 1) at the other end.
- the primary leads 30 may be continuous and run the entire length of the inner sheath 28 or they may be coupled to common leads as previously described.
- the primary leads 30 are secured to the front end 27 of the inner sheath 28 , as for example with a potting material 50 , so that the movement of the inner sheath 28 results in a corresponding movement of the primary leads 30 through the lumina 38 of the alignment device 36 .
- the primary leads 30 are not secured to the alignment device 36 and in essence are free-floating leads in the axial direction.
- the primary leads 30 travel through the alignment device 36 and exit through the distal orifice 14 as the front end of the inner sheath 28 is moved toward the rear 37 of the alignment device 36 .
- the primary leads 30 are formed, e.g., arced or bent, to move away from each other and thereby avoid contact.
- the “distal portion” of the primary leads 30 is the portion of the lead which extends from the front end of the alignment device 36 when the leads are fully extended through the distal orifice 14 . It is preferred that the distal portions 42 are formed to move radially outward from each other relative to the axis of the alignment device 36 and form a symmetrical arrangement. This is shown in both the embodiments of FIG. 2 a and FIG. 4 a .
- the degree of arc or bend in the primary leads 30 may be any that is sufficient to radially expand the leads as they exit the outer sheath 12 through the distal orifice 14 . It is essential that the degree of the arc or bend be sufficient to provide enough force so that the primary leads 30 expand through blood and the electrodes 34 come in apposition with the vein wall.
- the electrodes are preferably partially embedded in the vein wall to assure full contact.
- the rounded portion of the electrode is embedded into the vein wall to achieve full surface apposition so that the entire uninsulated surface area of the electrode is in contact with venous tissue for effective current distribution.
- the surface area of the electrodes in contact with the venous tissue preferably is sufficient to avoid a high current density which may lead to spot heating of the venous tissue.
- the heating effect is preferably distributed along a circumferential band of the vein.
- the apposed electrodes should be spaced no more than 4 or 5 millimeters from one another along the circumference of the vein.
- the electrode arrangement is related to the size or diameter of the vein being treated.
- Other properties of the primary leads 30 such as lead shape and insulation thickness, affect the push force of the lead and the degree of arc or bend must be adjusted to compensate for these factors.
- a wire having a diameter of between 0.18 mm (0.007 in) and 0.28 mm (0.011 in) with a total insulation thickness of between 0.05 mm (0.002 in) to 0.13 mm (0.005 in) is arced or bent at an acute angle to provide sufficient apposition with the anatomical structure. It is to be understood that these dimensions are provided for illustrative purposes, and not by way of limitation.
- the leads may be straight but are mounted in the alignment device at an angle such that they are normally directed outward.
- the primary leads 30 be strip-shaped, that is rectangular in cross section, with dimensions, for example, of a width from 0.76 mm (0.030 in.) to 1.0 mm (0.039 in) and a thickness of approximately 0.13 mm (0.005 in.).
- the rectangular cross section provides increased resistance to bending in the width dimension but allows bending more freely in the thickness dimension.
- This strip-shaped configuration of the primary leads 30 is shown in FIGS. 2, 2 a , and 3 and provides for increased stability in the lateral direction while allowing the necessary bending in the radial direction. In FIGS.
- each primary lead comprises a rectangular cross section mounted in relation to the catheter such that the thinner dimension of the rectangular cross section is aligned with the direction of expansion of the lead.
- the leads are less likely to bend sideways when expanded outward, and a uniform spacing between leads is more assured. Uniform spacing promotes uniform heating around the venous tissue which is in apposition with the electrodes at the distal ends of the leads.
- the length of the distal portion of the leads 30 also affects the configuration of the electrode device 24 .
- the maximum distance between two mutually opposed electrodes 34 i.e., the effective diameter of the electrode device 24 , is affected by the bend degree and length of the distal portion 42 .
- the longer the length of the distal portion 42 the greater the diameter of the electrode device 24 . Accordingly, by changing the distal portion 42 length and arc or bend degree, the catheter 10 can be configured for use in differently sized anatomical structures.
- Different numbers of leads 30 , 31 can be employed with the catheter.
- the number of leads 30 , 31 is limited by the diameter of the alignment device 36 and the number of lumina 36 , 38 , 47 that can be extruded through the alignment device.
- an even number of primary leads 30 are preferably available to form a number of oppositely charged electrode pairs.
- the electrodes in apposition with the anatomical structure should be maintained within a certain distance of each other.
- any number of commonly charged leads 30 can be present.
- distribution of RF energy through the anatomical tissue is obtained by creating a return path for current through the tissue by providing a return device at a point external from the tissue, such as a large metal pad.
- an actuator 25 controls the extension of the electrode device 24 through the distal orifice 14 .
- the actuator 25 may take the form of a switch, lever, threaded control knob, or other suitable mechanism, and is preferably one that can provide fine control over the movement of the outer sheath 12 or the inner sheath 28 , as the case may be.
- the actuator 25 (FIG. 1) interfaces with the outer sheath 12 (FIG. 2, 2 a and 3 ) to move it back and forth relative to the inner sheath 28 .
- the actuator 25 (FIG. 1) interfaces with the inner sheath 28 (FIGS. 4, 4 a and 5 ) to move it back and forth relative to the outer sheath 12 .
- the relative position between the outer sheath and inner sheath is thus controlled, but other control approaches may be used.
- the catheter 10 includes a temperature sensor 26 , such as a thermocouple.
- the temperature sensor 26 is mounted in place on an electrode 34 so that the sensor 26 is nearly or is substantially flush with the exposed surface of the electrode 34 .
- the sensor 26 is shown in the drawings as protruding from the electrodes for clarity of illustration only.
- the sensor 26 senses the temperature of the portion of the anatomical tissue that is in apposition with the exposed electrode surface. Monitoring the temperature of the anatomical tissue provides a good indication of when shrinkage of the tissue is ready to begin.
- a temperature sensor 26 placed on the electrode facing the anatomical tissue provides an indication of when shrinkage occurs (70° C.
- the temperature sensor 26 interfaces with the controller 23 (FIG. 1) through a pair of sensor leads 45 which preferably run through the auxiliary lumen 47 and then through the inner sheath 28 .
- the signals from the temperature sensor 26 are provided to the controller 23 which controls the magnitude of RF energy supplied to the electrodes 34 in accordance with the selected temperature criteria and the monitored temperature.
- Impedance can be used to detect the onset of coagulum formation.
- the catheter in the operation of one embodiment of the catheter 10 , the catheter is inserted into a hollow anatomical structure, such as a vein 52 .
- the catheter is similar to the embodiment discussed in connection with FIGS. 2 and 3.
- the catheter 10 further includes an external sheath 60 through which a fluid can be delivered to the treatment site.
- the fluid port (not shown) communicates with the interior of the external sheath 60 , and fluid is delivered from between the external sheath 60 and the outer sheath 12 .
- the external sheath 60 surrounds the outer sheath 12 to form a coaxial channel through which fluid may be flushed.
- Fluoroscopy, ultrasound, an angioscope imaging technique, or other technique may be used to direct the specific placement of the catheter and confirm the position in the vein.
- the actuator (not shown) is then operated to shift the outer sheath relative to the inner sheath by either retracting the outer sheath 12 backward or advancing the inner sheath 28 forward to expose the leads 30 , 31 through the distal orifice 14 .
- the primary leads 30 expand radially outward relative to the axis of the alignment device 36 , while the secondary lead 31 remains substantially linear.
- the primary leads 30 continue to move outward until apposition with the vein wall 54 occurs and the outward movement of the primary leads 30 is impeded.
- the primary leads 30 contact the vein along a generally circumferential band of the vein wall 54 . This outward movement of the primary leads 30 occurs in a substantially symmetrical fashion. As a result, the primary-lead electrodes 34 are substantially evenly spaced along the circumferential band of the vein wall 54 . The central-lead electrode 35 is suspended within the vein 52 without contacting the vein wall 54 .
- the power supply 22 is activated to provide suitable RF energy.
- suitable frequency is 510 kHz.
- One criterion used in selecting the frequency of the energy to be applied is the control desired over the spread, including the depth, of the thermal effect in the venous tissue. Another criterion is compatibility with filter circuits for eliminating RF noise from thermocouple signals.
- the primary leads 30 are initially charged such that adjacent leads are oppositely charged while the secondary lead is electrically neutral. These multiple pairs of oppositely charged leads 30 form active electrode pairs to produce an RF field between them.
- discrete RF fields are set up along the circumferential band of the vein wall 54 . These discrete fields form a symmetrical RF field pattern along the entire circumferential band of the vein wall 54 , as adjacent electrodes 34 of opposite polarity produce RF fields between each other. A uniform temperature distribution can be achieved along the vein wall being treated.
- the RF energy is converted within the adjacent venous tissue into heat, and this thermal effect causes the venous tissue to shrink, reducing the diameter of the vein.
- a uniform temperature distribution along the vein wall being treated avoids the formation of hot spots in the treatment area while promoting controlled uniform reduction in vein diameter.
- the thermal effect produces structural transfiguration of the collagen fibrils in the vein.
- the collagen fibrils shorten and thicken in cross-section in response to the heat from the thermal effect.
- the energy causes the vein wall 54 to collapse around the primary-lead electrodes 34 .
- the wall 54 continues to collapse until further collapse is impeded by the electrodes 34 .
- the electrodes are pressed farther and farther together by the shrinking vein wall 54 until they touch and at that point, further collapse or ligation of the wall 54 is impeded.
- the polarity of the primary-lead electrodes is switched so that all primary-lead electrodes are commonly charged.
- the switching of polarity for the leads need not be instantaneous.
- the application of RF energy can be ceased, the polarity switched, and then RF energy is applied again at the switched polarity.
- the secondary-lead electrode 35 is then charged so that its polarity is opposite that of the primary-lead electrodes 34 .
- the RF field is set up between the primary-lead electrodes 34 and the secondary-lead electrode 35 .
- the catheter 10 is then pulled back while energy is applied to the electrode device.
- the primary-lead electrodes 34 remain in apposition with the vein wall 54 while the secondary-lead electrode 35 comes in contact with the portion of the vein wall previously collapsed by the primary-lead electrodes 34 .
- RF energy passes through the vein wall 54 between the primary-lead electrodes 34 and the secondary-lead electrode 35 and the vein wall continues to collapse around the secondary-lead electrode 35 as the catheter 10 is being retracted.
- ligation in accordance with this method results in an occlusion along a length of the vein 52 .
- a lengthy occlusion as opposed to an acute occlusion, is stronger and less susceptible to recanalization.
- a similar result is achieved when the catheter 10 having both primary and secondary leads is operated in a monopolar manner.
- the secondary-lead electrode 35 remains neutral, while the primary leads 30 are commonly charged and act in conjunction with an independent electrical device, such as a large low-impedance return pad (not shown) placed in external contact with the body, to form a series of discrete RF fields.
- a large low-impedance return pad (not shown) placed in external contact with the body, to form a series of discrete RF fields.
- These RF fields are substantially evenly spaced around the circumference of the vein and travel along the axial length of the vein wall causing the vein wall to collapse around the primary-lead electrodes.
- the secondary-lead electrode Upon collapse of the vein wall, the secondary-lead electrode is charged to have the same polarity as that of the primary-lead electrodes. The electrode device is retracted and the vein wall collapses as described in the bipolar operation.
- the application of RF energy is substantially symmetrically distributed through the vein wall, regardless of the diameter of the vein 52 .
- This symmetrical distribution of RF energy increases the predictability and uniformity of the shrinkage and the strength of the occlusion.
- the uniform distribution of energy allows for the application of RF energy for a short duration and thereby reduces or avoids the formation of heat-induced coagulum on the electrodes 34 .
- the leads, including the non-convex outer portion of the electrode, are insulated to further prevent heating of the surrounding blood.
- Fluid can be delivered before and during RF heating of the vein being treated through a coaxial channel formed between the external sheath 60 and the outer sheath 12 . It is to be understood that another lumen can be formed in the catheter to deliver fluid to the treatment site. The delivered fluid displaces or exsanguinates blood from the vein so as to avoid heating and coagulation of blood. Fluid can continue to be delivered during RF treatment to prevent blood from circulating back to the treatment site. The delivery of a dielectric fluid increases the surrounding impedance so that RF energy is directed into the tissue of the vein wall.
- FIGS. 8, 8 a , 9 a and 9 b in the operation of an alternate embodiment of the catheter 10 that may be used with a guide wire 53 .
- the catheter 10 is inserted into a hollow anatomical structure, such as a vein 52 .
- the guide wire 53 is advanced past the point where energy application is desired.
- the catheter 10 is then inserted over the guide wire 53 by way of the central lumen 48 and the guide wire tube 49 (FIG. 4) and is advanced over the guide wire through the vein to the desired point.
- the guide wire 53 is typically pulled back or removed before RF energy is applied to the electrode device 24 .
- the actuator 25 (FIG. 1) is then manipulated to either retract the outer sheath 12 backward, or advance the inner sheath 28 forward to expose the leads 30 through the distal orifice 14 .
- the leads 30 exit the distal orifice 14 and expand radially outward relative to the axis of the alignment device 36 .
- the leads 30 continue to move outward until apposition with the vein wall 54 occurs.
- the leads 30 contact the vein along a generally circumferential band of the vein wall 54 . This outward movement of the leads occurs in a substantially symmetrical fashion.
- the electrodes 34 are substantially evenly spaced along the circumferential band of the vein wall 54 .
- the electrodes can be spaced apart in a staggered fashion such that the electrodes do not lie along the same plane.
- adjacent electrodes can extend different lengths from the catheter so that a smaller cross-sectional profile is achieved when the electrodes are collapsed toward one another.
- the power supply 22 is activated to provide suitable RF energy to the electrodes 34 so that the catheter 10 operates in either a bipolar or monopolar manner as previously described.
- the energy causes the vein wall 54 to collapse around the electrodes 34 causing the leads to substantially straighten and the electrodes to cluster around each other.
- the wall 54 continues to collapse until further collapse is impeded by the electrodes 34 (FIG. 9 b ).
- the electrodes can be configured to form a shape with a reduced profile when collapsed together.
- the electrodes can also be configured and insulated to continue applying RF energy after forming a reduced profile shape by the collapse of the vein wall.
- the catheter 10 can be pulled back to ligate the adjacent venous segment. If a temperature sensor 26 is included, the application of energy may cease prior to complete collapse if the temperature of the venous tissue rises above an acceptable level as defined by the controller 23 .
- fluid can be delivered before and during RF heating of the vein being treated.
- the fluid can displace blood from the treatment area in the vein to avoid the coagulation of blood.
- the fluid can be a dielectric medium.
- the fluid can include an anticoagulant such as heparin which can chemically discourage the coagulation of blood at the treatment site.
- the actuator mechanism causes the primary leads to return to the interior of the outer sheath 12 .
- Either the outer sheath or the inner sheath is moved to change the position of the two elements relative to one another.
- the catheter 10 may be moved to another venous section where the ligation process is repeated.
- the catheter 10 is removed from the vasculature. The access point of the vein is then sutured closed, or local pressure is applied until bleeding is controlled.
- FIG. 10 Another embodiment of the catheter is illustrated in FIG. 10.
- the inner member or sheath 28 is contained within the outer sheath 12 .
- the inner sheath is preferably constructed from a flexible polymer such as polyimide, polyethylene, or nylon, and can travel the entire length of the catheter. The majority of the catheter should be flexible so as to navigate the tortuous paths of the venous system.
- a hypotube having a flared distal end 39 and a circular cross-sectional shape is attached over the distal end of the inner sheath 28 .
- the hypotube is preferably no more than about two to three centimeters in length.
- the hypotube acts as part of the conductive secondary lead 31 .
- An uninsulated conductive electrode sphere 35 is slipped over the hypotube.
- the flared distal end of the hypotube prevents the electrode sphere from moving beyond the distal end of the hypotube.
- the sphere is permanently affixed to the hypotube, such as by soldering the sphere both front and back on the hypotube.
- the majority or the entire surface of the spherical electrode 35 remains uninsulated.
- the remainder of the hypotube is preferably insulated so that the sphere-shaped distal end can act as the electrode.
- the hypotube can be covered with an insulating material such as a coating of parylene.
- the interior lumen of the hypotube is lined by the inner sheath 28 which is attached to the flaired distal end of the hypotube by adhesive such as epoxy.
- a plurality of primary leads 30 Surrounding the secondary lead 31 and sphere-shaped electrode 35 are a plurality of primary leads 30 which preferably have a flat rectangular strip shape and can act as arms. As illustrated in FIG. 11, the plurality of primary leads are preferably connected to common conductive rings 62 . This configuration maintains the position of the plurality of primary leads, while reducing the number of internal electrical connections.
- the rings 62 are attached to the inner sheath 28 . The position of the rings and the primary leads relative to the outer sheath follows that of the inner sheath. As earlier described, the hypotube of the secondary lead 31 is also attached to the inner sheath 28 . Two separate conductive rings can be used so that the polarity of different primary leads can be controlled separately.
- adjacent primary leads can be connected to one of the two separate conductive rings so that the adjacent leads can be switched to have either opposite polarities or the same polarity.
- the rings are preferable spaced closely together, but remain electrically isolated from one another along the inner sheath. Both the rings and the hypotube are coupled with the inner sheath, and the primary leads 30 that are connected to the rings move together with and secondary lead while remaining electrically isolated from one another. Epoxy or another suitable adhesive can be used to attach the rings to the inner sheath.
- the primary leads from the respective rings each alternate with each other along the circumference of the inner sheath. The insulation along the underside of the leads prevents an electrical short between the rings.
- the ring and primary leads are attached together to act as cantilevers where the ring forms the base and the rectangular primary leads operate as the cantilever arms.
- the leads 30 are connected to the ring and are formed to have an arc or bend such that the leads act as arms which tend to spring outwardly away from the catheter and toward the surrounding venous tissue. Insulation along the underside of the leads and the rings prevents unintended electrical coupling between the leads and the opposing rings.
- the leads are formed straight and connected to the ring at an angle, such that the leads tend to expand or spring radially outward from the ring. The angle at which the leads are attached to the ring should be sufficient to force the primary distal ends and electrodes 34 through blood and into apposition with the vein wall.
- the rectangular cross section of the leads 30 can provide increased stability in the lateral direction while allowing the necessary bending in the radial direction.
- the leads 30 are less likely to bend sideways when expanded outward, and a uniform spacing between leads is more assured. Uniform spacing between the leads 30 and the distal ends promotes uniform heating around the vein by the electrodes 34 .
- the distal ends of the primary leads 30 are uninsulated to act as electrodes 34 having a spoon or hemispherical shape.
- the leads can be stamped to produce an integral shaped electrode at the distal end of the lead.
- the uninsulated outer portion of the distal end electrode 34 which is to come into apposition with the wall of the anatomical structure is preferably rounded and convex.
- the flattened or non-convex inner portion of the distal end is insulated to minimize any unintended thermal effect, such as on the surrounding blood in a vein.
- the distal end electrodes 34 are configured such that when the distal ends are forced toward the inner sheath 12 , as shown in FIG. 10 a , the distal ends combine to form a substantially spherical shape with a profile smaller than the profile for the spherical electrode 35 at the secondary distal end.
- the outer sheath 12 can slide over and surround the primary and secondary leads 30 , 31 .
- the outer sheath 12 includes an orifice which is dimensioned to have approximately the same size as the spherical electrode 35 at the secondary distal end which functions as an electrode. A close or snug fit between the electrode 35 at the secondary distal end and the orifice of the outer sheath 12 is achieved. This configuration provides an atraumatic tip for the catheter.
- the electrode 35 secondary distal end is preferably slightly larger than the orifice.
- the inner diameter of the outer sheath 12 is approximately the same as the reduced profile of the combined primary distal end electrodes 34 .
- the diameter of the reduced profile of the combined primary distal end electrodes 34 is preferably less than the inner diameter of the outer sheath.
- a fluid port (not shown) can communicate with the interior of the outer sheath 12 so that fluid can be flushed between the outer sheath 12 and the inner sheath 28 .
- a fluid port can communicate with a central lumen 48 in the hypotube which can also accept a guide wire.
- the catheter 10 can be periodically flushed with saline which can prevent the buildup of biological fluid, such as blood, within the catheter 10 .
- a guide wire can be introduced through the lumen 48 for use in guiding the catheter to the desired treatment site.
- a fluid can be flushed or delivered though the lumen as well. If a central lumen is not desired, the lumen of the hypotube can be filled with solder.
- the primary leads 30 and the connecting rings are connected to a power source 22 such that the polarity of the leads may be switched as desired.
- the electrode device 24 to operate in either a bipolar or a monopolar configuration.
- a bipolar electrode operation is available.
- a monopolar electrode operation is available in combination with a large return electrode pad placed in contact with the patient.
- a secondary lead 31 has an opposite polarity
- a bipolar electrode operation is available. More or fewer leads may be used. The number of leads can be dependent on the size or diameter of the hollow anatomical structure to be treated.
- the catheter 10 can include a temperature sensor, such as a thermocouple, mounted in place on the distal end or electrode 34 so that the sensor is substantially flush with the exposed surface of the electrode 34 .
- the sensor senses the temperature of the portion of the anatomical tissue that is in apposition with the exposed electrode surface.
- Application of the RF energy from the electrodes 34 is halted or reduced when the monitored temperature reaches or exceeds the specific temperature that was selected by the operator, such as the temperature at which anatomical tissue begins to cauterize.
- the catheter in the operation of one embodiment of the catheter 10 , the catheter is inserted into a hollow anatomical structure, such as a vein. Fluoroscopy, ultrasound, an angioscope imaging technique, or another technique may be used to direct and confirm the specific placement of the catheter in the vein.
- the actuator is then operated to retract the outer sheath 12 to expose the leads 30 , 31 . As the outer sheath no longer restrains the leads, the primary leads 30 move outward relative to the axis defined by the outer sheath, while the secondary lead 31 remains substantially linear along the axis defined by the outer sheath.
- the primary leads 30 continue to move outward until the distal end electrode 34 of the primary leads are placed in apposition with the vein wall 54 occurs and the outward movement of the primary leads 30 is impeded.
- the primary leads 30 contact the vein along a generally circumferential area of the vein wall 54 . This outward movement of the primary leads 30 occurs in a substantially symmetrical fashion so that the primary distal end electrodes 34 are substantially evenly spaced.
- the central-lead electrode 35 is suspended within the vein without contacting the vein wall 54 .
- the power supply 22 is activated to provide suitable RF energy.
- the primary leads 30 are initially charged such that adjacent leads are oppositely charged while the secondary lead is electrically neutral.
- These multiple pairs of oppositely charged leads 30 form active electrode pairs to produce an RF field between them, and form a symmetrical RF field pattern along a circumferential band of the vein wall to achieve a uniform temperature distribution along the vein wall being treated.
- the RF energy produces a thermal effect which causes the venous tissue to shrink, reducing the diameter of the vein.
- the energy causes the vein wall 54 to collapse until further collapse is impeded by the electrodes 34 .
- the electrodes are pressed closer together by the shrinking vein wall.
- the electrodes 34 are pressed together to assume a reduced profile shape which is sufficiently small so that the vein is effectively ligated.
- the polarity of the primary-lead electrodes is switched so that all of the primary-lead electrodes are commonly charged.
- the secondary-lead electrode 35 is then charged so that its polarity is opposite that of the primary-lead electrodes 34 .
- the electrode at the distal end of the secondary lead can also come into contact with the a portion of the vein wall so that an RF field is created between the primary electrodes 34 and the secondary electrode 35 .
- the catheter 10 is pulled back to ensure apposition between the electrodes at the distal ends of the leads and the vein wall.
- the primary-lead electrodes 34 remain in apposition with the vein wall 54 while the secondary-lead electrode 35 comes in contact with the portion of the vein wall previously collapsed by the primary-lead electrodes 34 .
- RF energy passes through the venous tissue between the primary-lead electrodes 34 and the secondary-lead electrode 35 .
- Ligation as the catheter is being retracted produces a lengthy occlusion which is stronger and less susceptible to recanalization than an acute point occlusion.
- the secondary-lead electrode 35 remains neutral, while the primary leads 30 are commonly charged and act in conjunction with an independent electrical device, such as a large low-impedance return pad (not shown) placed in external contact with the body, to form RF fields substantially evenly spaced around the circumference of the vein.
- an independent electrical device such as a large low-impedance return pad (not shown) placed in external contact with the body, to form RF fields substantially evenly spaced around the circumference of the vein.
- the thermal effect produced by those RF fields along the axial length of the vein wall causes the vein wall to collapse around the primary-lead electrodes.
- the secondary-lead electrode Upon collapse of the vein wall, the secondary-lead electrode is charged to have the same polarity as that of the primary-lead electrodes. The electrode device is retracted as described in the bipolar operation.
- the application of RF energy is substantially symmetrically distributed through the vein wall.
- the electrodes should be spaced no more than 4 or 5 millimeters apart along the circumference of the vein, which defines the target vein diameter for a designed electrode catheter. Where the electrodes are substantially evenly spaced in a substantially symmetrical arrangement, and the spacing between the electrodes is maintained, a symmetrical distribution of RF energy increases the predictability and uniformity of the shrinkage and the strength of the occlusion.
- an external tourniquet such as an elastic compressive wrap or an inflatable bladder with a window transparent to ultrasound, is used to compress the anatomy, such as a leg, surrounding the structure to reduce the diameter of the vein.
- the compressive force being applied by the tourniquet may effectively ligate the vein, or otherwise occlude the vein by flattening the vein, for certain veins, this compressive force will not fully occlude the vein.
- a fixed diameter electrode catheter in this instance would not be effective.
- the electrodes 34 which are expanded outward by the formed leads 30 can accommodate this situation.
- the reduction in vein diameter assists in pre-shaping the vein to prepare the vein to be molded to a ligated state.
- the use of an external tourniquet or elastic bandage also exsanguinates the vein and blood is forced away from the treatment site. Coagulation of blood during treatment can be avoided by this procedure. Energy is applied from the electrodes to the exsanguinated vein, and the vein is molded to a sufficiently reduced diameter to achieve ligation.
- the external tourniquet or elastic bandage can remain in place to facilitate healing.
- the catheter can be pulled back during the application of RF energy to ligate an extensive section of a vein. In doing so, instead of a single point where the diameter of the vein has been reduced, an extensive section of the vein has been painted by the RF energy from the catheter. Retracting the catheter in this manner produces a lengthy occlusion which is less susceptible to recanalization.
- the combined use of the primary and secondary electrodes can effectively produce a reduced diameter along an extensive length of the vein.
- the catheter can be moved while the tourniquet is compressing the vein, of after the tourniquet is removed.
- fluid can be delivered to the vein before RF energy is applied to the vein.
- the delivered fluid displaces blood from the treatment site to ensure that blood is not present at the treatment site, even after the tourniquet compresses the vein.
- the tourniquet is an inflatable bladder with a window transparent to ultrasound
- an ultrasound transducer is used to monitor the flattening or reduction of the vein diameter from the compressive force being applied by the inflating bladder.
- the window can be formed from polyurethane, or a stand-off of gel contained between a polyurethane pouch.
- a gel can be applied to the window to facilitate ultrasound imaging of the vein by the transducer.
- Ultrasound visualization through the window allows the operator to locate the desired venous treatment area, and to determine when the vein has been effectively ligated or occluded. Ultrasound visualization assists in monitoring any pre-shaping of the vein in preparation of being molded into a ligated state by the thermal effect produced by the RF energy from the electrodes.
- the actuator After completing the procedure for a selected venous section, the actuator causes the leads 30 to return to the interior of the outer sheath 12 . Once the leads 30 are within the outer sheath 12 , the catheter 10 may be moved to another venous section where the ligation process is repeated.
- a balloon 64 is located on the catheter, and can be inflated through ports 66 to occlude the vein.
- the inflated balloon obstructs blood flow and facilitates the infusion of a high-impedance fluid to the vein in order to reduce the occurrence of coagulation by directing the energy into the vein wall.
- the inflation of the balloon to occlude the vein before the application of energy can obviate the use of the tourniquet to occlude the vein.
- this also allows the vein to be occluded even for the deep veins where a compressive tourniquet may not be able to compress the vein to occlusion. It is to be understood that other mechanisms can be used to expand the diameter of the catheter to create an impermeable barrier that occludes the vein.
- Fluid 61 can be delivered after inflation of the balloon 64 and before the RF heating of the vein being treated through a coaxial channel 62 formed between the external sheath 60 and the outer sheath 12 .
- another lumen can be formed in the catheter to deliver fluid to the treatment site.
- the lumen through which the guide wire is passed may be used for the delivery of fluid.
- the delivered fluid displaces or exsanguinates the remaining blood from the treatment area of the vein so as to avoid heating and coagulation of blood. Fluid can continue to be delivered during RF treatment to prevent blood from circulating back to the treatment site.
- the delivery of a high-dielectric fluid increases the surrounding impedance so that RF energy is directed into the tissue of the vein wall.
- the vein wall can reach the desired temperature more rapidly than in the case where energy is permitted to reach the blood, which has a cooling effect. Additionally, blood clotting is avoided with this approach, because the blood has been replaced with another fluid such as deionized water mixed with heparin to displace blood and prevent the formation of blood clots.
- FIG. 16 A partial cross-sectional view of this embodiment is shown in FIG. 16, where an inflation sheath 70 surrounds the external sheath 60 to provide a coaxial inflation lumen 72 for the balloon 64 .
- the inflation lumen 72 is in fluid communication with the ports 66 .
- Saline or any other suitable fluid can be used to inflate the balloon.
- the balloon 64 can be used in combination with bowable members or arms 76 having electrodes, where perfusion holes 78 are formed in the catheter between the balloon 64 and the bowable arms 76 .
- the balloon 64 in this embodiment is inflated through a balloon inflation lumen 72 (as shown in FIG. 16).
- the use of bowable arms for treating veins is discussed in U.S. patent application Ser. No. 08/610,911, which is hereby incorporated by reference.
- the arms can be constructed so as to spring radially outward from the catheter, yet offer little resistance in moving back toward the catheter as the vein diameter is diminished to occlusion.
- An anti-coagulant or saline or a high-impedance fluid can be introduced or flushed through the perfusion holes 78 in the catheter.
- the high-impedance fluid forces blood away from the venous treatment area and prevents the energy from being dissipated in a more conductive medium such as blood.
- a flexible covering 80 is wrapped around or inside the leads 30 of the electrodes 34 to prevent blood flow in the vein.
- the covering 80 spans the area between the splayed leads along the circumference of the catheter when the leads are extended out the opening, such that the webbed covering blocks blood flow within the vein.
- the covering may be thought of as webbing or an umbrella to keep blood on one side away from the electrodes.
- the covering 80 should be impermeable to fluid. Suitable materials include PET and nylon.
- Elastomeric materials are also suitable as the leads will need to move close together as they are retracted, and interference with the movement of the leads as the vein diameter is reduced by the application of energy is preferably minimized.
- this embodiment is illustrated with only primary leads, it is to be understood that this embodiment is not so limited and that a secondary lead may be included with the catheter as well without affecting the use of the covering.
- the covering occludes the vein before the application of energy, such that the need for an external compressive tourniquet is not required to stop blood flow. Furthermore, this also allows the vein to be occluded even for the deep veins where a compressive tourniquet may not be able to compress the vein to occlusion.
- a high-impedance fluid such as deionized water, or an anti-coagulant such as heparin or saline, or both, or heparin with deionized water may be infused or flushed through a central lumen (not shown) similar to that shown in FIG. 4 as numeral 48 or to that shown in FIGS. 10 and 11 before the application of energy as well.
- the electrodes extend through the shaft lumen which also acts as a conduit for the fluid being flushed through a central lumen 48 (not shown).
- a sclerosing fluid may also be delivered to the venous treatment site to enhance the ligation effect from the application of RF energy.
- the sclerosing fluid may be added in addition to, or in substitution of, the previously discussed fluids.
- a covering 80 having a parachute shape can be oriented so that blood becomes trapped by the concave portion of the covering 80 and the volume of the blood maintains the deployment of the covering.
- the covering is a balloon having openings 84 which allow blood to gather in the balloon, and expand the balloon.
- the covering 80 can be permanently attached to the catheter shaft. The catheter can still be moved along the vein, even with the balloon in an inflated state.
- the covering 80 is coupled to an outer cannula 82 surrounding the catheter shaft and connected to an actuation mechanism or lever.
- the outer cannula 82 can be slid along the longitudinal axis of the catheter to allow one end of the parachute covering 80 to be moved axially along the catheter shaft.
- the movable end of the covering is pulled away from the connecting end of the catheter to collapse the covering against the catheter.
- the cannula 82 is slid toward the working end to deploy the covering 80 which then fills with blood entering through the openings 84 , thereby occluding the vein.
- the covering expands as it fills with blood, and when the covering comes into contact with the vein wall, the vein is occluded.
- Fluid as before, can be infused either through perfusion holes 78 or a coaxial channel 48 (not shown).
- the catheter 10 includes an expandable section having a skeleton 90 disposed along a portion of the working end of the catheter.
- the skeleton 90 is more flexible than the surrounding shaft of the catheter, and can be constructed from a metal or polymer braid.
- a flexible membrane 92 covers the skeleton 90 , with the ends of the membrane attached to the shaft of the catheter adjacent the skeleton.
- the membrane is preferably constructed from an elastomeric material. As shown in FIG. 22, when the tip of the connecting end is moved toward the working end of the catheter, or vice versa, the skeleton 90 is deformed and forces the membrane 92 out into contact with the vein wall.
- This embodiment does not require a separate lumen to provide an inflation fluid to a balloon.
- the skeleton 90 is preferably resilient so that it returns to its original shape once the working end and connecting end are no longer being forced toward one another.
- Mechanisms for moving the connecting end toward the working end of the catheter for expanding the diameter of a catheter are also discussed in U.S. patent application Ser. No. 08/610,911, which has been incorporated by reference.
- the expandable section may be controlled separately from the extension of the electrode, the expandable section can be controlled by the same mechanism which extends the electrodes away from the catheter.
- the access site is prepared.
- a guide wire is passed into the vein, and advanced through to the venous treatment site.
- the catheter may be inserted into the vein directly and manipulated without a guide wire.
- the guide wire can be advanced retrograde to the venous treatment site.
- Several intravenous paths may be taken to the hemorrhoidal treatment site, and it is to be understood that other access sites can be used to treat either internal or external hemorrhoids.
- Hemorrhoids are generally defined as internal or external depending on whether they are formed above or below the dentate line DL, respectively.
- Internal hemorrhoids IH are commonly formed when the smaller veins draining to the superior hemorrhoidal vein SHV or the middle hemorrhoidal vein MHV become dilated.
- External hemorrhoids are commonly formed when the smaller veins draining to the inferior hemorrhoidal vein IHV become dilated.
- One method of delivering the catheter 10 and guide wire 13 is to introduce the guide wire 13 into the external iliac vein El on the side opposite to the dilated veins of the hemorrhoid.
- the guide wire is steered across the bifurcated branch of the inferior vena cava IVC to the inferior iliac vein II.
- the guide wire is then maneuvered into either the middle hemorrhoidal vein MHV to treat internal hemorrhoids, or the pudendal vein PV and then the inferior hemorrhoidal vein IHV to treat external hemorrhoids.
- the guide wire 13 is deployed and maneuvered into the middle hemorrhoidal vein MHV to treat an internal hemorrhoid.
- the guide wire 13 is maneuvered through the venous system until it reaches the dilated veins of the hemorrhoid.
- the catheter 10 is then delivered to the venous treatment site over the guide wire 13 , as shown in FIG. 23.
- the working end 11 of the catheter 10 includes a plurality of leads and electrodes for applying RF energy once properly positioned at the venous treatment site to ligate or occlude the vein.
- the catheter should be flexible to allow tracking of the catheter over the guide wire and through bends in the venous vascular system. Fluoroscopy, x-ray, ultrasound, or a similar imaging technique could be used to direct the specific placement of the catheter and to confirm position within the vein.
- Another method of delivering the catheter and guide wire is to introduce the guide wire into the superior hemorrhoidal vein and maneuver the guide wire through the superior hemorrhoidal vein SHV to the hemorrhoidal region.
- the guide wire is maneuvered into position, and the catheter is then delivered over the guide wire to the venous treatment site for the internal hemorrhoid.
- the venous treatment site is within the lumen of a dilated vein, and the electrode leads expand away from the body of the catheter to come into apposition with the wall of the dilated vein.
- an RF generator is activated to provide suitable RF energy to cause heating of the surrounding venous tissue.
- the energy emitted from the electrodes is converted within the venous tissue into heat.
- the application of energy causes the vein to collapse and become effectively occluded or ligated.
- varicose veins called esophageal varices can form in the venous system along the submucosa of the lower esophagus, and bleeding can occur from the swollen veins.
- the access site is prepared, and a guide wire 13 is passed into the vein and advanced through to the venous treatment site.
- the guide wire can be deployed and manipulated so as to reach the treatment site for treating the esophageal varices.
- the venous treatment site is preferably within the lumen of a dilated vein.
- the wire is advanced to the venous treatment site, such as the level of the most proximal incompetent vein site which is to be treated.
- the guide wire and catheter are advanced antegrade to the esophageal treatment site.
- the catheter may be inserted into the vein directly and manipulated without a guide wire. Fluoroscopy, x-ray, ultrasound, or a similar imaging technique could be used to direct the specific placement of the catheter and to confirm position within the vein.
- a properly sized catheter 10 delivers the electrode leads 12 to the site of venous dysfunction along the esophageal varix.
- the electrodes apply RF energy or other forms of energy at a suitable power or frequency to cause the vein to collapse and become effectively occluded or ligated.
- the catheter 10 is advanced over the guide wire 13 to a dilated section of the vein.
- One method of delivering the catheter and guide wire is to introduce the guide wire through the superior mesenteric vein SMV to the portal vein PV and coronary vein CV which branches and leads to the lower esophagus E to form the esophageal veins EV.
- the guide wire could be introduced into the inferior mesenteric vein, and routed through the splenic vein SV, the portal vein PV, and the coronary vein CV to arrive at the esophageal varix to be treated.
- a guide wire 120 has been located in the fallopian tube F and the catheter 122 is also positioned in the fallopian tube F through the fallopian tube ostium 126 .
- the shaft of the catheter has been introduced through the uterus U with an endoscope 128 .
- the working end of the catheter may now be energized as described above to perform an intra-fallopian tube ligation.
- the second fallopian tube may then also be ligated in the same manner.
- the lumen may be exsanguinated by compression or by a fluid flush. Further, prior to or during the application of energy to the hollow anatomical structure, the structure may be compressed or pre-sized.
- the esophageal varix can be externally compressed by inflating a balloon, such as those used as a tamponade, within the esophagus to apply pressure external to the esophageal varices to be treated.
- One method for compressing the lumen of the fallopian tube by external means is with pnuemoperitoneum.
- the lumen, particularly the lumen of a fallopian tube may be compressed by the application of negative pressure through the catheter.
- a negative pressure may be applied to the lumen at that open end.
- an inflatable balloon may be mounted to the shaft of the catheter proximal to the orifice through which the negative pressure is applied to assist in its application to the lumen.
- Other arrangements are possible, such as the use of ports in the wall of the catheter through which negative pressure may be applied. Negative pressure can also be applied to compress or pre-size veins.
Abstract
A catheter includes a plurality of expandable primary leads to deliver energy to a fallopian tube, a vein such as a hemorrhoid or an esophageal varix, or another hollow anatomical structure requiring ligation or occlusion. Each of the primary leads includes an electrode located at the working end of the catheter. Separation is maintained between the primary leads such that the leads can receive power of selected polarity. The primary leads are constructed to expand outwardly to place the electrodes into apposition with a hollow anatomical structure. High frequency energy can be applied from the leads to create a heating effect in the surrounding tissue of the anatomical structure. The diameter of the hollow anatomical structure is reduced by the heating effect, and the electrodes of the primary leads are moved closer to one another.
Description
- This application is a continuation-in-part of co-pending application Ser. No. 08/927,251 filed on Sep. 11, 1997 and application Ser. No. 08/958,766 filed on Oct. 26, 1997.
- The invention relates generally to a method for applying energy to shrink a hollow anatomical structure, such as a fallopian tube or a vein, including, but not limited to, superficial and perforator veins, hemorrhoids, and esophageal varices, and more particularly, to a method using an electrode device having multiple leads for applying radio frequency (RF) energy, microwave energy, or thermal energy.
- The human venous system of the lower limbs consists essentially of the superficial venous system and the deep venous system with perforating veins connecting the two systems. The superficial system includes the long or great saphenous vein and the short saphenous vein. The deep venous system includes the anterior and posterior tibial veins which unite to form the popliteal vein, which in turn becomes the femoral vein when joined by the short saphenous vein.
- The venous system contains numerous one-way valves for directing blood flow back to the heart. Venous valves are usually bicuspid valves, with each cusp forming a sack or reservoir for blood which, under retrograde blood pressure, forces the free surfaces of the cusps together to prevent retrograde flow of the blood and allows only antegrade blood flow to the heart. When an incompetent valve is in the flow path, the valve is unable to close because the cusps do not form a proper seal and retrograde flow of the blood cannot be stopped. When a venous valve fails, increased strain and pressure occur within the lower venous sections and overlying tissues, sometimes leading to additional valvular failure. Two venous conditions which often result from valve failure are varicose veins and more symptomatic chronic venous insufficiency.
- The varicose vein condition includes dilation and tortuosity of the superficial veins of the lower limbs, resulting in unsightly discoloration, pain, swelling, and possibly ulceration. Varicose veins often involve incompetence of one or more venous valves, which allow reflux of blood within the superficial system. This can also worsen deep venous reflux and perforator reflux. Current treatments of vein insufficiency include surgical procedures such as vein stripping, ligation, and occasionally, vein-segment transplant.
- Chronic venous insufficiency involves an aggravated condition of varicose veins which may be caused by degenerative weakness in the vein valve segment, or by hydrodynamic forces acting on the tissues of the body, such as the legs, ankles, and feet. As the valves in the veins fail, the hydrostatic pressure increases on the next venous valves down, causing those veins to dilate. As this continues, more venous valves will eventually fail. As they fail, the effective height of the column of blood above the feet and ankles grows, and the weight and hydrostatic pressure exerted on the tissues of the ankle and foot increases. When the weight of that column reaches a critical point as a result of the valve failures, ulcerations of the ankle begin to form, which start deep and eventually come to the surface. These ulcerations do not heal easily because of poor venous circulation due to valvular incompetence in the deep venous system and other vein systems.
- Other related venous conditions include dilated hemorrhoids and esophageal varices. Pressure and dilation of the hemorrhoid venous plexus may cause internal hemorrhoids to dilate and/or prolapse and be forced through the anal opening. If a hemorrhoid remains prolapsed, considerable discomfort, including itching and bleeding, may result. The venous return from these prolapsed hemorrhoids becomes obstructed by the anal sphincters, which gives rise to a strangulated hemorrhoid. Thromboses result where the blood within the prolapsed vein becomes clotted. This extremely painful.
- Varicose veins called esophageal varices can form in the venous system with submucosa of the lower esophagus, and bleeding can occur from the dilated veins. Bleeding or hemorrhaging may result from esophageal varices, which can be difficult to stop and, if untreated, could develop into a life threatening condition. Such varices erode easily, and lead to a massive gastrointestinal hemorrhage.
- Ligation of a fallopian tube (tubal ligation) for sterilization or other purposes is typically performed by laparoscopy. A doctor severs the fallopian tube or tubes and ties the ends. External cauterization or clamps may also be used. General or regional anesthetic must be used. All of the above are performed from outside the fallopian tube.
- Hemorrhoids and esophageal varices may be alleviated by intra-luminal ligation. As used herein, “ligation” or “intra-luminal ligation” comprises the occlusion, collapse, or closure of a lumen or hollow anatomical structure by the application of electrical energy from within the lumen or structure. As used herein, “ligation” or “intra-luminal ligation” includes electro-ligation. In the case of fallopian tube ligation, it would be desirable to perform the ligation from within the fallopian tube itself (intra-fallopian tube) to avoid the trauma associated with external methods.
- Ligation involves the cauterization or coagulation of a lumen using energy, such as that applied through an electrode device. An electrode device is introduced into the lumen and positioned so that it contacts the lumen wall. Once properly positioned, RF energy is applied to the wall by the electrode device thereby causing the lumen to shrink in cross-sectional diameter. In the case of a vein, a reduction in cross-sectional diameter of the vein, for example from 5 mm (0.2 in) to 1 mm (0.04 in), significantly reduces the flow of blood through a lumen and results in an effective occlusion. Although not required for effective occlusion or ligation, the vein wall may completely collapse thereby resulting in a full-lumen obstruction that blocks the flow of blood through the vein. Likewise, a fallopian tube may collapse sufficient to effect a sterilization of the patient.
- One apparatus for performing ligation includes a tubular shaft having an electrode device attached at the distal tip. Running through the shaft, from the distal end to the proximal end, are electrical leads. At the proximal end of the shaft, the leads terminate at an electrical connector, while at the distal end of the shaft the leads are connected to the electrode device. The electrical connector provides the interface between the leads and a power source, typically an RF generator. The RF generator operates under the guidance of a control device, usually a microprocessor.
- The ligation apparatus may be operated in either a monopolar or bipolar configuration. In the monopolar configuration, the electrode device consists of an electrode that is either positively or negatively charged. A return path for the current passing through the electrode is provided externally from the body, as for example by placing the patient in physical contact with a large low-impedance pad. The current flows from the ligation device through the patient to the low impedance pad. In a bipolar configuration, the electrode device consists of a pair of oppositely charged electrodes of approximately equal size, separated from each other, such as by a dielectric material or by a spatial relationship. Accordingly, in the bipolar mode, the return path for current is provided by an electrode or electrodes of the electrode device itself. The current flows from one electrode, through the tissue, and returns by way of the oppositely charged electrode.
- To protect against tissue damage; i.e., charring, due to cauterization caused by overheating, a temperature sensing device is attached to the electrode device. The temperature sensing device may be a thermocouple that monitors the temperature of the venous tissue. The thermocouple interfaces with the RF generator and the controller through the shaft and provides electrical signals to the controller which monitors the temperature and adjusts the energy applied to the tissue through the electrode device accordingly.
- The overall effectiveness of an ligation apparatus is largely dependent on the electrode device contained within the apparatus. Monopolar and bipolar electrode devices that comprise solid devices having a fixed shape and size can limit the effectiveness of the ligating apparatus for several reasons. Firstly, a fixed-size electrode device typically contacts the vein wall at only one point on the circumference or inner diameter of the vein wall. As a result, the application of RF energy is highly concentrated within the contacting venous tissue, while the flow of RF current through the remainder of the venous tissue is disproportionately weak. Accordingly, the regions of the vein wall near the point of contact collapse at a faster rate then other regions of the vein wall, resulting in non-uniform shrinkage of the vein lumen which can result in inadequacy of the overall strength of the occlusion and the lumen may eventually reopen. To avoid an inadequate occlusion, RF energy must be applied for an extended period of time so that the current flows through the tissue generating thermal energy including through the tissue not in contact with the electrode to cause that tissue to shrink sufficiently also. Extended applications of energy have a greater possibility of increasing the temperature of the blood to an unacceptable level and may result in a significant amount of heat-induced coagulum forming on the electrode and in the vein which is not desirable. This can be prevented by exsanguination of the vein prior to the treatment, and through the use of temperature regulated power delivery.
- Secondly, the effectiveness of a ligating apparatus having a fixed-size electrode device is limited to certain sized veins. An attempt to ligate a vein having a diameter that is substantially greater than the electrode device can result in not only non-uniform heating of the vein wall as just described, but also insufficient shrinkage of the vein diameter. The greater the diameter of the vein relative to the diameter of the electrode device, the weaker the energy applied to the vein wall at points distant from the point of electrode contact. Accordingly the vein wall is likely to not completely collapse prior to the venous tissue becoming over cauterized at the point of electrode contact. While coagulation as such may initially occlude the vein, such occlusion may only be temporary in that the coagulated blood may eventually dissolve recanalizing the vein. One solution for this inadequacy is an apparatus having interchangeable electrode devices with various diameters. Another solution would be to have a set of catheters having different sizes so that one with the correct size for the diameter of the target vein will be at hand when needed. Such solutions, however, are both economically inefficient and can be tedious to use. It would be desirable to have a single catheter device that is usable with a large range of sizes of lumina.
- Although described above in terms of a vein, the concepts are generally applicable to other hollow anatomical structures in the body as well. For consideration of avoiding unnecessary repetition, the above description has been generally confined to veins.
- Hence those skilled in the art have recognized a need for a method capable of more evenly distributing RF energy along a circumferential band of a wall of the target anatomical structure where the wall is greater in diameter than the electrode device, and thereby provide more predictable and effective occlusion of anatomical structures while minimizing the formation of heat-induced coagulum. Such method should be applicable to the ligation of all the veins in the body, including but not limited to perforator and superficial veins, as well as hemorrhoids, esophageal varices, and also fallopian tubes. The invention fulfills these needs and others.
- Briefly, and in general terms, the present invention provides a method for applying energy along a generally circumferential band of the wall of a hollow anatomical structure, such as a fallopian tube, a hemorrhoid, or an esophageal varix. The application of energy in accordance with this method results in a more uniform and predictable shrinkage of the vein wall.
- In one aspect, the invention comprises a method of applying energy to a hollow anatomical structure from within the structure. The method includes the step of introducing a catheter into the anatomical structure; the catheter having a working end and a plurality of leads, each lead having a distal end, and each lead being connected to a power source. The method also includes the step of expanding the leads outwardly through the distal orifice and expanding the leads until each electrode contacts the anatomical structure. The method further includes the step of applying energy to the anatomical structure from the distal end of the leads, until the anatomical structure collapses to an effective occlusion.
- In further aspects, the invention is directed to a method of applying energy intraluminally to a fallopian tube from a power source, comprising the steps of introducing into the fallopian tube, hemorrhoid, or esophageal varix a catheter having a working end with a plurality of primary leads disposed at the working end, each primary lead having a distal end and being connected to the power source, expanding the primary leads outwardly from the working end of the catheter, wherein the distal ends of the primary leads move away from each other and into contact with the wall of the fallopian tube, hemorrhoid, or esophageal varix, and applying energy to the fallopian tube, hemorrhoid, or esophageal varix from the distal end of the primary leads to collapse the fallopian tube, hemorrhoid, or esophageal varix to effectively occlude the fallopian tube, hemorrhoid, or esophageal varix. In a further aspect, the step of expanding the primary leads comprises the step of expanding the primary leads such that the distal ends of the primary leads are spaced no more than five millimeters apart along the fallopian tube, hemorrhoid, or esophageal varix.
- In more detailed aspects, the method further comprises the step of extending the primary leads through an orifice formed in the working end of the catheter and expanding the primary leads, wherein the distance between two mutually opposed expanded distal ends is greater than the diameter of the working end. In another aspect, the method comprises the step of moving an outer sleeve away from the primary leads such that the primary leads extend past an orifice of the outer sleeve at the working end of the catheter and expand outwardly.
- In yet further aspects, the method further comprising the steps of maintaining separation between the primary leads at a selected location with an alignment device positioned inside an outer sheath of the catheter, and moving the outer sheath in relation to the alignment device to extend the primary leads out the orifice. Furthermore, the method further comprises the steps of attaching the primary leads to an inner sheath, maintaining separation between the primary leads at a selected location with an alignment device positioned inside an outer sheath of the catheter, and moving the outer sheath in relation to the inner sheath to extend the primary leads through the orifice.
- In other more detailed aspect, the step of introducing a catheter having a plurality of primary leads into the fallopian tube, hemorrhoid, or esophageal varix comprises the step of introducing a plurality of primary leads that are mounted to the working end in a cantilever arrangement. The method further comprises the step of moving an outer sleeve away from the cantilevered primary leads such that the primary leads extend past an orifice of the outer sleeve at the working end of the catheter and expand outwardly.
- In a further aspect, the method further comprises the step of moving the catheter in the fallopian tube, hemorrhoid, or esophageal varix while continuing to apply energy to the fallopian tube, hemorrhoid, or esophageal varix.
- In a further detailed aspect, the method further comprises the step of mounting a secondary lead to the working end, the secondary lead having a distal end and having a length exceeding that of the primary leads, wherein the step of extending the plurality of primary leads further includes the step of extending the secondary lead through the distal orifice. In another aspect, the step of applying energy to the fallopian tube, hemorrhoid, or esophageal varix comprises the steps of controlling the power source so that adjacent primary leads are of opposite polarity while maintaining the secondary lead so that it is electrically neutral, switching the polarity of the primary leads so that they are all of the same polarity upon collapse of the fallopian tube, hemorrhoid, or esophageal varix around the primary leads, and controlling the power source so that the secondary lead is of opposite polarity relative to the primary leads upon performing the step of switching the polarity of the primary leads so that they are of the same polarity.
- In further aspects, a bend is formed in each primary lead, the bend formed in the direction away from the other primary leads such that each primary lead tends to move outward away from the other primary leads in the step of expanding the primary leads away from each other. The steps of sensing the temperature at the distal end of a primary lead and controlling the application of power to the primary leads in response to the temperature sensed at the distal end may also be included.
- In another aspect, the method includes the step of compressing the hollow anatomical structure, such as a vein or fallopian tube, to reduce the anatomical structure to a desired size, and for exsanguination, before and/or during the application of energy to occlude or ligate the structure.
- In yet another aspect, the method includes the step of flushing the hollow anatomical structure with fluid before the step of applying energy.
- These and other aspects and advantages of the present invention will become apparent from the following more detailed description, when taken in conjunction with the accompanying drawings which illustrate, by way of example, embodiments of the invention.
- FIG. 1 is a diagram of an energy application system with a partial cutaway view of a catheter showing both the working end which includes a plurality of outwardly expandable electrodes for applying energy to tissue and the connecting end which is connected to a power source controlled by a microprocessor controller for controlling the energy applied to the electrodes of the working end;
- FIG. 2 is a cross-sectional view of the working end of a first embodiment of a catheter in accordance with aspects of the invention depicting the electrodes in a fully expanded position;
- FIG. 2a is an end view of the working end of the first embodiment of the catheter taken along line 2 a-2 a of FIG. 2;
- FIG. 3 is a cross-sectional view of the working end of the first embodiment depicting the electrodes in a fully retracted position;
- FIG. 4 is a cross-sectional view of the working end of a second catheter in accordance with principles of the invention depicting the electrodes in a fully expanded position;
- FIG. 4a is an end view of the second embodiment of the invention taken along line 4 a-4 a of FIG. 4;
- FIG. 5 is a cross-sectional view of the working end of the second embodiment of the catheter of FIG. 4 depicting the electrodes in a fully retracted position;
- FIG. 6 is a cross-sectional view of an anatomical structure containing the catheter of FIG. 2 with the electrodes in apposition with the anatomical structure;
- FIG. 6a is an end view of the anatomical structure containing the catheter taken along line 6 a-6 a of FIG. 6;
- FIGS. 7a through 7 c are cross-sectional views of the anatomical structure containing a catheter in accordance with the first embodiment of the invention and depicting the anatomical structure at various stages of ligation;
- FIG. 8 is a cross-sectional view of an anatomical structure containing a catheter in accordance with the second embodiment of the invention as depicted in FIG. 4;
- FIG. 8a is an end view of the anatomical structure containing the catheter taken along line 8 a-8 a of FIG. 8;
- FIGS. 9a and 9 b are cross-sectional views of the anatomical structure containing the catheter in accordance with the second embodiment of the invention and depicting the anatomical structure at various stages of ligation;
- FIG. 10 is a cross-sectional view of the working end of a third embodiment of a catheter in accordance with the invention depicting the electrodes in a fully retracted position;
- FIG. 10a is an end view of the working end of the third embodiment of the catheter taken along
line 10 a-10 a of FIG. 10; - FIG. 11 is a cross-sectional view of the working end of the third embodiment depicting the electrodes in a fully expanded position;
- FIG. 12 is a cross-sectional view of an anatomical structure containing the catheter of FIG. 10 with the electrodes in apposition with the anatomical structure;
- FIG. 13 is a cross-sectional view of the anatomical structure containing the catheter of FIG. 10 where the anatomical structure is being ligated by the application of energy from the electrodes;
- FIG. 14 is a cross-sectional view of an anatomical structure containing the catheter of FIG. 10 with the electrodes in apposition with the anatomical structure where external compression is being applied to reduce the diameter of the hollow structure before the application of energy from the electrodes to ligate the structure;
- FIG. 15 is a side view of another embodiment of an electrode catheter having a balloon and a coaxial fluid channel;
- FIG. 16 is a view of the balloon and catheter of FIG. 15 showing the balloon inflation ports formed in an inflation sheath of the catheter, also showing the inflation lumen that communicates with the inflation ports;
- FIG. 17 is a cross-sectional view of an anatomical structure containing another embodiment of the catheter having a balloon located proximal to bowable arms with electrodes, the portion of the catheter distal to the balloon having perfusion holes;
- FIG. 18 is a side view of another embodiment of an electrode catheter having a covering spanning the splayed leads of the electrodes extended out the catheter;
- FIG. 19 is a side view of another embodiment of an electrode catheter having a balloon and a coaxial fluid channel located proximal to expandable leads, the balloon having openings for receiving blood to maintain deployment of the balloon;
- FIG. 20 is a side view of another embodiment of an electrode catheter having a balloon and a coaxial fluid channel located proximal to expandable leads, the balloon having openings for receiving blood to maintain deployment of the balloon;
- FIG. 21 is a partial cross-sectional side view of another embodiment of an electrode catheter having an expandable section which is covered by a membrane;
- FIG. 22 is a partial cross-sectional side view of the embodiment of an electrode catheter of FIG. 21 in an expanded condition;
- FIG. 23 is a view of a catheter used in a method in accordance with the invention to treat a hemorrhoid;
- FIG. 24 is a view of a catheter used in a method in accordance with the invention to treat an esophageal varix; and
- FIG. 25 is a view of a catheter used in a method in accordance with the invention for fallopian tube ligation.
- Turning now to the drawings with more particularity wherein like reference numerals indicate like or corresponding elements among the figures, shown in FIG. 1 is a
catheter 10 for applying energy to an anatomical structure such as a vein. Thecatheter 10 includes anouter sheath 12 having adistal orifice 14 at its workingend 15. Theconnector end 17 of theouter sheath 12 is attached to ahandle 16 that includes anelectrical connector 18 for interfacing with apower source 22, typically an RF generator, and amicroprocessor controller 23. Thepower source 22 andmicroprocessor 23 are usually contained in one unit. Thecontroller 23 controls thepower source 22 in response to external commands and data from a sensor, such as a thermocouple, located at an intraluminal venous treatment site. In another embodiment, the user can select a constant power output so that automated temperature control is not present and the user can manually adjust the power output in view of the temperature on a display readout. Thecatheter 10 includes an expandable electrode device 24 (partially shown) that moves in and out of theouter sheath 12 by way of thedistal orifice 14. The electrode device includes a plurality of electrodes which can be expanded by moving the electrodes within the shaft, or by moving the outer shaft relative to the electrodes. Although FIG. 1 illustrates a plurality of electrodes surrounding a single central electrode, different electrode configurations will be described for the catheter. - Contained within the
outer sheath 12 is aninner sheath 28 or inner member. Afluid port 21 communicates with the interior of theouter sheath 12. Thecatheter 10 can be periodically flushed out with saline through theport 21. The flushing fluid can travel between the outer sheath and the inner sheath. The port also allows for the delivery of drug therapies. Flushing out the catheter prevents the buildup of biological fluid, such as blood, within thecatheter 10. The treatment area of the hollow anatomical structure such as a vein can be flushed with a fluid such as saline, or a dielectric fluid, in order to evacuate blood from the treatment area of the vein so as to prevent the formation of coagulum or thrombosis. The use of a dielectric fluid can minimize unintended heating effects away from the treatment area. The dielectric fluid prevents the current of RF energy from flowing away from the vein wall. - In one embodiment, the
catheter 10 includes a lumen which begins at the distal tip of theouter sheath 12 and runs substantially along the axis of theouter sheath 12 before terminating at the guide-wire port 20 of thehandle 16. A guide wire can be introduced through the lumen of thecatheter 10 for use in guiding the catheter to the desired treatment site. Where the catheter is sized to treat smaller veins, the outer diameter of the catheter may not allow for a fluid flush between theouter sheath 12 and theinner sheath 28. However, a fluid flush can be introduced through the lumen for the guide wire in such an embodiment. - Referring now to FIGS. 2, 2a, 3, 4, 4 a and 5, the
outer sheath 12 includes ashell 44 and atip portion 46. To provide an atraumatic tip for thecatheter 10 as it is manipulated through the vein, thetip 46 is preferably tapered inward at its distal end or is “nosecone” shaped. Thetip 46, however, can have other shapes that facilitate tracking of thecatheter 10 over a guide wire and through the bends in the venous vascular system. The nosecone-shapedtip 46 can, for example, be fabricated from a polymer having a soft durometer, such as 70 Shore A. Theshell 44 comprises a biocompatible material having a low coefficient of friction. In one configuration, theouter sheath 12 is sized to fit within a venous lumen and for example may be between 5 and 9 French, which corresponds to a diameter of between 1.7 mm (0.07 in) and 3.0 mm (1.2 in), or other sizes as appropriate. - The
electrode device 24 contains a number of leads, including insulated primary leads 30 and, in some embodiments, asecondary lead 31. Preferably, the leads are connected to the power source 22 (FIG. 1) such that the polarity of the leads may be switched as desired. Alternately, a microprocessor controller can be used to switch the polarity, as well as control other characteristics of the power for the electrode device. Thus the electrode device can operate in either a bipolar or a monopolar configuration. When adjacent primary leads 30 have opposite polarity theelectrode device 24 operates as a bipolar electrode device. When the primary leads 30 are commonly charged theelectrode device 24 can operate as a monopolar electrode device. When the primary leads 30 are commonly charged, and asecondary lead 31 has an opposite polarity, theelectrode device 24 operates as a bipolar electrode device. The embodiment of the invention shown in FIGS. 2 and 3 depict anelectrode device 24 having fourprimary leads 30 and asecondary lead 31, while the embodiment of the invention shown in FIGS. 4 and 5 depict anelectrode device 24 having only four primary leads. The invention is not limited to fourprimary leads 30; more or fewer leads may be used in either embodiment. The number of leads can be dependent on the size or diameter of the hollow anatomical structure to be treated. The apposed electrodes should be kept within a certain distance of one another. Larger vessels may require more primary leads to ensure proper current density and proper heat distribution. - The insulation on each of the
leads distal end electrode 34 has a hemispherical shape. In a second configuration, the electrode can have either a generally spherical shape or a spoon shape. As shown in FIGS. 4, 4a and 5, the electrodes have a spoon shape which can be combined to form a sphere or other shape so as to minimize its profile when the vein collapses. Theelectrodes 34 are either integrally formed at thedistal end 32, soldered, or otherwise formed to the distal end of eachprimary lead 30. It is to be understood that when thedistal end 32 is referred to as acting as an electrode, this is not limited to where theelectrode 34 is integrally formed at thedistal end 32. For example, the distal end can apply energy to the surrounding tissue where there is an electrode integrally formed at the distal end, or where an electrode is separately soldered to the distal end, or where there is another energy delivery device located at the distal end. Theelectrode 34 typically has a diameter greater than the diameter of theprimary lead 30. For example, theprimary lead 30 may have a diameter ranging from 0.18 mm (0.007 in.) to 0.28 mm (0.011 in.), while theelectrode 34 has a diameter of 0.36 mm (0.014 in.) to 0.51 mm (0.020 in.). The primary leads 30 and theelectrodes 34 are preferably made from a biologically-compatible material such as stainless steel. The insulation surrounding the primary leads 30 generally has a thickness of between 0.03 mm (0.001 in.) and 0.06 mm (0.0025 in.), resulting in a combined lead-insulation diameter of between 0.23 mm (0.009 in.) and 0.41 mm (0.016 in.). In an alternate configuration, as shown in FIGS. 2 and 3, eachprimary lead 30 is strip-shaped with a width from 0.76 mm (0.03 in.) to 1.0 mm (0.04 in) and a thickness of approximately 0.13 mm (0.005 in.), while thesecondary lead 31 is typically tubular-shaped. It should be noted that these dimensions are provided for illustrative purposes, and not by way of limitation. Ahemispherical electrode 34 is shaped at the distal end, as for example, by sanding down a sixteenth-inch (1.6 mm) diameter sphere which is soldered to thedistal end 32 of theprimary lead 30. The electrodes can also be constructed by stamping the desired shape or configuration from the conductive lead. The electrode is integral with the lead, and the remainder of the lead is insulated. Thedistal end 33 of thesecondary lead 31 preferably includes a generally spherically-shapedelectrode 35. - An
alignment device 36 arranges theleads alignment device 36 includes a plurality of off-center, axially-alignedlumina 38 which are substantially symmetrically positioned relative to the axis of thealignment device 36. Thealignment device 36 is formed, for example, by extruding the plurality of axially-alignedlumina 38 through a solid cylinder composed of a dielectric material, such as polyamide. Each lead 30 passes through an individual off-center lumen 38 and exits out the rear of thealignment device 36. Thealignment device 36 may further include acentral lumen 48 that may be aligned with the axis. In some embodiments thecentral lumen 48 is used for accepting a guide wire or for the delivery or perfusion of medicant and cooling solution to the treatment area during application of RF energy. In other embodiments, thecentral lumen 48 may be used for thesecondary lead 31. Thealignment device 36 may also further include anauxiliary lumen 47 for additional leads, such as the leads of a thermocouple used as a temperature sensor. Thealignment device 36 comprises a dielectric material to prevent or minimize any coupling effect theleads - In the embodiment of the invention shown in FIGS. 2, 2a and 3, the
inner sheath 28 is attached to thealignment device 36 and extends beyond the rear 37 of the alignment device. Preferably, theinner sheath 28 completely surrounds the exterior wall of thealignment device 36 and is mounted to it by adhesive or press fit or in other manner such that it remains in a fixed position relative to the inner sheath. The inner sheath and alignment device can act as an inner member relative to the outer sheath. Theinner sheath 28 comprises a biocompatible material with a low coefficient of friction. Theinner sheath 28 provides a pathway for the interconnection between theleads inner sheath 28. In the alternative (not shown), the positively charged leads 30, 31 may couple with a common positively charged conductor housed in theinner sheath 28. Likewise, the negatively charged leads 30, 31 may couple with a common negative conductor. Preferably, theleads inner sheath 28. To reduce the amount of wire contained in the catheter, it is advantageous to couple theleads alignment device 36. To add further stability to theelectrode device 24, it is preferred thatbonding material 40 surround theleads alignment device 36. In this embodiment, theleads distal orifice 14 as theouter sheath 12 is retracted backwards over thealignment device 36. The inwardly taperedtip 46 impedes the retracting movement of theouter sheath 12 to prevent the exposure of thealignment device 36. - FIG. 3 shows the
leads tip portion 46 and theouter shell 44. Thealignment device 36 has been moved relative to theouter shell 44. The soft nosecone provides an atraumatic tip for when the catheter is maneuvered through the tortuous venous system. The electrode at the distal end of thesecondary lead 31 can be sized to approximately the same size as the opening formed in thenosecone 46. The nosecone forms a closed atraumatic tip together with the electrode of the secondary lead when the alignment device is retracted into the outer sheath of the catheter. This can present an atraumatic tip even where the nosecone is not constructed from a material having a soft durometer. - Referring now to FIGS. 4 and 5, in another embodiment, the
alignment device 36 is attached to theouter sheath 12 and thereby remains immobile in relation to it. Theinner sheath 28 is movably positioned at the rear of thealignment device 36 and again provides a pathway for the interconnection between the primary leads 30 and the electrical connector 18 (FIG. 1). In some embodiments theinner sheath 28 contains a guide-wire tube 49 that runs the entire length of the inner sheath. The guide-wire tube 49 is aligned to communicate with thecentral lumen 48 of thealignment device 36 at one end and with the guide-wire port 20 (FIG. 1) at the other end. The primary leads 30 may be continuous and run the entire length of theinner sheath 28 or they may be coupled to common leads as previously described. The primary leads 30 are secured to thefront end 27 of theinner sheath 28, as for example with apotting material 50, so that the movement of theinner sheath 28 results in a corresponding movement of the primary leads 30 through thelumina 38 of thealignment device 36. In this embodiment, the primary leads 30 are not secured to thealignment device 36 and in essence are free-floating leads in the axial direction. The primary leads 30 travel through thealignment device 36 and exit through thedistal orifice 14 as the front end of theinner sheath 28 is moved toward the rear 37 of thealignment device 36. - In the above embodiments, the primary leads30 are formed, e.g., arced or bent, to move away from each other and thereby avoid contact. The “distal portion” of the primary leads 30 is the portion of the lead which extends from the front end of the
alignment device 36 when the leads are fully extended through thedistal orifice 14. It is preferred that thedistal portions 42 are formed to move radially outward from each other relative to the axis of thealignment device 36 and form a symmetrical arrangement. This is shown in both the embodiments of FIG. 2a and FIG. 4a. The degree of arc or bend in the primary leads 30 may be any that is sufficient to radially expand the leads as they exit theouter sheath 12 through thedistal orifice 14. It is essential that the degree of the arc or bend be sufficient to provide enough force so that the primary leads 30 expand through blood and theelectrodes 34 come in apposition with the vein wall. The electrodes are preferably partially embedded in the vein wall to assure full contact. The rounded portion of the electrode is embedded into the vein wall to achieve full surface apposition so that the entire uninsulated surface area of the electrode is in contact with venous tissue for effective current distribution. The surface area of the electrodes in contact with the venous tissue preferably is sufficient to avoid a high current density which may lead to spot heating of the venous tissue. The heating effect is preferably distributed along a circumferential band of the vein. The apposed electrodes should be spaced no more than 4 or 5 millimeters from one another along the circumference of the vein. Thus, the electrode arrangement is related to the size or diameter of the vein being treated. Other properties of the primary leads 30, such as lead shape and insulation thickness, affect the push force of the lead and the degree of arc or bend must be adjusted to compensate for these factors. For example, in one configuration of theelectrode device 24, a wire having a diameter of between 0.18 mm (0.007 in) and 0.28 mm (0.011 in) with a total insulation thickness of between 0.05 mm (0.002 in) to 0.13 mm (0.005 in) is arced or bent at an acute angle to provide sufficient apposition with the anatomical structure. It is to be understood that these dimensions are provided for illustrative purposes, and not by way of limitation. - Other techniques for expanding the leads outwardly once they have been extended from the working end of the catheter may be possible. For example, the leads may be straight but are mounted in the alignment device at an angle such that they are normally directed outward.
- For increased appositional force, it is preferred that the primary leads30 be strip-shaped, that is rectangular in cross section, with dimensions, for example, of a width from 0.76 mm (0.030 in.) to 1.0 mm (0.039 in) and a thickness of approximately 0.13 mm (0.005 in.). The rectangular cross section provides increased resistance to bending in the width dimension but allows bending more freely in the thickness dimension. This strip-shaped configuration of the primary leads 30 is shown in FIGS. 2, 2a, and 3 and provides for increased stability in the lateral direction while allowing the necessary bending in the radial direction. In FIGS. 2, 2a, and 3, each primary lead comprises a rectangular cross section mounted in relation to the catheter such that the thinner dimension of the rectangular cross section is aligned with the direction of expansion of the lead. The leads are less likely to bend sideways when expanded outward, and a uniform spacing between leads is more assured. Uniform spacing promotes uniform heating around the venous tissue which is in apposition with the electrodes at the distal ends of the leads.
- The length of the distal portion of the
leads 30 also affects the configuration of theelectrode device 24. The maximum distance between two mutuallyopposed electrodes 34; i.e., the effective diameter of theelectrode device 24, is affected by the bend degree and length of thedistal portion 42. The longer the length of thedistal portion 42 the greater the diameter of theelectrode device 24. Accordingly, by changing thedistal portion 42 length and arc or bend degree, thecatheter 10 can be configured for use in differently sized anatomical structures. - Different numbers of
leads leads alignment device 36 and the number oflumina - Now referring again to FIG. 1, an
actuator 25 controls the extension of theelectrode device 24 through thedistal orifice 14. Theactuator 25 may take the form of a switch, lever, threaded control knob, or other suitable mechanism, and is preferably one that can provide fine control over the movement of theouter sheath 12 or theinner sheath 28, as the case may be. In one embodiment of the invention, the actuator 25 (FIG. 1) interfaces with the outer sheath 12 (FIG. 2, 2a and 3) to move it back and forth relative to theinner sheath 28. In another embodiment the actuator 25 (FIG. 1) interfaces with the inner sheath 28 (FIGS. 4, 4a and 5) to move it back and forth relative to theouter sheath 12. The relative position between the outer sheath and inner sheath is thus controlled, but other control approaches may be used. - Referring again to FIGS. 2, 2a, 3, 4, 4 a and 5, the
catheter 10 includes atemperature sensor 26, such as a thermocouple. Thetemperature sensor 26 is mounted in place on anelectrode 34 so that thesensor 26 is nearly or is substantially flush with the exposed surface of theelectrode 34. Thesensor 26 is shown in the drawings as protruding from the electrodes for clarity of illustration only. Thesensor 26 senses the temperature of the portion of the anatomical tissue that is in apposition with the exposed electrode surface. Monitoring the temperature of the anatomical tissue provides a good indication of when shrinkage of the tissue is ready to begin. Atemperature sensor 26 placed on the electrode facing the anatomical tissue provides an indication of when shrinkage occurs (70° C. or higher) and when significant amounts of heat-induced coagulum may begin to form on the electrodes. Therefore maintaining the temperature above 70 degrees Centigrade produces a therapeutic shrinkage of the anatomical structure. Application of the RF energy from theelectrodes 34 is halted or reduced when the monitored temperature reaches or exceeds the specific temperature that was selected by the operator, typically the temperature at which anatomical tissue begins to cauterize. Thetemperature sensor 26 interfaces with the controller 23 (FIG. 1) through a pair of sensor leads 45 which preferably run through theauxiliary lumen 47 and then through theinner sheath 28. The signals from thetemperature sensor 26 are provided to thecontroller 23 which controls the magnitude of RF energy supplied to theelectrodes 34 in accordance with the selected temperature criteria and the monitored temperature. Other techniques such as impedance monitoring, and ultrasonic pulse echoing can be utilized in an automated system which shuts down or regulates the application of RF energy from the electrodes to the venous section when sufficient shrinkage of the vein is detected and to avoid overheating the vein. Impedance can be used to detect the onset of coagulum formation. - Referring now to FIGS. 6, 6a and 7 a through 7 c, in the operation of one embodiment of the
catheter 10, the catheter is inserted into a hollow anatomical structure, such as avein 52. The catheter is similar to the embodiment discussed in connection with FIGS. 2 and 3. Thecatheter 10 further includes anexternal sheath 60 through which a fluid can be delivered to the treatment site. In this embodiment, the fluid port (not shown) communicates with the interior of theexternal sheath 60, and fluid is delivered from between theexternal sheath 60 and theouter sheath 12. Theexternal sheath 60 surrounds theouter sheath 12 to form a coaxial channel through which fluid may be flushed. - Fluoroscopy, ultrasound, an angioscope imaging technique, or other technique may be used to direct the specific placement of the catheter and confirm the position in the vein. The actuator (not shown) is then operated to shift the outer sheath relative to the inner sheath by either retracting the
outer sheath 12 backward or advancing theinner sheath 28 forward to expose theleads distal orifice 14. As the leads 30, 31 exit thedistal orifice 14, the primary leads 30 expand radially outward relative to the axis of thealignment device 36, while thesecondary lead 31 remains substantially linear. The primary leads 30 continue to move outward until apposition with thevein wall 54 occurs and the outward movement of the primary leads 30 is impeded. The primary leads 30 contact the vein along a generally circumferential band of thevein wall 54. This outward movement of the primary leads 30 occurs in a substantially symmetrical fashion. As a result, the primary-lead electrodes 34 are substantially evenly spaced along the circumferential band of thevein wall 54. The central-lead electrode 35 is suspended within thevein 52 without contacting thevein wall 54. - When the
electrodes 34 are positioned at the treatment site of the vein, thepower supply 22 is activated to provide suitable RF energy. One suitable frequency is 510 kHz. One criterion used in selecting the frequency of the energy to be applied is the control desired over the spread, including the depth, of the thermal effect in the venous tissue. Another criterion is compatibility with filter circuits for eliminating RF noise from thermocouple signals. - In bipolar operation, the primary leads30 are initially charged such that adjacent leads are oppositely charged while the secondary lead is electrically neutral. These multiple pairs of oppositely charged leads 30 form active electrode pairs to produce an RF field between them. Thus, discrete RF fields are set up along the circumferential band of the
vein wall 54. These discrete fields form a symmetrical RF field pattern along the entire circumferential band of thevein wall 54, asadjacent electrodes 34 of opposite polarity produce RF fields between each other. A uniform temperature distribution can be achieved along the vein wall being treated. - The RF energy is converted within the adjacent venous tissue into heat, and this thermal effect causes the venous tissue to shrink, reducing the diameter of the vein. A uniform temperature distribution along the vein wall being treated avoids the formation of hot spots in the treatment area while promoting controlled uniform reduction in vein diameter. The thermal effect produces structural transfiguration of the collagen fibrils in the vein. The collagen fibrils shorten and thicken in cross-section in response to the heat from the thermal effect. As shown in FIG. 7a, the energy causes the
vein wall 54 to collapse around the primary-lead electrodes 34. Thewall 54 continues to collapse until further collapse is impeded by theelectrodes 34. The electrodes are pressed farther and farther together by the shrinkingvein wall 54 until they touch and at that point, further collapse or ligation of thewall 54 is impeded. Upon collapse of thevein wall 54 around the primary-lead electrodes 34, the polarity of the primary-lead electrodes is switched so that all primary-lead electrodes are commonly charged. The switching of polarity for the leads need not be instantaneous. The application of RF energy can be ceased, the polarity switched, and then RF energy is applied again at the switched polarity. The secondary-lead electrode 35 is then charged so that its polarity is opposite that of the primary-lead electrodes 34. The RF field is set up between the primary-lead electrodes 34 and the secondary-lead electrode 35. - The
catheter 10 is then pulled back while energy is applied to the electrode device. As shown in FIG. 7b, while thecatheter 10 is being pulled back, the primary-lead electrodes 34 remain in apposition with thevein wall 54 while the secondary-lead electrode 35 comes in contact with the portion of the vein wall previously collapsed by the primary-lead electrodes 34. Accordingly, RF energy passes through thevein wall 54 between the primary-lead electrodes 34 and the secondary-lead electrode 35 and the vein wall continues to collapse around the secondary-lead electrode 35 as thecatheter 10 is being retracted. As shown in FIG. 7c, ligation in accordance with this method results in an occlusion along a length of thevein 52. A lengthy occlusion, as opposed to an acute occlusion, is stronger and less susceptible to recanalization. - A similar result is achieved when the
catheter 10 having both primary and secondary leads is operated in a monopolar manner. In a monopolar operation, the secondary-lead electrode 35 remains neutral, while the primary leads 30 are commonly charged and act in conjunction with an independent electrical device, such as a large low-impedance return pad (not shown) placed in external contact with the body, to form a series of discrete RF fields. These RF fields are substantially evenly spaced around the circumference of the vein and travel along the axial length of the vein wall causing the vein wall to collapse around the primary-lead electrodes. Upon collapse of the vein wall, the secondary-lead electrode is charged to have the same polarity as that of the primary-lead electrodes. The electrode device is retracted and the vein wall collapses as described in the bipolar operation. - In either bipolar or monopolar operation the application of RF energy is substantially symmetrically distributed through the vein wall, regardless of the diameter of the
vein 52. This symmetrical distribution of RF energy increases the predictability and uniformity of the shrinkage and the strength of the occlusion. Furthermore, the uniform distribution of energy allows for the application of RF energy for a short duration and thereby reduces or avoids the formation of heat-induced coagulum on theelectrodes 34. The leads, including the non-convex outer portion of the electrode, are insulated to further prevent heating of the surrounding blood. - Fluid can be delivered before and during RF heating of the vein being treated through a coaxial channel formed between the
external sheath 60 and theouter sheath 12. It is to be understood that another lumen can be formed in the catheter to deliver fluid to the treatment site. The delivered fluid displaces or exsanguinates blood from the vein so as to avoid heating and coagulation of blood. Fluid can continue to be delivered during RF treatment to prevent blood from circulating back to the treatment site. The delivery of a dielectric fluid increases the surrounding impedance so that RF energy is directed into the tissue of the vein wall. - Referring now to FIGS. 8, 8a, 9 a and 9 b, in the operation of an alternate embodiment of the
catheter 10 that may be used with aguide wire 53. As in the previous embodiment, thecatheter 10 is inserted into a hollow anatomical structure, such as avein 52. Theguide wire 53 is advanced past the point where energy application is desired. Thecatheter 10 is then inserted over theguide wire 53 by way of thecentral lumen 48 and the guide wire tube 49 (FIG. 4) and is advanced over the guide wire through the vein to the desired point. Theguide wire 53 is typically pulled back or removed before RF energy is applied to theelectrode device 24. - The actuator25 (FIG. 1) is then manipulated to either retract the
outer sheath 12 backward, or advance theinner sheath 28 forward to expose theleads 30 through thedistal orifice 14. The leads 30 exit thedistal orifice 14 and expand radially outward relative to the axis of thealignment device 36. The leads 30 continue to move outward until apposition with thevein wall 54 occurs. The leads 30 contact the vein along a generally circumferential band of thevein wall 54. This outward movement of the leads occurs in a substantially symmetrical fashion. As a result, theelectrodes 34 are substantially evenly spaced along the circumferential band of thevein wall 54. Alternately, the electrodes can be spaced apart in a staggered fashion such that the electrodes do not lie along the same plane. For example, adjacent electrodes can extend different lengths from the catheter so that a smaller cross-sectional profile is achieved when the electrodes are collapsed toward one another. - When the
electrodes 34 are positioned at the treatment site of the vein, thepower supply 22 is activated to provide suitable RF energy to theelectrodes 34 so that thecatheter 10 operates in either a bipolar or monopolar manner as previously described. As shown in FIGS. 9a and 9 b, the energy causes thevein wall 54 to collapse around theelectrodes 34 causing the leads to substantially straighten and the electrodes to cluster around each other. Thewall 54 continues to collapse until further collapse is impeded by the electrodes 34 (FIG. 9b). At this point the application of energy may cease. The electrodes can be configured to form a shape with a reduced profile when collapsed together. The electrodes can also be configured and insulated to continue applying RF energy after forming a reduced profile shape by the collapse of the vein wall. Thecatheter 10 can be pulled back to ligate the adjacent venous segment. If atemperature sensor 26 is included, the application of energy may cease prior to complete collapse if the temperature of the venous tissue rises above an acceptable level as defined by thecontroller 23. - Where the catheter includes a fluid delivery lumen (not shown), fluid can be delivered before and during RF heating of the vein being treated. The fluid can displace blood from the treatment area in the vein to avoid the coagulation of blood. The fluid can be a dielectric medium. The fluid can include an anticoagulant such as heparin which can chemically discourage the coagulation of blood at the treatment site.
- After completing the procedure for a selected venous section, the actuator mechanism causes the primary leads to return to the interior of the
outer sheath 12. Either the outer sheath or the inner sheath is moved to change the position of the two elements relative to one another. Once theleads 30 are within theouter sheath 12, thecatheter 10 may be moved to another venous section where the ligation process is repeated. Upon treatment of all venous sites, thecatheter 10 is removed from the vasculature. The access point of the vein is then sutured closed, or local pressure is applied until bleeding is controlled. - Another embodiment of the catheter is illustrated in FIG. 10. The inner member or
sheath 28 is contained within theouter sheath 12. The inner sheath is preferably constructed from a flexible polymer such as polyimide, polyethylene, or nylon, and can travel the entire length of the catheter. The majority of the catheter should be flexible so as to navigate the tortuous paths of the venous system. A hypotube having a flared distal end 39 and a circular cross-sectional shape is attached over the distal end of theinner sheath 28. The hypotube is preferably no more than about two to three centimeters in length. The hypotube acts as part of the conductivesecondary lead 31. An uninsulatedconductive electrode sphere 35 is slipped over the hypotube. The flared distal end of the hypotube prevents the electrode sphere from moving beyond the distal end of the hypotube. The sphere is permanently affixed to the hypotube, such as by soldering the sphere both front and back on the hypotube. The majority or the entire surface of thespherical electrode 35 remains uninsulated. The remainder of the hypotube is preferably insulated so that the sphere-shaped distal end can act as the electrode. For example, the hypotube can be covered with an insulating material such as a coating of parylene. The interior lumen of the hypotube is lined by theinner sheath 28 which is attached to the flaired distal end of the hypotube by adhesive such as epoxy. - Surrounding the
secondary lead 31 and sphere-shapedelectrode 35 are a plurality of primary leads 30 which preferably have a flat rectangular strip shape and can act as arms. As illustrated in FIG. 11, the plurality of primary leads are preferably connected to common conductive rings 62. This configuration maintains the position of the plurality of primary leads, while reducing the number of internal electrical connections. Therings 62 are attached to theinner sheath 28. The position of the rings and the primary leads relative to the outer sheath follows that of the inner sheath. As earlier described, the hypotube of thesecondary lead 31 is also attached to theinner sheath 28. Two separate conductive rings can be used so that the polarity of different primary leads can be controlled separately. For example, adjacent primary leads can be connected to one of the two separate conductive rings so that the adjacent leads can be switched to have either opposite polarities or the same polarity. The rings are preferable spaced closely together, but remain electrically isolated from one another along the inner sheath. Both the rings and the hypotube are coupled with the inner sheath, and the primary leads 30 that are connected to the rings move together with and secondary lead while remaining electrically isolated from one another. Epoxy or another suitable adhesive can be used to attach the rings to the inner sheath. The primary leads from the respective rings each alternate with each other along the circumference of the inner sheath. The insulation along the underside of the leads prevents an electrical short between the rings. - The ring and primary leads are attached together to act as cantilevers where the ring forms the base and the rectangular primary leads operate as the cantilever arms. The leads30 are connected to the ring and are formed to have an arc or bend such that the leads act as arms which tend to spring outwardly away from the catheter and toward the surrounding venous tissue. Insulation along the underside of the leads and the rings prevents unintended electrical coupling between the leads and the opposing rings. Alternately, the leads are formed straight and connected to the ring at an angle, such that the leads tend to expand or spring radially outward from the ring. The angle at which the leads are attached to the ring should be sufficient to force the primary distal ends and
electrodes 34 through blood and into apposition with the vein wall. Other properties of the primary leads 30, such as lead shape and insulation thickness, affect the push force of the lead and the degree of arc or bend must be adjusted to compensate for these factors. The rectangular cross section of theleads 30 can provide increased stability in the lateral direction while allowing the necessary bending in the radial direction. The leads 30 are less likely to bend sideways when expanded outward, and a uniform spacing between leads is more assured. Uniform spacing between theleads 30 and the distal ends promotes uniform heating around the vein by theelectrodes 34. - The distal ends of the primary leads30 are uninsulated to act as
electrodes 34 having a spoon or hemispherical shape. The leads can be stamped to produce an integral shaped electrode at the distal end of the lead. The uninsulated outer portion of thedistal end electrode 34 which is to come into apposition with the wall of the anatomical structure is preferably rounded and convex. The flattened or non-convex inner portion of the distal end is insulated to minimize any unintended thermal effect, such as on the surrounding blood in a vein. Thedistal end electrodes 34 are configured such that when the distal ends are forced toward theinner sheath 12, as shown in FIG. 10a, the distal ends combine to form a substantially spherical shape with a profile smaller than the profile for thespherical electrode 35 at the secondary distal end. - The
outer sheath 12 can slide over and surround the primary andsecondary leads outer sheath 12 includes an orifice which is dimensioned to have approximately the same size as thespherical electrode 35 at the secondary distal end which functions as an electrode. A close or snug fit between theelectrode 35 at the secondary distal end and the orifice of theouter sheath 12 is achieved. This configuration provides an atraumatic tip for the catheter. Theelectrode 35 secondary distal end is preferably slightly larger than the orifice. The inner diameter of theouter sheath 12 is approximately the same as the reduced profile of the combined primarydistal end electrodes 34. The diameter of the reduced profile of the combined primarydistal end electrodes 34 is preferably less than the inner diameter of the outer sheath. - A fluid port (not shown) can communicate with the interior of the
outer sheath 12 so that fluid can be flushed between theouter sheath 12 and theinner sheath 28. Alternately, a fluid port can communicate with acentral lumen 48 in the hypotube which can also accept a guide wire. As previously stated, thecatheter 10 can be periodically flushed with saline which can prevent the buildup of biological fluid, such as blood, within thecatheter 10. A guide wire can be introduced through thelumen 48 for use in guiding the catheter to the desired treatment site. As previously described, a fluid can be flushed or delivered though the lumen as well. If a central lumen is not desired, the lumen of the hypotube can be filled with solder. - Preferably, the primary leads30 and the connecting rings are connected to a
power source 22 such that the polarity of the leads may be switched as desired. This allows for theelectrode device 24 to operate in either a bipolar or a monopolar configuration. When adjacent primary leads 30 have opposite polarity, a bipolar electrode operation is available. When the primary leads 30 are commonly charged a monopolar electrode operation is available in combination with a large return electrode pad placed in contact with the patient. When the primary leads 30 are commonly charged, and asecondary lead 31 has an opposite polarity, a bipolar electrode operation is available. More or fewer leads may be used. The number of leads can be dependent on the size or diameter of the hollow anatomical structure to be treated. - Although not shown, it is to be understood that the
catheter 10 can include a temperature sensor, such as a thermocouple, mounted in place on the distal end orelectrode 34 so that the sensor is substantially flush with the exposed surface of theelectrode 34. The sensor senses the temperature of the portion of the anatomical tissue that is in apposition with the exposed electrode surface. Application of the RF energy from theelectrodes 34 is halted or reduced when the monitored temperature reaches or exceeds the specific temperature that was selected by the operator, such as the temperature at which anatomical tissue begins to cauterize. Other techniques such as impedance monitoring, and ultrasonic pulse echoing can be utilized in an automated system which shuts down or regulates the application of RF energy from the electrodes to the venous section when sufficient shrinkage of the vein is detected and to avoid overheating the vein. - Referring now to FIGS. 12 through 14, in the operation of one embodiment of the
catheter 10, the catheter is inserted into a hollow anatomical structure, such as a vein. Fluoroscopy, ultrasound, an angioscope imaging technique, or another technique may be used to direct and confirm the specific placement of the catheter in the vein. The actuator is then operated to retract theouter sheath 12 to expose theleads secondary lead 31 remains substantially linear along the axis defined by the outer sheath. The primary leads 30 continue to move outward until thedistal end electrode 34 of the primary leads are placed in apposition with thevein wall 54 occurs and the outward movement of the primary leads 30 is impeded. The primary leads 30 contact the vein along a generally circumferential area of thevein wall 54. This outward movement of the primary leads 30 occurs in a substantially symmetrical fashion so that the primarydistal end electrodes 34 are substantially evenly spaced. The central-lead electrode 35 is suspended within the vein without contacting thevein wall 54. - When the
electrodes 34 are positioned at the treatment site of the vein, thepower supply 22 is activated to provide suitable RF energy. In a bipolar operation, the primary leads 30 are initially charged such that adjacent leads are oppositely charged while the secondary lead is electrically neutral. These multiple pairs of oppositely charged leads 30 form active electrode pairs to produce an RF field between them, and form a symmetrical RF field pattern along a circumferential band of the vein wall to achieve a uniform temperature distribution along the vein wall being treated. - The RF energy produces a thermal effect which causes the venous tissue to shrink, reducing the diameter of the vein. As shown in FIG. 13, the energy causes the
vein wall 54 to collapse until further collapse is impeded by theelectrodes 34. The electrodes are pressed closer together by the shrinking vein wall. Theelectrodes 34 are pressed together to assume a reduced profile shape which is sufficiently small so that the vein is effectively ligated. Upon collapse of thevein wall 54 around the primary-lead electrodes 34, the polarity of the primary-lead electrodes is switched so that all of the primary-lead electrodes are commonly charged. The secondary-lead electrode 35 is then charged so that its polarity is opposite that of the primary-lead electrodes 34. Where theprimary electrodes 34 and thesecondary electrode 35 are spaced sufficiently close together, when the vein wall collapses around the primary lead electrodes, the electrode at the distal end of the secondary lead can also come into contact with the a portion of the vein wall so that an RF field is created between theprimary electrodes 34 and thesecondary electrode 35. - The
catheter 10 is pulled back to ensure apposition between the electrodes at the distal ends of the leads and the vein wall. When thecatheter 10 is being pulled back, the primary-lead electrodes 34 remain in apposition with thevein wall 54 while the secondary-lead electrode 35 comes in contact with the portion of the vein wall previously collapsed by the primary-lead electrodes 34. RF energy passes through the venous tissue between the primary-lead electrodes 34 and the secondary-lead electrode 35. Ligation as the catheter is being retracted produces a lengthy occlusion which is stronger and less susceptible to recanalization than an acute point occlusion. - In a monopolar operation, the secondary-
lead electrode 35 remains neutral, while the primary leads 30 are commonly charged and act in conjunction with an independent electrical device, such as a large low-impedance return pad (not shown) placed in external contact with the body, to form RF fields substantially evenly spaced around the circumference of the vein. The thermal effect produced by those RF fields along the axial length of the vein wall causes the vein wall to collapse around the primary-lead electrodes. Upon collapse of the vein wall, the secondary-lead electrode is charged to have the same polarity as that of the primary-lead electrodes. The electrode device is retracted as described in the bipolar operation. - In either bipolar or monopolar operation the application of RF energy is substantially symmetrically distributed through the vein wall. As previously described, the electrodes should be spaced no more than 4 or 5 millimeters apart along the circumference of the vein, which defines the target vein diameter for a designed electrode catheter. Where the electrodes are substantially evenly spaced in a substantially symmetrical arrangement, and the spacing between the electrodes is maintained, a symmetrical distribution of RF energy increases the predictability and uniformity of the shrinkage and the strength of the occlusion.
- As shown in FIG. 14, after the
electrodes 34 come into apposition with the vein wall (FIG. 12), and before the energy is applied to ligate the vein (FIG. 13), an external tourniquet, such as an elastic compressive wrap or an inflatable bladder with a window transparent to ultrasound, is used to compress the anatomy, such as a leg, surrounding the structure to reduce the diameter of the vein. Although the compressive force being applied by the tourniquet may effectively ligate the vein, or otherwise occlude the vein by flattening the vein, for certain veins, this compressive force will not fully occlude the vein. A fixed diameter electrode catheter in this instance would not be effective. Theelectrodes 34 which are expanded outward by the formed leads 30 can accommodate this situation. - The reduction in vein diameter assists in pre-shaping the vein to prepare the vein to be molded to a ligated state. The use of an external tourniquet or elastic bandage also exsanguinates the vein and blood is forced away from the treatment site. Coagulation of blood during treatment can be avoided by this procedure. Energy is applied from the electrodes to the exsanguinated vein, and the vein is molded to a sufficiently reduced diameter to achieve ligation. The external tourniquet or elastic bandage can remain in place to facilitate healing.
- The catheter can be pulled back during the application of RF energy to ligate an extensive section of a vein. In doing so, instead of a single point where the diameter of the vein has been reduced, an extensive section of the vein has been painted by the RF energy from the catheter. Retracting the catheter in this manner produces a lengthy occlusion which is less susceptible to recanalization. The combined use of the primary and secondary electrodes can effectively produce a reduced diameter along an extensive length of the vein. The catheter can be moved while the tourniquet is compressing the vein, of after the tourniquet is removed.
- Where the catheter includes a fluid delivery lumen, fluid can be delivered to the vein before RF energy is applied to the vein. The delivered fluid displaces blood from the treatment site to ensure that blood is not present at the treatment site, even after the tourniquet compresses the vein.
- Where the tourniquet is an inflatable bladder with a window transparent to ultrasound, an ultrasound transducer is used to monitor the flattening or reduction of the vein diameter from the compressive force being applied by the inflating bladder. The window can be formed from polyurethane, or a stand-off of gel contained between a polyurethane pouch. A gel can be applied to the window to facilitate ultrasound imaging of the vein by the transducer. Ultrasound visualization through the window allows the operator to locate the desired venous treatment area, and to determine when the vein has been effectively ligated or occluded. Ultrasound visualization assists in monitoring any pre-shaping of the vein in preparation of being molded into a ligated state by the thermal effect produced by the RF energy from the electrodes.
- After completing the procedure for a selected venous section, the actuator causes the
leads 30 to return to the interior of theouter sheath 12. Once theleads 30 are within theouter sheath 12, thecatheter 10 may be moved to another venous section where the ligation process is repeated. - In another embodiment, as illustrated in FIG. 15, a
balloon 64 is located on the catheter, and can be inflated throughports 66 to occlude the vein. The inflated balloon obstructs blood flow and facilitates the infusion of a high-impedance fluid to the vein in order to reduce the occurrence of coagulation by directing the energy into the vein wall. The inflation of the balloon to occlude the vein before the application of energy can obviate the use of the tourniquet to occlude the vein. Furthermore, this also allows the vein to be occluded even for the deep veins where a compressive tourniquet may not be able to compress the vein to occlusion. It is to be understood that other mechanisms can be used to expand the diameter of the catheter to create an impermeable barrier that occludes the vein. -
Fluid 61 can be delivered after inflation of theballoon 64 and before the RF heating of the vein being treated through acoaxial channel 62 formed between theexternal sheath 60 and theouter sheath 12. It is to be understood that another lumen can be formed in the catheter to deliver fluid to the treatment site. For example, the lumen through which the guide wire is passed may be used for the delivery of fluid. The delivered fluid displaces or exsanguinates the remaining blood from the treatment area of the vein so as to avoid heating and coagulation of blood. Fluid can continue to be delivered during RF treatment to prevent blood from circulating back to the treatment site. The delivery of a high-dielectric fluid increases the surrounding impedance so that RF energy is directed into the tissue of the vein wall. Less energy is used because the energy is directed to the target; i.e., the vein wall, rather than being dissipated in the blood. Therefore, the vein wall can reach the desired temperature more rapidly than in the case where energy is permitted to reach the blood, which has a cooling effect. Additionally, blood clotting is avoided with this approach, because the blood has been replaced with another fluid such as deionized water mixed with heparin to displace blood and prevent the formation of blood clots. - A partial cross-sectional view of this embodiment is shown in FIG. 16, where an
inflation sheath 70 surrounds theexternal sheath 60 to provide acoaxial inflation lumen 72 for theballoon 64. Theinflation lumen 72 is in fluid communication with theports 66. Saline or any other suitable fluid can be used to inflate the balloon. - As shown in the FIG. 17, in one embodiment, the
balloon 64 can be used in combination with bowable members orarms 76 having electrodes, where perfusion holes 78 are formed in the catheter between theballoon 64 and thebowable arms 76. Theballoon 64 in this embodiment is inflated through a balloon inflation lumen 72 (as shown in FIG. 16). The use of bowable arms for treating veins is discussed in U.S. patent application Ser. No. 08/610,911, which is hereby incorporated by reference. The arms can be constructed so as to spring radially outward from the catheter, yet offer little resistance in moving back toward the catheter as the vein diameter is diminished to occlusion. An anti-coagulant or saline or a high-impedance fluid can be introduced or flushed through the perfusion holes 78 in the catheter. As discussed earlier, the high-impedance fluid forces blood away from the venous treatment area and prevents the energy from being dissipated in a more conductive medium such as blood. - As shown in FIG. 18, in another embodiment, a
flexible covering 80 is wrapped around or inside theleads 30 of theelectrodes 34 to prevent blood flow in the vein. The covering 80 spans the area between the splayed leads along the circumference of the catheter when the leads are extended out the opening, such that the webbed covering blocks blood flow within the vein. The covering may be thought of as webbing or an umbrella to keep blood on one side away from the electrodes. When the electrodes come into apposition with the vein wall, then the gap, if any, between theelectrodes 34 and the covering 80 should be eliminated or otherwise minimized. The covering 80 should be impermeable to fluid. Suitable materials include PET and nylon. Elastomeric materials are also suitable as the leads will need to move close together as they are retracted, and interference with the movement of the leads as the vein diameter is reduced by the application of energy is preferably minimized. Although this embodiment is illustrated with only primary leads, it is to be understood that this embodiment is not so limited and that a secondary lead may be included with the catheter as well without affecting the use of the covering. - As with the balloon disclosed earlier, the covering occludes the vein before the application of energy, such that the need for an external compressive tourniquet is not required to stop blood flow. Furthermore, this also allows the vein to be occluded even for the deep veins where a compressive tourniquet may not be able to compress the vein to occlusion. A high-impedance fluid such as deionized water, or an anti-coagulant such as heparin or saline, or both, or heparin with deionized water may be infused or flushed through a central lumen (not shown) similar to that shown in FIG. 4 as numeral48 or to that shown in FIGS. 10 and 11 before the application of energy as well. The electrodes extend through the shaft lumen which also acts as a conduit for the fluid being flushed through a central lumen 48 (not shown). A sclerosing fluid may also be delivered to the venous treatment site to enhance the ligation effect from the application of RF energy. The sclerosing fluid may be added in addition to, or in substitution of, the previously discussed fluids.
- In the embodiment shown in FIG. 19, a covering80 having a parachute shape can be oriented so that blood becomes trapped by the concave portion of the covering 80 and the volume of the blood maintains the deployment of the covering. In this example, the covering is a balloon having openings 84 which allow blood to gather in the balloon, and expand the balloon. The covering 80 can be permanently attached to the catheter shaft. The catheter can still be moved along the vein, even with the balloon in an inflated state.
- In the embodiment shown in FIG. 20, the covering80 is coupled to an
outer cannula 82 surrounding the catheter shaft and connected to an actuation mechanism or lever. Theouter cannula 82 can be slid along the longitudinal axis of the catheter to allow one end of the parachute covering 80 to be moved axially along the catheter shaft. During insertion of the catheter, the movable end of the covering is pulled away from the connecting end of the catheter to collapse the covering against the catheter. After the catheter is delivered to the venous treatment site, thecannula 82 is slid toward the working end to deploy the covering 80 which then fills with blood entering through the openings 84, thereby occluding the vein. The covering expands as it fills with blood, and when the covering comes into contact with the vein wall, the vein is occluded. Fluid, as before, can be infused either through perfusion holes 78 or a coaxial channel 48 (not shown). - In the embodiment shown in the cross-sectional view of FIG. 21, the
catheter 10 includes an expandable section having askeleton 90 disposed along a portion of the working end of the catheter. Theskeleton 90 is more flexible than the surrounding shaft of the catheter, and can be constructed from a metal or polymer braid. Aflexible membrane 92 covers theskeleton 90, with the ends of the membrane attached to the shaft of the catheter adjacent the skeleton. The membrane is preferably constructed from an elastomeric material. As shown in FIG. 22, when the tip of the connecting end is moved toward the working end of the catheter, or vice versa, theskeleton 90 is deformed and forces themembrane 92 out into contact with the vein wall. This embodiment does not require a separate lumen to provide an inflation fluid to a balloon. Theskeleton 90 is preferably resilient so that it returns to its original shape once the working end and connecting end are no longer being forced toward one another. Mechanisms for moving the connecting end toward the working end of the catheter for expanding the diameter of a catheter are also discussed in U.S. patent application Ser. No. 08/610,911, which has been incorporated by reference. Although the expandable section may be controlled separately from the extension of the electrode, the expandable section can be controlled by the same mechanism which extends the electrodes away from the catheter. - The description of the component parts discussed above are for a catheter to be used in a vein ranging in size from 3 mm (0.12 in) to 10 mm (0.39 in) in diameter. It is to be understood that these dimensions do not limit the scope of the invention and are merely exemplary in nature. The dimensions of the component parts may be changed to configure a
catheter 10 that may used in various-sized veins or other anatomical structures. - When treating the veins of the lower hemorrhoidal region, the access site is prepared. A guide wire is passed into the vein, and advanced through to the venous treatment site. Alternatively, the catheter may be inserted into the vein directly and manipulated without a guide wire. The guide wire can be advanced retrograde to the venous treatment site. Several intravenous paths may be taken to the hemorrhoidal treatment site, and it is to be understood that other access sites can be used to treat either internal or external hemorrhoids.
- A partial cross-sectional view of the venous system leading to the hemorrhoidal region is shown in FIG. 23. Hemorrhoids are generally defined as internal or external depending on whether they are formed above or below the dentate line DL, respectively. Internal hemorrhoids IH are commonly formed when the smaller veins draining to the superior hemorrhoidal vein SHV or the middle hemorrhoidal vein MHV become dilated. External hemorrhoids are commonly formed when the smaller veins draining to the inferior hemorrhoidal vein IHV become dilated.
- One method of delivering the
catheter 10 and guide wire 13 is to introduce the guide wire 13 into the external iliac vein El on the side opposite to the dilated veins of the hemorrhoid. The guide wire is steered across the bifurcated branch of the inferior vena cava IVC to the inferior iliac vein II. The guide wire is then maneuvered into either the middle hemorrhoidal vein MHV to treat internal hemorrhoids, or the pudendal vein PV and then the inferior hemorrhoidal vein IHV to treat external hemorrhoids. The guide wire 13 is deployed and maneuvered into the middle hemorrhoidal vein MHV to treat an internal hemorrhoid. The guide wire 13 is maneuvered through the venous system until it reaches the dilated veins of the hemorrhoid. Thecatheter 10 is then delivered to the venous treatment site over the guide wire 13, as shown in FIG. 23. The working end 11 of thecatheter 10 includes a plurality of leads and electrodes for applying RF energy once properly positioned at the venous treatment site to ligate or occlude the vein. The catheter should be flexible to allow tracking of the catheter over the guide wire and through bends in the venous vascular system. Fluoroscopy, x-ray, ultrasound, or a similar imaging technique could be used to direct the specific placement of the catheter and to confirm position within the vein. - Another method of delivering the catheter and guide wire is to introduce the guide wire into the superior hemorrhoidal vein and maneuver the guide wire through the superior hemorrhoidal vein SHV to the hemorrhoidal region. The guide wire is maneuvered into position, and the catheter is then delivered over the guide wire to the venous treatment site for the internal hemorrhoid. The venous treatment site is within the lumen of a dilated vein, and the electrode leads expand away from the body of the catheter to come into apposition with the wall of the dilated vein.
- When the electrode leads of the
catheter 10 are positioned at the venous treatment site, an RF generator is activated to provide suitable RF energy to cause heating of the surrounding venous tissue. The energy emitted from the electrodes is converted within the venous tissue into heat. As previously discussed, the application of energy causes the vein to collapse and become effectively occluded or ligated. - In another anatomical region, varicose veins called esophageal varices can form in the venous system along the submucosa of the lower esophagus, and bleeding can occur from the swollen veins. When treating the veins of the lower esophageal region, the access site is prepared, and a guide wire13 is passed into the vein and advanced through to the venous treatment site. The guide wire can be deployed and manipulated so as to reach the treatment site for treating the esophageal varices. The venous treatment site is preferably within the lumen of a dilated vein. The wire is advanced to the venous treatment site, such as the level of the most proximal incompetent vein site which is to be treated. Preferably, the guide wire and catheter are advanced antegrade to the esophageal treatment site. Alternatively, the catheter may be inserted into the vein directly and manipulated without a guide wire. Fluoroscopy, x-ray, ultrasound, or a similar imaging technique could be used to direct the specific placement of the catheter and to confirm position within the vein. A properly
sized catheter 10 delivers the electrode leads 12 to the site of venous dysfunction along the esophageal varix. The electrodes apply RF energy or other forms of energy at a suitable power or frequency to cause the vein to collapse and become effectively occluded or ligated. - As shown in FIG. 24, in a partial view of the venous system leading to the esophageal region, the
catheter 10 is advanced over the guide wire 13 to a dilated section of the vein. One method of delivering the catheter and guide wire is to introduce the guide wire through the superior mesenteric vein SMV to the portal vein PV and coronary vein CV which branches and leads to the lower esophagus E to form the esophageal veins EV. As an alternate route, the guide wire could be introduced into the inferior mesenteric vein, and routed through the splenic vein SV, the portal vein PV, and the coronary vein CV to arrive at the esophageal varix to be treated. - Referring now to FIG. 25, ligation of a fallopian tube is shown. A
guide wire 120 has been located in the fallopian tube F and thecatheter 122 is also positioned in the fallopian tube F through thefallopian tube ostium 126. The shaft of the catheter has been introduced through the uterus U with anendoscope 128. The working end of the catheter may now be energized as described above to perform an intra-fallopian tube ligation. The second fallopian tube may then also be ligated in the same manner. - The lumen may be exsanguinated by compression or by a fluid flush. Further, prior to or during the application of energy to the hollow anatomical structure, the structure may be compressed or pre-sized. The esophageal varix can be externally compressed by inflating a balloon, such as those used as a tamponade, within the esophagus to apply pressure external to the esophageal varices to be treated. One method for compressing the lumen of the fallopian tube by external means is with pnuemoperitoneum. In a further feature, the lumen, particularly the lumen of a fallopian tube, may be compressed by the application of negative pressure through the catheter. For example, in an open end catheter, a negative pressure may be applied to the lumen at that open end. If desired, an inflatable balloon may be mounted to the shaft of the catheter proximal to the orifice through which the negative pressure is applied to assist in its application to the lumen. Other arrangements are possible, such as the use of ports in the wall of the catheter through which negative pressure may be applied. Negative pressure can also be applied to compress or pre-size veins.
- Although described above as positively charged, negatively charged, or as a first polarity, opposite polarity, or as a positive conductor or negative conductor, these terms are used for purposes of illustration only. These terms are generally meant to refer to different electrode potentials and are not meant to indicate that any particular voltage is positive or negative. Furthermore, other types of energy such as light energy from fiber optics or microwaves can be used to create a thermal effect in the hollow anatomical structure undergoing treatment. While the particular hollow anatomical structure may be a vein (e.g., varicose veins, hemorrhoids, esophageal varices, etc.) or a fallopian tube, it is to be understood that other anatomical structures can be ligated using the system disclosed herein.
- While several particular forms of the invention have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
Claims (46)
1. A method of applying energy intraluminally to a fallopian tube from a power source, the method comprising the steps of:
introducing into the fallopian tube a catheter having a working end with a plurality of expandable primary leads disposed at the working end, each primary lead having a distal end and being connected to the power source;
expanding the primary leads outwardly from the working end of the catheter, wherein the distal ends of the primary leads move away from each other and into contact with the wall of the fallopian tube; and
applying energy to the fallopian tube from the distal end of the primary leads to collapse and effectively occlude the fallopian tube.
2. The method of claim 1 further comprising the step of moving a sheath and the plurality of expandable primary leads in relation to each other to selectively expand the primary leads outwardly or contract the primary leads.
3. The method of claim 1 wherein the step of introducing a catheter into the fallopian tube comprises the step of introducing a plurality of expandable primary leads that are mounted to the working end in a cantilever arrangement.
4. The method of claim 3 further comprising the step of moving a sheath away from the cantilevered expandable primary leads such that the primary leads extend past an orifice of the sheath at the working end of the catheter and expand outwardly.
5. The method of claim 1 further comprising the step of moving the catheter in the fallopian tube during the step of applying energy to the fallopian tube.
6. The method of claim 5 further comprising the step of compressing the fallopian tube to reduce the fallopian tube to a desired size during the step of applying energy to the fallopian tube.
7. The method of claim 1 wherein the step of introducing a catheter into the fallopian tube comprises introducing a catheter also having a secondary lead mounted at the working end, the secondary lead having a distal end and having a length exceeding that of the primary leads; and
wherein the step of extending the plurality of primary leads further includes the step of extending the secondary lead through the distal orifice.
8. The method of claim 1 wherein the step of applying energy to the fallopian tube comprises the steps of:
controlling the power source so that adjacent primary leads are of opposite polarity while maintaining the secondary lead so that it is electrically neutral;
switching the polarity of the primary leads so that they are all of the same polarity upon collapse of the fallopian tube around the primary leads; and
controlling the power source so that the secondary lead is of opposite polarity relative to the primary leads upon performing the step of switching the polarity of the primary leads so that they are of the same polarity.
9. The method of claim 1 wherein the step of introducing a catheter into the fallopian tube comprises introducing a catheter also having an outward bend formed in each primary lead, the bend formed in the direction away from the other primary leads such that each primary lead tends to move outward away from the other primary leads in the step of expanding the primary leads.
10. The method of claim 1 further comprising the steps of:
sensing the temperature at a primary lead;
controlling the application of power to the primary lead in response to the temperature sensed at the lead.
11. The method of claim 1 further comprising the step of flushing the fallopian tube with fluid before the step of applying energy.
12. The method of claim 1 further comprising the step of compressing the fallopian tube during the step of applying energy.
13. The method of claim 12 wherein the step of compressing the fallopian tube comprises the step of applying negative pressure to the fallopian tube.
14. The method of claim 12 wherein the step of compressing the fallopian tube comprises the step of creating a pneumoperitoneum.
15. The method of claim 1 further comprising the step of compressing the fallopian tube to a desired size before and during the step of applying energy.
16. A method of applying energy intraluminally to a hemorrhoid from a power source, the method comprising the steps of:
introducing into the hemorrhoid a catheter having a working end with a plurality of expandable primary leads disposed at the working end, each expandable primary lead having a distal end and being connected to the power source;
expanding the primary leads outwardly from the working end of the catheter, wherein the distal ends of the primary leads move away from each other and into contact with the wall of the hemorrhoid; and
applying energy to the hemorrhoid from the distal end of the primary leads to collapse the hemorrhoid to effectively occlude the hemorrhoid.
17. The method of claim 16 further comprising the step of moving a sheath and the plurality of expandable primary leads in relation to each other to selectively expand the primary leads outwardly or contract the primary leads.
18. The method of claim 16 wherein the step of introducing a catheter into the hemorrhoid comprises the step of introducing a plurality of expandable primary leads that are mounted to the working end in a cantilever arrangement.
19. The method of claim 18 further comprising the step of moving a sheath away from the cantilevered expandable primary leads such that the primary leads extend past an orifice of the sheath at the working end of the catheter and expand outwardly.
20. The method of claim 16 further comprising the step of moving the catheter in the hemorrhoid while continuing to apply energy to the hemorrhoid.
21. The method of claim 20 further comprising the step of compressing the hemorrhoid during the step of applying energy.
22. The method of claim 16 wherein the step of introducing a catheter into the hemorrhoid comprises introducing a catheter also having a secondary lead mounted at the working end, the secondary lead having a distal end and having a length exceeding that of the primary leads; and
wherein the step of extending the plurality of primary leads further includes the step of extending the secondary lead through the distal orifice.
23. The method of claim 16 wherein the step of applying energy to the hemorrhoid comprises the steps of:
controlling the power source so that adjacent primary leads are of opposite polarity while maintaining the secondary lead so that it is electrically neutral;
switching the polarity of the primary leads so that they are all of the same polarity upon collapse of the hemorrhoid around the primary leads; and
controlling the power source so that the secondary lead is of opposite polarity relative to the primary leads upon performing the step of switching the polarity of the primary leads so that they are of the same polarity.
24. The method of claim 16 wherein the step of introducing a catheter into the hemorrhoid comprises introducing a catheter also having an outward bend formed in each primary lead, the bend formed in the direction away from the other primary leads such that each primary lead tends to move outward away from the other primary leads in the step of expanding the primary leads.
25. The method of claim 16 further comprising the steps of:
sensing the temperature at a primary lead;
controlling the application of power to the primary lead in response to the temperature sensed at the lead.
26. The method of claim 16 further comprising the step of flushing the hemorrhoid with fluid before the step of applying energy.
27. The method of claim 16 further comprising the step of compressing the hemorrhoid to a desired size before and during the step of applying energy.
28. The method of claim 27 wherein the step of compressing the hemorrhoid comprises the step of applying negative pressure to the hemorrhoid.
29. The method of claim 16 further comprising the step of exsanguinating the hemorrhoid before and during the step of applying energy.
30. The method of claim 29 wherein the step of exsanguinating the hollow anatomical structure comprises the step of delivering fluid to displace blood from the hemorrhoid.
31. A method of applying energy intraluminally to an esophageal varix from a power source, the method comprising the steps of:
introducing into the esophageal varix a catheter having a working end with a plurality of primary leads disposed at the working end, each primary lead having a distal end and being connected to the power source;
expanding the primary leads outwardly from the working end of the catheter, wherein the distal ends of the primary leads move away from each other and into contact with the wall of the esophageal varix; and
applying energy to the esophageal varix from the distal end of the primary leads to collapse the esophageal varix to effectively occlude the esophageal varix.
32. The method of claim 31 further comprising the step of moving a sheath and the plurality of expandable primary leads in relation to each other to selectively expand the primary leads outwardly or contract the primary leads.
33. The method of claim 31 wherein the step of introducing a catheter into the esophageal varix comprises the step of introducing a plurality of expandable primary leads that are mounted to the working end in a cantilever arrangement.
34. The method of claim 33 further comprising the step of moving a sheath away from the cantilevered expandable primary leads such that the primary leads extend past an orifice of the sheath at the working end of the catheter and expand outwardly.
35. The method of claim 31 further comprising the step of moving the catheter in the esophageal varix while continuing to apply energy to the esophageal varix.
36. The method of claim 31 further comprising the step of compressing the esophageal varix during the step of applying energy.
37. The method of claim 31 wherein the step of introducing a catheter into the esophageal varix comprises introducing a catheter also having a secondary lead mounted at the working end, the secondary lead having a distal end and having a length exceeding that of the primary leads; and
wherein the step of extending the plurality of primary leads further includes the step of extending the secondary lead through the distal orifice.
38. The method of claim 31 wherein the step of applying energy to the esophageal varix comprises the steps of:
controlling the power source so that adjacent primary leads are of opposite polarity while maintaining the secondary lead so that it is electrically neutral;
switching the polarity of the primary leads so that they are all of the same polarity upon collapse of the esophageal varix around the primary leads; and
controlling the power source so that the secondary lead is of opposite polarity relative to the primary leads upon performing the step of switching the polarity of the primary leads so that they are of the same polarity.
39. The method of claim 31 wherein the step of introducing a catheter into the esophageal varix comprises introducing a catheter also having an outward bend formed in each primary lead, the bend formed in the direction away from the other primary leads such that each primary lead tends to move outward away from the other primary leads in the step of expanding the primary leads.
40. The method of claim 31 further comprising the steps of:
sensing the temperature at a primary lead;
controlling the application of power to the primary lead in response to the temperature sensed at the lead.
41. The method of claim 31 further comprising the step of flushing the esophageal varix with fluid before the step of applying energy.
42. The method of claim 31 further comprising the step of compressing the esophageal varix to a desired size before the step of applying energy.
43. The method of claim 42 wherein the step of compressing the esophageal varix comprises the step of applying negative pressure to the esophageal varix.
44. The method of claim 42 wherein the step of compressing the esophageal varix comprises the step of applying pressure external to the esophageal varix from within the esophagus.
45. The method of claim 31 further comprising the step of exsanguinating the esophageal varix before and during the step of applying energy.
46. The method of claim 45 wherein the step of exsanguinating the hollow anatomical structure comprises the step of delivering fluid to displace blood from the esophageal varix.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/164,928 US20020148476A1 (en) | 1997-09-11 | 2002-06-07 | Method of ligating hollow anatomical structures |
US12/258,358 US8267931B2 (en) | 1997-09-11 | 2008-10-24 | Method of ligating hollow anatomical structures |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/927,251 US6200312B1 (en) | 1997-09-11 | 1997-09-11 | Expandable vein ligator catheter having multiple electrode leads |
US08/958,766 US6165172A (en) | 1997-09-11 | 1997-10-26 | Expandable vein ligator catheter and method of use |
US09/138,808 US6401719B1 (en) | 1997-09-11 | 1998-08-21 | Method of ligating hollow anatomical structures |
US10/164,928 US20020148476A1 (en) | 1997-09-11 | 2002-06-07 | Method of ligating hollow anatomical structures |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/138,808 Continuation US6401719B1 (en) | 1997-09-11 | 1998-08-21 | Method of ligating hollow anatomical structures |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/258,358 Division US8267931B2 (en) | 1997-09-11 | 2008-10-24 | Method of ligating hollow anatomical structures |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020148476A1 true US20020148476A1 (en) | 2002-10-17 |
Family
ID=27129940
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/138,808 Expired - Lifetime US6401719B1 (en) | 1997-09-11 | 1998-08-21 | Method of ligating hollow anatomical structures |
US09/497,278 Expired - Fee Related US6689126B1 (en) | 1997-09-11 | 2000-02-03 | Expandable vein ligator catheter and method of use |
US09/497,099 Expired - Lifetime US6398780B1 (en) | 1997-09-11 | 2000-02-03 | Expandable vein ligator catheter and method of use |
US10/162,057 Expired - Fee Related US7041098B2 (en) | 1997-09-11 | 2002-06-03 | Expandable vein ligator catheter and method of use |
US10/164,928 Abandoned US20020148476A1 (en) | 1997-09-11 | 2002-06-07 | Method of ligating hollow anatomical structures |
US10/775,841 Abandoned US20040162555A1 (en) | 1997-09-11 | 2004-02-09 | Expandable vein ligator catheter and method of use |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/138,808 Expired - Lifetime US6401719B1 (en) | 1997-09-11 | 1998-08-21 | Method of ligating hollow anatomical structures |
US09/497,278 Expired - Fee Related US6689126B1 (en) | 1997-09-11 | 2000-02-03 | Expandable vein ligator catheter and method of use |
US09/497,099 Expired - Lifetime US6398780B1 (en) | 1997-09-11 | 2000-02-03 | Expandable vein ligator catheter and method of use |
US10/162,057 Expired - Fee Related US7041098B2 (en) | 1997-09-11 | 2002-06-03 | Expandable vein ligator catheter and method of use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/775,841 Abandoned US20040162555A1 (en) | 1997-09-11 | 2004-02-09 | Expandable vein ligator catheter and method of use |
Country Status (13)
Country | Link |
---|---|
US (6) | US6401719B1 (en) |
EP (1) | EP1035796A2 (en) |
JP (1) | JP4131609B2 (en) |
CN (1) | CN1154447C (en) |
AU (1) | AU740000B2 (en) |
BR (1) | BR9814738A (en) |
CA (1) | CA2303021C (en) |
IL (1) | IL135008A0 (en) |
NO (1) | NO328108B1 (en) |
NZ (1) | NZ503367A (en) |
PL (1) | PL339518A1 (en) |
RU (1) | RU2207822C2 (en) |
WO (1) | WO1999012489A2 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6964274B1 (en) | 2004-06-07 | 2005-11-15 | Ethicon, Inc. | Tubal sterilization device having expanding electrodes and method for performing sterilization using the same |
US20060030849A1 (en) * | 2004-08-05 | 2006-02-09 | Vnus Medical Technologies, Inc. | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US20060089637A1 (en) * | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US20060189967A1 (en) * | 2005-02-21 | 2006-08-24 | Leonardo Masotti | Device, a catheter, and a method for the curative treatment of varicose veins |
US20060189979A1 (en) * | 2005-02-23 | 2006-08-24 | Esch Brady D | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US7250050B2 (en) | 2004-06-07 | 2007-07-31 | Ethicon, Inc. | Tubal sterilization device having sesquipolar electrodes and method for performing sterilization using the same |
US20080161893A1 (en) * | 2006-12-29 | 2008-07-03 | Saurav Paul | Fabric electrode head |
US20090156981A1 (en) * | 2006-10-04 | 2009-06-18 | Celon Ag Medical Instruments | Flexible Catheter for High-Frequency Therapy of Biological Tissue and Method of Using Same |
US8048101B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US8048086B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US8052669B2 (en) | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US20130012940A1 (en) * | 2005-05-13 | 2013-01-10 | Kai Desinger | Flexible application device for the high-frequency treatment of biological tissue |
US20140194716A1 (en) * | 2013-01-08 | 2014-07-10 | Biosense Webster (Israel), Ltd. | Catheter with multiple spines of different lengths arranged in one or more distal assemblies |
US8936631B2 (en) | 2010-01-04 | 2015-01-20 | Covidien Lp | Apparatus and methods for treating hollow anatomical structures |
US9238127B2 (en) | 2004-02-25 | 2016-01-19 | Femasys Inc. | Methods and devices for delivering to conduit |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
Families Citing this family (255)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6705323B1 (en) | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US6176240B1 (en) | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
AU733465B2 (en) * | 1996-03-05 | 2001-05-17 | Tyco Healthcare Group, Lp | Vascular catheter-based system for heating tissue |
US7604633B2 (en) | 1996-04-12 | 2009-10-20 | Cytyc Corporation | Moisture transport system for contact electrocoagulation |
US5957920A (en) * | 1997-08-28 | 1999-09-28 | Isothermix, Inc. | Medical instruments and techniques for treatment of urinary incontinence |
DE69836801D1 (en) | 1997-03-04 | 2007-02-15 | Vnus Med Tech Inc | DEVICE FOR TREATING VENOUS INSUFFICIENCY BY MEANS OF DIRECTIVE ENERGY |
EP1005296B8 (en) * | 1997-06-05 | 2005-06-08 | Adiana, Inc. | Apparatus for tubal occlusion |
US6401719B1 (en) * | 1997-09-11 | 2002-06-11 | Vnus Medical Technologies, Inc. | Method of ligating hollow anatomical structures |
US6258084B1 (en) * | 1997-09-11 | 2001-07-10 | Vnus Medical Technologies, Inc. | Method for applying energy to biological tissue including the use of tumescent tissue compression |
US6200312B1 (en) * | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
US6179832B1 (en) * | 1997-09-11 | 2001-01-30 | Vnus Medical Technologies, Inc. | Expandable catheter having two sets of electrodes |
US8551082B2 (en) | 1998-05-08 | 2013-10-08 | Cytyc Surgical Products | Radio-frequency generator for powering an ablation device |
US6740082B2 (en) | 1998-12-29 | 2004-05-25 | John H. Shadduck | Surgical instruments for treating gastro-esophageal reflux |
US6889089B2 (en) * | 1998-07-28 | 2005-05-03 | Scimed Life Systems, Inc. | Apparatus and method for treating tumors near the surface of an organ |
US6309384B1 (en) * | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
US8702727B1 (en) | 1999-02-01 | 2014-04-22 | Hologic, Inc. | Delivery catheter with implant ejection mechanism |
US8285393B2 (en) * | 1999-04-16 | 2012-10-09 | Laufer Michael D | Device for shaping infarcted heart tissue and method of using the device |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6709667B1 (en) * | 1999-08-23 | 2004-03-23 | Conceptus, Inc. | Deployment actuation system for intrafallopian contraception |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US7150727B2 (en) * | 2000-05-11 | 2006-12-19 | Zevex, Inc. | Apparatus and method for preventing free flow in an infusion line |
US7815612B2 (en) | 2000-05-11 | 2010-10-19 | Zevex, Inc. | Apparatus and method for preventing free flow in an infusion line |
US6595950B1 (en) * | 2000-05-11 | 2003-07-22 | Zevex, Inc. | Apparatus and method for preventing free flow in an infusion line |
US20030120256A1 (en) * | 2001-07-03 | 2003-06-26 | Syntheon, Llc | Methods and apparatus for sclerosing the wall of a varicose vein |
US20050113798A1 (en) * | 2000-07-21 | 2005-05-26 | Slater Charles R. | Methods and apparatus for treating the interior of a blood vessel |
US7077836B2 (en) * | 2000-07-21 | 2006-07-18 | Vein Rx, Inc. | Methods and apparatus for sclerosing the wall of a varicose vein |
US20050107738A1 (en) * | 2000-07-21 | 2005-05-19 | Slater Charles R. | Occludable intravascular catheter for drug delivery and method of using the same |
DE10042493A1 (en) | 2000-08-30 | 2002-03-14 | Ethicon Endo Surgery Europe | System for treating varicose veins |
US6620128B1 (en) * | 2000-10-20 | 2003-09-16 | Advanced Cardiovascular Systems, Inc. | Balloon blowing process with metered volumetric inflation |
EP1357842B1 (en) * | 2001-01-16 | 2010-11-03 | Cytyc Surgical Products | Apparatus and method for treating venous reflux |
DE60210111T2 (en) * | 2001-09-28 | 2007-03-29 | Rita Medical Systems, Inc., Mountain View | IMPEDANCE-CONTROLLED DEVICE FOR THE ABLATION OF TISSUE |
US6669693B2 (en) * | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
US6736822B2 (en) * | 2002-02-20 | 2004-05-18 | Mcclellan Scott B. | Device and method for internal ligation of tubular structures |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US6780182B2 (en) * | 2002-05-23 | 2004-08-24 | Adiana, Inc. | Catheter placement detection system and operator interface |
US20060267255A1 (en) * | 2003-01-31 | 2006-11-30 | Daniela Tomova | Process for producing a performance enhanced single-layer blow-moulded container |
US7223266B2 (en) * | 2003-02-04 | 2007-05-29 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US7115127B2 (en) * | 2003-02-04 | 2006-10-03 | Cardiodex, Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
WO2004087235A2 (en) * | 2003-03-27 | 2004-10-14 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
US7293562B2 (en) * | 2003-03-27 | 2007-11-13 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
JP2007504910A (en) | 2003-09-12 | 2007-03-08 | ミノウ・メディカル・エルエルシイ | Selectable biased reshaping and / or excision of atherosclerotic material |
DE10345023A1 (en) * | 2003-09-24 | 2005-04-21 | Biotronik Gmbh & Co Kg | Ablation catheter, comprising electrode holding elements in radial extended position when released |
US7431717B2 (en) * | 2003-09-30 | 2008-10-07 | Serene Medical, Inc. | Central nervous system administration of medications by means of pelvic venous catheterization and reversal of Batson's Plexus |
US20050107867A1 (en) * | 2003-11-17 | 2005-05-19 | Taheri Syde A. | Temporary absorbable venous occlusive stent and superficial vein treatment method |
US20050137646A1 (en) * | 2003-12-22 | 2005-06-23 | Scimed Life Systems, Inc. | Method of intravascularly delivering stimulation leads into brain |
US8060207B2 (en) * | 2003-12-22 | 2011-11-15 | Boston Scientific Scimed, Inc. | Method of intravascularly delivering stimulation leads into direct contact with tissue |
DE102004015641B3 (en) * | 2004-03-31 | 2006-03-09 | Siemens Ag | Device for elimination of complete occlusion with IVUS monitoring |
WO2006023203A1 (en) * | 2004-08-19 | 2006-03-02 | Vein Rx, Inc. | An occludable intravascular catheter for drug delivery and method of using the same |
US7402320B2 (en) * | 2004-08-31 | 2008-07-22 | Vnus Medical Technologies, Inc. | Apparatus, material compositions, and methods for permanent occlusion of a hollow anatomical structure |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US20060069303A1 (en) * | 2004-09-30 | 2006-03-30 | Couvillon Lucien A Jr | Endoscopic apparatus with integrated hemostasis device |
JP5068662B2 (en) | 2004-11-22 | 2012-11-07 | カーディオデックス リミテッド | Heat treatment technology for varicose veins |
US7731712B2 (en) | 2004-12-20 | 2010-06-08 | Cytyc Corporation | Method and system for transcervical tubal occlusion |
KR20060072734A (en) * | 2004-12-23 | 2006-06-28 | 두산인프라코어 주식회사 | Appareatus for supplying compressed air of construction heavy equipments |
US20070156210A1 (en) * | 2005-01-14 | 2007-07-05 | Co-Repair, Inc., A California Corporation | Method for the treatment of heart tissue |
US20070156209A1 (en) * | 2005-01-14 | 2007-07-05 | Co-Repair, Inc. | System for the treatment of heart tissue |
US7455670B2 (en) * | 2005-01-14 | 2008-11-25 | Co-Repair, Inc. | System and method for the treatment of heart tissue |
US7972354B2 (en) | 2005-01-25 | 2011-07-05 | Tyco Healthcare Group Lp | Method and apparatus for impeding migration of an implanted occlusive structure |
US20080015569A1 (en) | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Methods and apparatus for treatment of atrial fibrillation |
US9510732B2 (en) | 2005-10-25 | 2016-12-06 | Intuitive Surgical Operations, Inc. | Methods and apparatus for efficient purging |
US8078266B2 (en) | 2005-10-25 | 2011-12-13 | Voyage Medical, Inc. | Flow reduction hood systems |
US7930016B1 (en) | 2005-02-02 | 2011-04-19 | Voyage Medical, Inc. | Tissue closure system |
US8137333B2 (en) | 2005-10-25 | 2012-03-20 | Voyage Medical, Inc. | Delivery of biological compounds to ischemic and/or infarcted tissue |
US7918787B2 (en) | 2005-02-02 | 2011-04-05 | Voyage Medical, Inc. | Tissue visualization and manipulation systems |
US8050746B2 (en) | 2005-02-02 | 2011-11-01 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US11478152B2 (en) | 2005-02-02 | 2022-10-25 | Intuitive Surgical Operations, Inc. | Electrophysiology mapping and visualization system |
US10064540B2 (en) | 2005-02-02 | 2018-09-04 | Intuitive Surgical Operations, Inc. | Visualization apparatus for transseptal access |
US7860555B2 (en) | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue visualization and manipulation system |
US7860556B2 (en) | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue imaging and extraction systems |
DE102005038694A1 (en) * | 2005-04-11 | 2006-10-26 | Erbe Elektromedizin Gmbh | Endoscopic surgery device |
US7674260B2 (en) | 2005-04-28 | 2010-03-09 | Cytyc Corporation | Emergency hemostasis device utilizing energy |
EP2662042A3 (en) | 2005-07-21 | 2017-03-22 | Covidien LP | Systems and methods for treating a hollow anatomical structure |
CN102225024B (en) | 2005-07-21 | 2013-05-01 | 泰科医疗集团有限合伙公司 | Systems and methods for treating a hollow anatomical structure |
US7957815B2 (en) | 2005-10-11 | 2011-06-07 | Thermage, Inc. | Electrode assembly and handpiece with adjustable system impedance, and methods of operating an energy-based medical system to treat tissue |
US8702691B2 (en) * | 2005-10-19 | 2014-04-22 | Thermage, Inc. | Treatment apparatus and methods for delivering energy at multiple selectable depths in tissue |
US8221310B2 (en) | 2005-10-25 | 2012-07-17 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US9101742B2 (en) * | 2005-10-28 | 2015-08-11 | Baxter International Inc. | Gastrointestinal applicator and method of using same |
US9017361B2 (en) | 2006-04-20 | 2015-04-28 | Covidien Lp | Occlusive implant and methods for hollow anatomical structure |
US9138250B2 (en) | 2006-04-24 | 2015-09-22 | Ethicon Endo-Surgery, Inc. | Medical instrument handle and medical instrument having a handle |
US20070250012A1 (en) * | 2006-04-24 | 2007-10-25 | Ifung Lu | Medical instrument having a medical needle-knife |
US8211114B2 (en) | 2006-04-24 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Medical instrument having a medical snare |
US7837620B2 (en) | 2006-04-25 | 2010-11-23 | Ethicon Endo-Surgery, Inc. | Medical tubular assembly |
US7927327B2 (en) * | 2006-04-25 | 2011-04-19 | Ethicon Endo-Surgery, Inc. | Medical instrument having an articulatable end effector |
US20070255312A1 (en) * | 2006-05-01 | 2007-11-01 | Ifung Lu | Medical instrument having an end-effector-associated member |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US7758593B2 (en) * | 2006-05-04 | 2010-07-20 | Ethicon Endo-Surgery, Inc. | Medical instrument handle and medical instrument having same |
US7597661B2 (en) * | 2006-05-11 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Medical instrument having a catheter and method for using a catheter |
US7959642B2 (en) | 2006-05-16 | 2011-06-14 | Ethicon Endo-Surgery, Inc. | Medical instrument having a needle knife |
US7892166B2 (en) * | 2006-05-18 | 2011-02-22 | Ethicon Endo-Surgery, Inc. | Medical instrument including a catheter having a catheter stiffener and method for using |
US20080039746A1 (en) | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US9055906B2 (en) | 2006-06-14 | 2015-06-16 | Intuitive Surgical Operations, Inc. | In-vivo visualization systems |
US20080097476A1 (en) | 2006-09-01 | 2008-04-24 | Voyage Medical, Inc. | Precision control systems for tissue visualization and manipulation assemblies |
US10004388B2 (en) | 2006-09-01 | 2018-06-26 | Intuitive Surgical Operations, Inc. | Coronary sinus cannulation |
WO2008028149A2 (en) | 2006-09-01 | 2008-03-06 | Voyage Medical, Inc. | Electrophysiology mapping and visualization system |
JP4201037B2 (en) * | 2006-09-14 | 2008-12-24 | ソニー株式会社 | Lens barrel rotation imaging device |
US8486060B2 (en) | 2006-09-18 | 2013-07-16 | Cytyc Corporation | Power ramping during RF ablation |
AU2007216674A1 (en) * | 2006-09-21 | 2008-04-10 | Cathrx Ltd | A catheter assembly |
EP2954868A1 (en) | 2006-10-18 | 2015-12-16 | Vessix Vascular, Inc. | Tuned rf energy and electrical tissue characterization for selective treatment of target tissues |
WO2008049082A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | Inducing desirable temperature effects on body tissue |
AU2007310991B2 (en) | 2006-10-18 | 2013-06-20 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US10335131B2 (en) | 2006-10-23 | 2019-07-02 | Intuitive Surgical Operations, Inc. | Methods for preventing tissue migration |
US20090036840A1 (en) * | 2006-11-22 | 2009-02-05 | Cytyc Corporation | Atraumatic ball tip and side wall opening |
US20100063360A1 (en) * | 2006-11-28 | 2010-03-11 | Adiana, Inc. | Side-arm Port Introducer |
JP2008132163A (en) * | 2006-11-28 | 2008-06-12 | Olympus Medical Systems Corp | Tool for treatment of body lumen occlusion |
US20080183036A1 (en) | 2006-12-18 | 2008-07-31 | Voyage Medical, Inc. | Systems and methods for unobstructed visualization and ablation |
US9226648B2 (en) | 2006-12-21 | 2016-01-05 | Intuitive Surgical Operations, Inc. | Off-axis visualization systems |
US8131350B2 (en) | 2006-12-21 | 2012-03-06 | Voyage Medical, Inc. | Stabilization of visualization catheters |
US7846160B2 (en) | 2006-12-21 | 2010-12-07 | Cytyc Corporation | Method and apparatus for sterilization |
US20080200873A1 (en) * | 2007-02-16 | 2008-08-21 | Alejandro Espinosa | Methods and Apparatus for Infusing the Interior of a Blood Vessel |
WO2008134457A1 (en) | 2007-04-27 | 2008-11-06 | Voyage Medical, Inc. | Complex shape steerable tissue visualization and manipulation catheter |
EP2150194B1 (en) | 2007-04-27 | 2012-09-12 | Tyco Healthcare Group LP | System for treating hollow anatomical structures |
US8579886B2 (en) * | 2007-05-01 | 2013-11-12 | Covidien Lp | Accordion style cable stand-off |
US8657805B2 (en) | 2007-05-08 | 2014-02-25 | Intuitive Surgical Operations, Inc. | Complex shape steerable tissue visualization and manipulation catheter |
WO2008141238A1 (en) | 2007-05-11 | 2008-11-20 | Voyage Medical, Inc. | Visual electrode ablation systems |
US8216218B2 (en) | 2007-07-10 | 2012-07-10 | Thermage, Inc. | Treatment apparatus and methods for delivering high frequency energy across large tissue areas |
US8702609B2 (en) * | 2007-07-27 | 2014-04-22 | Meridian Cardiovascular Systems, Inc. | Image-guided intravascular therapy catheters |
US8366706B2 (en) * | 2007-08-15 | 2013-02-05 | Cardiodex, Ltd. | Systems and methods for puncture closure |
WO2009028285A1 (en) * | 2007-08-28 | 2009-03-05 | Terumo Kabushiki Kaisha | Device for opening/closing biological tissue |
US8235985B2 (en) | 2007-08-31 | 2012-08-07 | Voyage Medical, Inc. | Visualization and ablation system variations |
US20090125023A1 (en) * | 2007-11-13 | 2009-05-14 | Cytyc Corporation | Electrosurgical Instrument |
US8292880B2 (en) | 2007-11-27 | 2012-10-23 | Vivant Medical, Inc. | Targeted cooling of deployable microwave antenna |
US8858609B2 (en) | 2008-02-07 | 2014-10-14 | Intuitive Surgical Operations, Inc. | Stent delivery under direct visualization |
US8157747B2 (en) * | 2008-02-15 | 2012-04-17 | Lary Research & Development, Llc | Single-use indicator for a surgical instrument and a surgical instrument incorporating same |
CA2903692A1 (en) * | 2008-04-01 | 2009-10-08 | Zevex, Inc. | Anti-free flow mechanism for enteral feeding pumps |
AU2009251680B2 (en) * | 2008-04-01 | 2015-04-09 | Zevex, Inc. | Safety occluder and method of use |
US8425470B2 (en) | 2008-04-01 | 2013-04-23 | Zevex, Inc. | Anti-free-flow mechanism for enteral feeding pumps |
US9770297B2 (en) * | 2008-06-04 | 2017-09-26 | Covidien Lp | Energy devices and methods for treating hollow anatomical structures |
US9101735B2 (en) | 2008-07-07 | 2015-08-11 | Intuitive Surgical Operations, Inc. | Catheter control systems |
US8333012B2 (en) | 2008-10-10 | 2012-12-18 | Voyage Medical, Inc. | Method of forming electrode placement and connection systems |
US8894643B2 (en) | 2008-10-10 | 2014-11-25 | Intuitive Surgical Operations, Inc. | Integral electrode placement and connection systems |
US9468364B2 (en) | 2008-11-14 | 2016-10-18 | Intuitive Surgical Operations, Inc. | Intravascular catheter with hood and image processing systems |
CN102271603A (en) | 2008-11-17 | 2011-12-07 | 明诺医学股份有限公司 | Selective accumulation of energy with or without knowledge of tissue topography |
US20100198209A1 (en) * | 2009-01-30 | 2010-08-05 | Tartaglia Joseph M | Hemorrhoid Therapy and Method |
US7998121B2 (en) * | 2009-02-06 | 2011-08-16 | Zevex, Inc. | Automatic safety occluder |
CN102686180B (en) * | 2009-11-04 | 2015-09-30 | 艾姆西森有限公司 | Intracavity remodeling device and method |
US8231619B2 (en) * | 2010-01-22 | 2012-07-31 | Cytyc Corporation | Sterilization device and method |
US8694071B2 (en) | 2010-02-12 | 2014-04-08 | Intuitive Surgical Operations, Inc. | Image stabilization techniques and methods |
US8728067B2 (en) * | 2010-03-08 | 2014-05-20 | Covidien Lp | Microwave antenna probe having a deployable ground plane |
US9814522B2 (en) | 2010-04-06 | 2017-11-14 | Intuitive Surgical Operations, Inc. | Apparatus and methods for ablation efficacy |
EP2555699B1 (en) | 2010-04-09 | 2019-04-03 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8550086B2 (en) | 2010-05-04 | 2013-10-08 | Hologic, Inc. | Radiopaque implant |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
USD672455S1 (en) | 2010-10-01 | 2012-12-11 | Zevex, Inc. | Fluid delivery cassette |
CN103298506B (en) | 2010-10-01 | 2016-05-04 | 泽维克斯公司 | Anti-free-pouring plugging device and infusion actuation pad |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
AU2012207357B2 (en) | 2011-01-19 | 2016-07-28 | Fractyl Health, Inc. | Devices and methods for the treatment of tissue |
WO2012161875A1 (en) | 2011-04-08 | 2012-11-29 | Tyco Healthcare Group Lp | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
EP2701623B1 (en) | 2011-04-25 | 2016-08-17 | Medtronic Ardian Luxembourg S.à.r.l. | Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
AU2012287189B2 (en) | 2011-07-22 | 2016-10-06 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
WO2013055815A1 (en) | 2011-10-11 | 2013-04-18 | Boston Scientific Scimed, Inc. | Off -wall electrode device for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
EP2768563B1 (en) | 2011-10-18 | 2016-11-09 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
EP2768568B1 (en) | 2011-10-18 | 2020-05-06 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
CN104023662B (en) | 2011-11-08 | 2018-02-09 | 波士顿科学西美德公司 | Hole portion renal nerve melts |
WO2013071293A1 (en) * | 2011-11-13 | 2013-05-16 | Nvision Medical Corporation | Device and process to confirm occlusion of the fallopian tube |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
EP3138521B1 (en) | 2011-12-23 | 2019-05-29 | Vessix Vascular, Inc. | Apparatuses for remodeling tissue of or adjacent to a body passage |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
KR102086184B1 (en) | 2012-02-27 | 2020-03-06 | 프랙틸 래브러토리스 인코포레이티드 | Heat ablation systems,devices and methods for the treatment of tissue |
KR102231179B1 (en) | 2012-04-19 | 2021-03-22 | 프랙틸 래브러토리스 인코포레이티드 | Tissue expansion devices, systems and methods |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US9878132B2 (en) | 2012-06-15 | 2018-01-30 | W. L. Gore & Associates, Inc. | Vascular occlusion and drug delivery devices, systems, and methods |
EP3714826A1 (en) | 2012-07-30 | 2020-09-30 | Fractyl Laboratories, Inc. | Electrical energy ablation systems and devices for the treatment of tissue |
EP2882362B1 (en) | 2012-08-09 | 2024-01-03 | Fractyl Health, Inc. | Ablation systems, devices and methods for the treatment of tissue |
WO2014032016A1 (en) | 2012-08-24 | 2014-02-27 | Boston Scientific Scimed, Inc. | Intravascular catheter with a balloon comprising separate microporous regions |
CN102784006B (en) * | 2012-08-24 | 2015-11-25 | 邹英华 | Be used for the treatment of hypertensive radio-frequency ablation electrode |
CN104780859B (en) | 2012-09-17 | 2017-07-25 | 波士顿科学西美德公司 | Self-positioning electrode system and method for renal regulation |
WO2014047454A2 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
WO2014047411A1 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US9433528B2 (en) | 2012-09-28 | 2016-09-06 | Zoll Circulation, Inc. | Intravascular heat exchange catheter with rib cage-like coolant path |
WO2014055997A1 (en) | 2012-10-05 | 2014-04-10 | Fractyl Laboratories Inc. | Methods, systems and devices for performing multiple treatments on a patient |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US8956340B2 (en) * | 2012-12-13 | 2015-02-17 | University Of South Florida | Urethral catheter assembly with a guide wire |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
EP2968919B1 (en) | 2013-03-15 | 2021-08-25 | Medtronic Ardian Luxembourg S.à.r.l. | Controlled neuromodulation systems |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
AU2014237950B2 (en) | 2013-03-15 | 2017-04-13 | Boston Scientific Scimed, Inc. | Control unit for use with electrode pads and a method for estimating an electrical leakage |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
EP3003461B1 (en) | 2013-06-04 | 2019-05-01 | Fractyl Laboratories, Inc. | Systems and devices for reducing the luminal surface area of the gastrointestinal tract |
WO2014205388A1 (en) | 2013-06-21 | 2014-12-24 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
WO2014205399A1 (en) | 2013-06-21 | 2014-12-24 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
EP3016605B1 (en) | 2013-07-01 | 2019-06-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
CN105377170A (en) | 2013-07-11 | 2016-03-02 | 波士顿科学国际有限公司 | Medical device with stretchable electrode assemblies |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
CN105682594B (en) | 2013-07-19 | 2018-06-22 | 波士顿科学国际有限公司 | Helical bipolar electrodes renal denervation dominates air bag |
CN109771100B (en) * | 2013-07-22 | 2021-07-16 | 梅约医学教育与研究基金会 | Device for self-centering a guide catheter |
WO2015013301A1 (en) | 2013-07-22 | 2015-01-29 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
WO2015013205A1 (en) | 2013-07-22 | 2015-01-29 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
EP4049605A1 (en) | 2013-08-22 | 2022-08-31 | Boston Scientific Scimed Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
CN105555218B (en) | 2013-09-04 | 2019-01-15 | 波士顿科学国际有限公司 | With radio frequency (RF) foley's tube rinsed with cooling capacity |
CN105530885B (en) | 2013-09-13 | 2020-09-22 | 波士顿科学国际有限公司 | Ablation balloon with vapor deposited covering |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
CN105636537B (en) | 2013-10-15 | 2018-08-17 | 波士顿科学国际有限公司 | Medical instrument sacculus |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
KR102284469B1 (en) | 2013-11-22 | 2021-08-02 | 프랙틸 헬쓰, 인코포레이티드 | Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract |
CN105899157B (en) | 2014-01-06 | 2019-08-09 | 波士顿科学国际有限公司 | Tear-proof flexible circuit assembly |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
CN106572881B (en) | 2014-02-04 | 2019-07-26 | 波士顿科学国际有限公司 | Substitution of the heat sensor on bipolar electrode is placed |
JP6332998B2 (en) * | 2014-02-28 | 2018-05-30 | オリンパス株式会社 | Atrial ligation instrument |
US10959774B2 (en) | 2014-03-24 | 2021-03-30 | Fractyl Laboratories, Inc. | Injectate delivery devices, systems and methods |
CN106659874B (en) | 2014-03-26 | 2021-01-05 | 文科罗斯公司 | Treatment of venous diseases |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US11185367B2 (en) | 2014-07-16 | 2021-11-30 | Fractyl Health, Inc. | Methods and systems for treating diabetes and related diseases and disorders |
WO2016011269A1 (en) | 2014-07-16 | 2016-01-21 | Fractyl Laboratories, Inc. | Methods and systems for treating diabetes and related diseases and disorders |
US9844641B2 (en) | 2014-07-16 | 2017-12-19 | Fractyl Laboratories, Inc. | Systems, devices and methods for performing medical procedures in the intestine |
US10206584B2 (en) | 2014-08-08 | 2019-02-19 | Medlumics S.L. | Optical coherence tomography probe for crossing coronary occlusions |
US10376308B2 (en) | 2015-02-05 | 2019-08-13 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure by splanchnic nerve ablation |
US11844615B2 (en) * | 2015-03-12 | 2023-12-19 | The Regents Of The University Of Michigan | Catheter and method to localize ectopic and reentrant activity in the heart |
CN105147389B (en) * | 2015-10-22 | 2018-03-16 | 上海魅丽纬叶医疗科技有限公司 | Include the radio frequency ablation device and its ablation method of balloon occlusion type guiding catheter |
EP3366246B1 (en) * | 2015-10-22 | 2023-06-28 | Shanghai Golden Leaf Med Tec Co., Ltd. | Radio frequency ablation device comprising balloon blocking catheter and ablation method therefor |
US11154354B2 (en) | 2016-07-29 | 2021-10-26 | Axon Therapies, Inc. | Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation |
CN109952062B (en) * | 2016-11-15 | 2022-05-10 | 皇家飞利浦有限公司 | Ultrasonic device contact |
US11497507B2 (en) | 2017-02-19 | 2022-11-15 | Orpheus Ventures, Llc | Systems and methods for closing portions of body tissue |
JP7082987B2 (en) * | 2017-04-05 | 2022-06-09 | ナショナル・ユニバーシティ・オブ・アイルランド・ガルウェイ | Implantable medical device |
US10492760B2 (en) | 2017-06-26 | 2019-12-03 | Andreas Hadjicostis | Image guided intravascular therapy catheter utilizing a thin chip multiplexor |
US11109909B1 (en) | 2017-06-26 | 2021-09-07 | Andreas Hadjicostis | Image guided intravascular therapy catheter utilizing a thin ablation electrode |
US10188368B2 (en) | 2017-06-26 | 2019-01-29 | Andreas Hadjicostis | Image guided intravascular therapy catheter utilizing a thin chip multiplexor |
CN107320175A (en) * | 2017-07-07 | 2017-11-07 | 中国人民解放军第八医院 | It is a kind of from light source RF coagulation tumor resection device |
US10561461B2 (en) | 2017-12-17 | 2020-02-18 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
US11751939B2 (en) | 2018-01-26 | 2023-09-12 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
EP4241836A3 (en) | 2019-06-20 | 2023-11-29 | Axon Therapies, Inc. | Devices for endovascular ablation of a splanchnic nerve |
US11413090B2 (en) | 2020-01-17 | 2022-08-16 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
Citations (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US373399A (en) * | 1887-11-15 | hamilton | ||
US659409A (en) * | 1900-08-25 | 1900-10-09 | Charles L Mosher | Electric bipolar dilator. |
US833759A (en) * | 1905-07-27 | 1906-10-23 | John D Sourwine | Surgical instrument. |
US985865A (en) * | 1910-06-29 | 1911-03-07 | William H Turner Jr | Embalming instrument. |
US3230957A (en) * | 1960-03-23 | 1966-01-25 | Philips Corp | High frequency therapeutic apparatus |
US3301258A (en) * | 1963-10-03 | 1967-01-31 | Medtronic Inc | Method and apparatus for treating varicose veins |
US3557794A (en) * | 1968-07-30 | 1971-01-26 | Us Air Force | Arterial dilation device |
US3920021A (en) * | 1973-05-16 | 1975-11-18 | Siegfried Hiltebrandt | Coagulating devices |
US4016886A (en) * | 1974-11-26 | 1977-04-12 | The United States Of America As Represented By The United States Energy Research And Development Administration | Method for localizing heating in tumor tissue |
US4043338A (en) * | 1973-04-30 | 1977-08-23 | Ortho Pharmaceutical Corporation | Pharmaceutical formulation applicator device |
US4119102A (en) * | 1975-07-11 | 1978-10-10 | Leveen Harry H | Radio frequency treatment of tumors while inducing hypotension |
US4154246A (en) * | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
US4312364A (en) * | 1977-04-08 | 1982-01-26 | C.G.R. Mev | Apparatus for localized heating of a living tissue, using electromagnetic waves of ultra high frequency, for medical applications |
US4436715A (en) * | 1981-09-14 | 1984-03-13 | Kms Fusion, Inc. | Storage and retrieval of singlet oxygen |
US4522205A (en) * | 1980-09-03 | 1985-06-11 | The University Court Of The University Of Edinburgh | Therapeutic device and method of inducing thrombosis in a blood vessel |
US4643186A (en) * | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
US4660571A (en) * | 1985-07-18 | 1987-04-28 | Cordis Corporation | Percutaneous lead having radially adjustable electrode |
US4664120A (en) * | 1986-01-22 | 1987-05-12 | Cordis Corporation | Adjustable isodiametric atrial-ventricular pervenous lead |
US4699147A (en) * | 1985-09-25 | 1987-10-13 | Cordis Corporation | Intraventricular multielectrode cardial mapping probe and method for using same |
US4709698A (en) * | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US4765331A (en) * | 1987-02-10 | 1988-08-23 | Circon Corporation | Electrosurgical device with treatment arc of less than 360 degrees |
US4776349A (en) * | 1985-10-04 | 1988-10-11 | Basem Nashef | Tubular device for the treatment of hollow organs with electric current |
US4807620A (en) * | 1987-05-22 | 1989-02-28 | Advanced Interventional Systems, Inc. | Apparatus for thermal angioplasty |
US4823812A (en) * | 1986-05-12 | 1989-04-25 | Biodan Medical Systems Ltd. | Applicator for insertion into a body opening for medical purposes |
US4945912A (en) * | 1988-11-25 | 1990-08-07 | Sensor Electronics, Inc. | Catheter with radiofrequency heating applicator |
US4966597A (en) * | 1988-11-04 | 1990-10-30 | Cosman Eric R | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
US4967711A (en) * | 1988-07-29 | 1990-11-06 | Fuji Jukogyo Kabushiki Kaisha | Fuel injection control system for automotive engine |
US4979948A (en) * | 1989-04-13 | 1990-12-25 | Purdue Research Foundation | Method and apparatus for thermally destroying a layer of an organ |
US5010894A (en) * | 1988-01-07 | 1991-04-30 | Edhag Knut O | Intravascular electrode lead usable for cardiac defibrillation |
US5057107A (en) * | 1989-04-13 | 1991-10-15 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5078717A (en) * | 1989-04-13 | 1992-01-07 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5117828A (en) * | 1989-09-25 | 1992-06-02 | Arzco Medical Electronics, Inc. | Expandable esophageal catheter |
US5122137A (en) * | 1990-04-27 | 1992-06-16 | Boston Scientific Corporation | Temperature controlled rf coagulation |
US5156151A (en) * | 1991-02-15 | 1992-10-20 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe |
US5188602A (en) * | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5215103A (en) * | 1986-11-14 | 1993-06-01 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US5255678A (en) * | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5263493A (en) * | 1992-02-24 | 1993-11-23 | Boaz Avitall | Deflectable loop electrode array mapping and ablation catheter for cardiac chambers |
US5275610A (en) * | 1991-05-13 | 1994-01-04 | Cook Incorporated | Surgical retractors and method of use |
US5282845A (en) * | 1990-10-01 | 1994-02-01 | Ventritex, Inc. | Multiple electrode deployable lead |
US5293869A (en) * | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
US5383917A (en) * | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
US5397339A (en) * | 1986-11-14 | 1995-03-14 | Desai; Jawahar M. | Catheter for mapping and ablation and method therefor |
US5405322A (en) * | 1993-08-12 | 1995-04-11 | Boston Scientific Corporation | Method for treating aneurysms with a thermal source |
US5409000A (en) * | 1993-09-14 | 1995-04-25 | Cardiac Pathways Corporation | Endocardial mapping and ablation system utilizing separately controlled steerable ablation catheter with ultrasonic imaging capabilities and method |
US5411025A (en) * | 1992-06-30 | 1995-05-02 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array |
US5423815A (en) * | 1994-01-25 | 1995-06-13 | Fugo; Richard J. | Method of ocular refractive surgery |
US5437664A (en) * | 1994-01-18 | 1995-08-01 | Endovascular, Inc. | Apparatus and method for venous ligation |
US5449381A (en) * | 1991-02-15 | 1995-09-12 | Cardiac Pathways Corp | Endocardial catheter for defibrillation, cardioversion and pacing, and a system and method utilizing the same |
US5458596A (en) * | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
US5465717A (en) * | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
US5472441A (en) * | 1993-11-08 | 1995-12-05 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5505730A (en) * | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5514130A (en) * | 1994-10-11 | 1996-05-07 | Dorsal Med International | RF apparatus for controlled depth ablation of soft tissue |
US5545161A (en) * | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
US5556396A (en) * | 1994-01-18 | 1996-09-17 | Endovascular, Inc. | Method for tubal electroligation |
US5709224A (en) * | 1995-06-07 | 1998-01-20 | Radiotherapeutics Corporation | Method and device for permanent vessel occlusion |
US5810804A (en) * | 1995-08-15 | 1998-09-22 | Rita Medical Systems | Multiple antenna ablation apparatus and method with cooling element |
US5817092A (en) * | 1995-11-09 | 1998-10-06 | Radio Therapeutics Corporation | Apparatus, system and method for delivering radio frequency energy to a treatment site |
US5827268A (en) * | 1996-10-30 | 1998-10-27 | Hearten Medical, Inc. | Device for the treatment of patent ductus arteriosus and method of using the device |
US5863290A (en) * | 1995-08-15 | 1999-01-26 | Rita Medical Systems | Multiple antenna ablation apparatus and method |
US5868740A (en) * | 1995-03-24 | 1999-02-09 | Board Of Regents-Univ Of Nebraska | Method for volumetric tissue ablation |
US5872268A (en) * | 1995-12-13 | 1999-02-16 | Mitsubishi Chemical Corporation | Process for preparing salt of fatty acid ester of hydroxycarboxylic |
US5916235A (en) * | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US5951547A (en) * | 1995-08-15 | 1999-09-14 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5964753A (en) * | 1993-10-14 | 1999-10-12 | Ep Technologies, Inc. | Integrated cardiac mapping and ablation probe |
US6036687A (en) * | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US6139527A (en) * | 1996-03-05 | 2000-10-31 | Vnus Medical Technologies, Inc. | Method and apparatus for treating hemorrhoids |
US6401719B1 (en) * | 1997-09-11 | 2002-06-11 | Vnus Medical Technologies, Inc. | Method of ligating hollow anatomical structures |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US373339A (en) | 1887-11-15 | Isidobe eskell cliffoed | ||
US4043339A (en) | 1976-02-02 | 1977-08-23 | The Upjohn Company | Method of and vaginal insert for prostaglandin administration |
US4346715A (en) | 1978-07-12 | 1982-08-31 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hyperthermia heating apparatus |
US4564011A (en) * | 1982-03-22 | 1986-01-14 | Leon Goldman | Laser optic device and method |
US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
EP0189329A3 (en) | 1985-01-25 | 1987-06-03 | Robert E. Fischell | A tunneling catheter system for transluminal arterial angioplasty |
DE3516830A1 (en) | 1985-05-10 | 1986-11-13 | Max Dr. 8520 Erlangen Hubmann | CATHETER |
US5779698A (en) * | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
US4976711A (en) | 1989-04-13 | 1990-12-11 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5022399A (en) * | 1989-05-10 | 1991-06-11 | Biegeleisen Ken P | Venoscope |
US5178618A (en) | 1991-01-16 | 1993-01-12 | Brigham And Womens Hospital | Method and device for recanalization of a body passageway |
US5277201A (en) | 1992-05-01 | 1994-01-11 | Vesta Medical, Inc. | Endometrial ablation apparatus and method |
WO1994007446A1 (en) | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
WO1994021170A1 (en) | 1993-03-16 | 1994-09-29 | Ep Technologies, Inc. | Flexible circuit assemblies employing ribbon cable |
DE4320532C1 (en) | 1993-06-21 | 1994-09-08 | Siemens Ag | Dental turbine drive with means for automatic speed control |
WO1995010322A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Creating complex lesion patterns in body tissue |
WO1995010236A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | System for making long thin lesions |
US5683384A (en) | 1993-11-08 | 1997-11-04 | Zomed | Multiple antenna ablation apparatus |
US5531739A (en) * | 1994-09-23 | 1996-07-02 | Coherent, Inc. | Method of treating veins |
US5722401A (en) | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
EP0738501B1 (en) | 1994-11-02 | 2000-05-24 | Olympus Optical Co., Ltd. | Endoscope operative instrument |
IT1278372B1 (en) | 1995-02-15 | 1997-11-20 | Sorin Biomedica Cardio Spa | CATHETER, PARTICULARLY FOR THE TREATMENT OF HEART ARRHYTHMIA. |
CA2197065A1 (en) | 1995-04-20 | 1996-10-24 | Jawahar M. Desai | Apparatus for cardiac ablation |
US6090105A (en) * | 1995-08-15 | 2000-07-18 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus and method |
AU733465B2 (en) * | 1996-03-05 | 2001-05-17 | Tyco Healthcare Group, Lp | Vascular catheter-based system for heating tissue |
US6077257A (en) * | 1996-05-06 | 2000-06-20 | Vidacare, Inc. | Ablation of rectal and other internal body structures |
US6091995A (en) | 1996-11-08 | 2000-07-18 | Surx, Inc. | Devices, methods, and systems for shrinking tissues |
US6666858B2 (en) * | 2001-04-12 | 2003-12-23 | Scimed Life Systems, Inc. | Cryo balloon for atrial ablation |
-
1998
- 1998-08-21 US US09/138,808 patent/US6401719B1/en not_active Expired - Lifetime
- 1998-09-11 CA CA002303021A patent/CA2303021C/en not_active Expired - Fee Related
- 1998-09-11 EP EP98948228A patent/EP1035796A2/en not_active Ceased
- 1998-09-11 JP JP2000510391A patent/JP4131609B2/en not_active Expired - Fee Related
- 1998-09-11 AU AU94845/98A patent/AU740000B2/en not_active Ceased
- 1998-09-11 RU RU2000106049/14A patent/RU2207822C2/en not_active IP Right Cessation
- 1998-09-11 PL PL98339518A patent/PL339518A1/en unknown
- 1998-09-11 NZ NZ503367A patent/NZ503367A/en not_active IP Right Cessation
- 1998-09-11 WO PCT/US1998/019181 patent/WO1999012489A2/en active IP Right Grant
- 1998-09-11 CN CNB988110210A patent/CN1154447C/en not_active Expired - Fee Related
- 1998-09-11 BR BR9814738-2A patent/BR9814738A/en not_active IP Right Cessation
- 1998-09-11 IL IL13500898A patent/IL135008A0/en active IP Right Grant
-
2000
- 2000-02-03 US US09/497,278 patent/US6689126B1/en not_active Expired - Fee Related
- 2000-02-03 US US09/497,099 patent/US6398780B1/en not_active Expired - Lifetime
- 2000-03-10 NO NO20001267A patent/NO328108B1/en not_active IP Right Cessation
-
2002
- 2002-06-03 US US10/162,057 patent/US7041098B2/en not_active Expired - Fee Related
- 2002-06-07 US US10/164,928 patent/US20020148476A1/en not_active Abandoned
-
2004
- 2004-02-09 US US10/775,841 patent/US20040162555A1/en not_active Abandoned
Patent Citations (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US373399A (en) * | 1887-11-15 | hamilton | ||
US659409A (en) * | 1900-08-25 | 1900-10-09 | Charles L Mosher | Electric bipolar dilator. |
US833759A (en) * | 1905-07-27 | 1906-10-23 | John D Sourwine | Surgical instrument. |
US985865A (en) * | 1910-06-29 | 1911-03-07 | William H Turner Jr | Embalming instrument. |
US3230957A (en) * | 1960-03-23 | 1966-01-25 | Philips Corp | High frequency therapeutic apparatus |
US3301258A (en) * | 1963-10-03 | 1967-01-31 | Medtronic Inc | Method and apparatus for treating varicose veins |
US3557794A (en) * | 1968-07-30 | 1971-01-26 | Us Air Force | Arterial dilation device |
US4043338A (en) * | 1973-04-30 | 1977-08-23 | Ortho Pharmaceutical Corporation | Pharmaceutical formulation applicator device |
US3920021A (en) * | 1973-05-16 | 1975-11-18 | Siegfried Hiltebrandt | Coagulating devices |
US4016886A (en) * | 1974-11-26 | 1977-04-12 | The United States Of America As Represented By The United States Energy Research And Development Administration | Method for localizing heating in tumor tissue |
US4119102A (en) * | 1975-07-11 | 1978-10-10 | Leveen Harry H | Radio frequency treatment of tumors while inducing hypotension |
US4312364A (en) * | 1977-04-08 | 1982-01-26 | C.G.R. Mev | Apparatus for localized heating of a living tissue, using electromagnetic waves of ultra high frequency, for medical applications |
US4154246A (en) * | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
US4522205A (en) * | 1980-09-03 | 1985-06-11 | The University Court Of The University Of Edinburgh | Therapeutic device and method of inducing thrombosis in a blood vessel |
US4436715A (en) * | 1981-09-14 | 1984-03-13 | Kms Fusion, Inc. | Storage and retrieval of singlet oxygen |
US4660571A (en) * | 1985-07-18 | 1987-04-28 | Cordis Corporation | Percutaneous lead having radially adjustable electrode |
US4699147A (en) * | 1985-09-25 | 1987-10-13 | Cordis Corporation | Intraventricular multielectrode cardial mapping probe and method for using same |
US4776349A (en) * | 1985-10-04 | 1988-10-11 | Basem Nashef | Tubular device for the treatment of hollow organs with electric current |
US4643186A (en) * | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
US4664120A (en) * | 1986-01-22 | 1987-05-12 | Cordis Corporation | Adjustable isodiametric atrial-ventricular pervenous lead |
US4823812A (en) * | 1986-05-12 | 1989-04-25 | Biodan Medical Systems Ltd. | Applicator for insertion into a body opening for medical purposes |
US4709698A (en) * | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US5215103A (en) * | 1986-11-14 | 1993-06-01 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US5397339A (en) * | 1986-11-14 | 1995-03-14 | Desai; Jawahar M. | Catheter for mapping and ablation and method therefor |
US4765331A (en) * | 1987-02-10 | 1988-08-23 | Circon Corporation | Electrosurgical device with treatment arc of less than 360 degrees |
US4807620A (en) * | 1987-05-22 | 1989-02-28 | Advanced Interventional Systems, Inc. | Apparatus for thermal angioplasty |
US5010894A (en) * | 1988-01-07 | 1991-04-30 | Edhag Knut O | Intravascular electrode lead usable for cardiac defibrillation |
US4967711A (en) * | 1988-07-29 | 1990-11-06 | Fuji Jukogyo Kabushiki Kaisha | Fuel injection control system for automotive engine |
US4966597A (en) * | 1988-11-04 | 1990-10-30 | Cosman Eric R | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
US4945912A (en) * | 1988-11-25 | 1990-08-07 | Sensor Electronics, Inc. | Catheter with radiofrequency heating applicator |
US4979948A (en) * | 1989-04-13 | 1990-12-25 | Purdue Research Foundation | Method and apparatus for thermally destroying a layer of an organ |
US5057107A (en) * | 1989-04-13 | 1991-10-15 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5078717A (en) * | 1989-04-13 | 1992-01-07 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5117828A (en) * | 1989-09-25 | 1992-06-02 | Arzco Medical Electronics, Inc. | Expandable esophageal catheter |
US5122137A (en) * | 1990-04-27 | 1992-06-16 | Boston Scientific Corporation | Temperature controlled rf coagulation |
US5188602A (en) * | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5282845A (en) * | 1990-10-01 | 1994-02-01 | Ventritex, Inc. | Multiple electrode deployable lead |
US5156151A (en) * | 1991-02-15 | 1992-10-20 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe |
US5465717A (en) * | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
US5449381A (en) * | 1991-02-15 | 1995-09-12 | Cardiac Pathways Corp | Endocardial catheter for defibrillation, cardioversion and pacing, and a system and method utilizing the same |
US5275610A (en) * | 1991-05-13 | 1994-01-04 | Cook Incorporated | Surgical retractors and method of use |
US5255678A (en) * | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5383917A (en) * | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
US5263493A (en) * | 1992-02-24 | 1993-11-23 | Boaz Avitall | Deflectable loop electrode array mapping and ablation catheter for cardiac chambers |
US5411025A (en) * | 1992-06-30 | 1995-05-02 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array |
US5293869A (en) * | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
US5545161A (en) * | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
US5405322A (en) * | 1993-08-12 | 1995-04-11 | Boston Scientific Corporation | Method for treating aneurysms with a thermal source |
US5409000A (en) * | 1993-09-14 | 1995-04-25 | Cardiac Pathways Corporation | Endocardial mapping and ablation system utilizing separately controlled steerable ablation catheter with ultrasonic imaging capabilities and method |
US5964753A (en) * | 1993-10-14 | 1999-10-12 | Ep Technologies, Inc. | Integrated cardiac mapping and ablation probe |
US5472441A (en) * | 1993-11-08 | 1995-12-05 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5437664A (en) * | 1994-01-18 | 1995-08-01 | Endovascular, Inc. | Apparatus and method for venous ligation |
US5556396A (en) * | 1994-01-18 | 1996-09-17 | Endovascular, Inc. | Method for tubal electroligation |
US5423815A (en) * | 1994-01-25 | 1995-06-13 | Fugo; Richard J. | Method of ocular refractive surgery |
US5458596A (en) * | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
US5505730A (en) * | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5514130A (en) * | 1994-10-11 | 1996-05-07 | Dorsal Med International | RF apparatus for controlled depth ablation of soft tissue |
US5868740A (en) * | 1995-03-24 | 1999-02-09 | Board Of Regents-Univ Of Nebraska | Method for volumetric tissue ablation |
US5709224A (en) * | 1995-06-07 | 1998-01-20 | Radiotherapeutics Corporation | Method and device for permanent vessel occlusion |
US5951547A (en) * | 1995-08-15 | 1999-09-14 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5810804A (en) * | 1995-08-15 | 1998-09-22 | Rita Medical Systems | Multiple antenna ablation apparatus and method with cooling element |
US5863290A (en) * | 1995-08-15 | 1999-01-26 | Rita Medical Systems | Multiple antenna ablation apparatus and method |
US5817092A (en) * | 1995-11-09 | 1998-10-06 | Radio Therapeutics Corporation | Apparatus, system and method for delivering radio frequency energy to a treatment site |
US5872268A (en) * | 1995-12-13 | 1999-02-16 | Mitsubishi Chemical Corporation | Process for preparing salt of fatty acid ester of hydroxycarboxylic |
US6036687A (en) * | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US6139527A (en) * | 1996-03-05 | 2000-10-31 | Vnus Medical Technologies, Inc. | Method and apparatus for treating hemorrhoids |
US5827268A (en) * | 1996-10-30 | 1998-10-27 | Hearten Medical, Inc. | Device for the treatment of patent ductus arteriosus and method of using the device |
US5916235A (en) * | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US6401719B1 (en) * | 1997-09-11 | 2002-06-11 | Vnus Medical Technologies, Inc. | Method of ligating hollow anatomical structures |
Cited By (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8316853B2 (en) | 2004-02-25 | 2012-11-27 | Femasys Inc. | Method and devices for conduit occlusion |
US8052669B2 (en) | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US10292732B2 (en) | 2004-02-25 | 2019-05-21 | Femasys, Inc. | Methods and devices for conduit occlusion |
US10111687B2 (en) | 2004-02-25 | 2018-10-30 | Femasys, Inc. | Methods and devices for conduit occlusion |
US9839444B2 (en) | 2004-02-25 | 2017-12-12 | Femasys Inc. | Methods and devices for conduit occlusion |
US9238127B2 (en) | 2004-02-25 | 2016-01-19 | Femasys Inc. | Methods and devices for delivering to conduit |
US9402762B2 (en) | 2004-02-25 | 2016-08-02 | Femasys Inc. | Methods and devices for conduit occlusion |
US9034053B2 (en) | 2004-02-25 | 2015-05-19 | Femasys Inc. | Methods and devices for conduit occlusion |
US8336552B2 (en) | 2004-02-25 | 2012-12-25 | Femasys Inc. | Methods and devices for conduit occlusion |
US8324193B2 (en) | 2004-02-25 | 2012-12-04 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US9308023B2 (en) | 2004-02-25 | 2016-04-12 | Femasys Inc. | Methods and devices for conduit occlusion |
US8048101B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US8048086B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US11779372B2 (en) | 2004-02-25 | 2023-10-10 | Femasys Inc. | Methods and devices for conduit occlusion |
US8726906B2 (en) | 2004-02-25 | 2014-05-20 | Femasys Inc. | Methods and devices for conduit occlusion |
US8695606B2 (en) | 2004-02-25 | 2014-04-15 | Femasys Inc. | Methods and devices for conduit occlusion |
US8316854B2 (en) | 2004-02-25 | 2012-11-27 | Femasys Inc. | Methods and devices for conduit occlusion |
US9220880B2 (en) | 2004-02-25 | 2015-12-29 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US6964274B1 (en) | 2004-06-07 | 2005-11-15 | Ethicon, Inc. | Tubal sterilization device having expanding electrodes and method for performing sterilization using the same |
US7250050B2 (en) | 2004-06-07 | 2007-07-31 | Ethicon, Inc. | Tubal sterilization device having sesquipolar electrodes and method for performing sterilization using the same |
US8721639B2 (en) | 2004-08-05 | 2014-05-13 | Covidien Lp | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US7824408B2 (en) | 2004-08-05 | 2010-11-02 | Tyco Healthcare Group, Lp | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US20060030849A1 (en) * | 2004-08-05 | 2006-02-09 | Vnus Medical Technologies, Inc. | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US8357157B2 (en) | 2004-08-05 | 2013-01-22 | Covidien Lp | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US8083738B2 (en) | 2004-08-05 | 2011-12-27 | Tyco Healthcare Group Lp | Method and apparatus for coagulating and/or constricting hollow anatomical structures |
US8486063B2 (en) | 2004-10-14 | 2013-07-16 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US20060089637A1 (en) * | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US9642675B2 (en) | 2004-10-14 | 2017-05-09 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US20060189967A1 (en) * | 2005-02-21 | 2006-08-24 | Leonardo Masotti | Device, a catheter, and a method for the curative treatment of varicose veins |
US8361061B2 (en) | 2005-02-23 | 2013-01-29 | Covidien Lp | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US8795266B2 (en) | 2005-02-23 | 2014-08-05 | Covidien Lp | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US20060189979A1 (en) * | 2005-02-23 | 2006-08-24 | Esch Brady D | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US7625372B2 (en) | 2005-02-23 | 2009-12-01 | Vnus Medical Technologies, Inc. | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US20130012940A1 (en) * | 2005-05-13 | 2013-01-10 | Kai Desinger | Flexible application device for the high-frequency treatment of biological tissue |
US20090156981A1 (en) * | 2006-10-04 | 2009-06-18 | Celon Ag Medical Instruments | Flexible Catheter for High-Frequency Therapy of Biological Tissue and Method of Using Same |
US9750564B2 (en) * | 2006-10-04 | 2017-09-05 | Celon Ag Medical Instruments | Flexible catheter for high-frequency therapy of biological tissue and method of using same |
US9474566B2 (en) | 2006-12-29 | 2016-10-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Fabric electrode head |
US20080161893A1 (en) * | 2006-12-29 | 2008-07-03 | Saurav Paul | Fabric electrode head |
WO2008083108A3 (en) * | 2006-12-29 | 2008-09-25 | St Jude Medical Atrial Fibrill | Fabric electrode head |
US10172643B2 (en) | 2008-10-03 | 2019-01-08 | Femasys, Inc. | Contrast agent generation and injection system for sonographic imaging |
US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
US10258375B2 (en) | 2008-10-03 | 2019-04-16 | Femasys, Inc. | Methods and devices for sonographic imaging |
US11154326B2 (en) | 2008-10-03 | 2021-10-26 | Femasys Inc. | Methods and devices for sonographic imaging |
US11648033B2 (en) | 2008-10-03 | 2023-05-16 | Femasys Inc. | Methods and devices for sonographic imaging |
US9616246B2 (en) | 2010-01-04 | 2017-04-11 | Covidien Lp | Apparatus and methods for treating hollow anatomical structures |
US8936631B2 (en) | 2010-01-04 | 2015-01-20 | Covidien Lp | Apparatus and methods for treating hollow anatomical structures |
US10537286B2 (en) * | 2013-01-08 | 2020-01-21 | Biosense Webster (Israel) Ltd. | Catheter with multiple spines of different lengths arranged in one or more distal assemblies |
US20140194716A1 (en) * | 2013-01-08 | 2014-07-10 | Biosense Webster (Israel), Ltd. | Catheter with multiple spines of different lengths arranged in one or more distal assemblies |
Also Published As
Publication number | Publication date |
---|---|
CA2303021A1 (en) | 1999-03-18 |
US7041098B2 (en) | 2006-05-09 |
AU9484598A (en) | 1999-03-29 |
CN1278711A (en) | 2001-01-03 |
AU740000B2 (en) | 2001-10-25 |
US20020147445A1 (en) | 2002-10-10 |
BR9814738A (en) | 2000-10-10 |
WO1999012489A3 (en) | 1999-06-17 |
US6401719B1 (en) | 2002-06-11 |
RU2207822C2 (en) | 2003-07-10 |
US20040162555A1 (en) | 2004-08-19 |
IL135008A0 (en) | 2001-05-20 |
NO20001267D0 (en) | 2000-03-10 |
US6398780B1 (en) | 2002-06-04 |
NO20001267L (en) | 2000-05-09 |
NZ503367A (en) | 2003-01-31 |
JP4131609B2 (en) | 2008-08-13 |
US6689126B1 (en) | 2004-02-10 |
WO1999012489A2 (en) | 1999-03-18 |
NO328108B1 (en) | 2009-12-07 |
JP2001515752A (en) | 2001-09-25 |
PL339518A1 (en) | 2000-12-18 |
EP1035796A2 (en) | 2000-09-20 |
CA2303021C (en) | 2006-05-30 |
CN1154447C (en) | 2004-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6401719B1 (en) | Method of ligating hollow anatomical structures | |
US8267931B2 (en) | Method of ligating hollow anatomical structures | |
US6682526B1 (en) | Expandable catheter having two sets of electrodes, and method of use | |
US6258084B1 (en) | Method for applying energy to biological tissue including the use of tumescent tissue compression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |